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3 Abstract 
Microsatellites are a ubiquitous feature of eukaryotic genomes.  Simply defined, they 
are consecutive repeats of a short DNA motif.  Microsatellites are among the least stable 
DNA regions in many genomes, primarily due to their unique mutation mechanism.  
Microsatellites are a useful tool in genetic analyses, a source of phenotypic variation, and a 
contributor to the etiology of many severe human diseases. 
Until recently, microsatellite genotyping methods have been unable to leverage the 
dramatic advances in DNA sequencing technology to enable genome-wide genotyping.  
While there are some existing methods that call microsatellite genotypes from high 
throughput sequencing data, none have sufficient accuracy to identify de novo mutations 
(Gymrek et al. 2012; Highnam et al. 2013).  This is particularly important in analyzing the 
role of microsatellite mutations in human diseases that may be caused by de novo mutations. 
We have developed the uSeq pipeline to call microsatellite genotypes in sequencing 
data from large study populations.  This pipeline detects, aligns and filters reads with 
microsatellites and then assembles microsatellite profiles for each individual in the study.  By 
considering the wealth of information available from the population at a single microsatellite 
locus, uSeq infers individual-, locus-, and allele-specific parameters that allow for highly 
accurate genotypes and specific identification of de novo mutations.   
We have applied the uSeq pipeline to exome sequencing data from the Simons 
Simplex Collection of families with autism.  De novo mutations are known to play a 
significant role in the incidence of autism and autism spectrum disorders, particularly in the 
sporadic cases enriched for in the SSC (Sebat et al. 2007; Zhao et al. 2007; Levy et al. 2011; 
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Iossifov et al. 2012; Neale et al. 2012; O'Roak et al. 2012b; Sanders et al. 2012).  We are able 
to identify microsatellite de novo mutations in this population with >90% specificity, which 
is on par with traditional microsatellite genotyping methods such as capillary electrophoresis 
or Sanger sequencing.  In analyzing these mutations, we observe that children with autism 
are more likely to have de novo microsatellite insertions in exons than their siblings (p = 
0.03).  Although not statistically significant, we also observe several frameshift mutations in 
children with autism, while we observe none in their siblings.  We have developed a novel 
and highly accurate microsatellite genotyping method and have used it to demonstrate a 
potential role for de novo microsatellite mutations in autism incidence.  It is reasonable to 
expect that microsatellite polymorphism and de novo mutations play a much larger role in 
human disease than what is currently known. 
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4 Introduction 
4.1 Microsatellites 
4.1.1 Microsatellite traits 
4.1.1.1 Basic microsatellite characteristics 
Several features define any microsatellite locus.  Every microsatellite is composed of 
a short, repeated motif, which is described by its composition and length.  In most genome-
wide microsatellite studies, all motif compositions are considered, and only motif length is 
limited.  Typically, any repeated tract with a motif length between 1 and 6 bp is considered to 
be a microsatellite (Ellegren 2004).  Motifs can be combined into “equivalence classes”.  A 
microsatellite equivalence class is defined by all circular shifts of a microsatellite motif and 
its reverse complement.  Within this framework, an AC motif is equivalent to CA, TG, and 
GT motifs. 
In addition to its constituent motif, a microsatellite tract has three other 
characteristics.  The repeat number is the number of times a motif is repeated within a 
microsatellite tract, which can be a non-integer.  The tract length is the length of the 
microsatellite tract in base pairs.  This is simply obtained by multiplying the tract’s motif 
length and repeat number.  Finally, the microsatellite tract is defined by its sequence identity.  
An uninterrupted microsatellite tract contains no interrupting SNPs or indels and therefore 
has perfect sequence identity.  As interruptions are introduced, the sequence identity of a 
microsatellite tract decreases. 
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Microsatellites can also be defined relative to the reference genome.  The 
chromosome, start coordinate, and stop coordinate provide the location of a microsatellite 
within the reference genome.  Microsatellite genomic coordinates can be compared to 
coordinates for other relevant genomic features—such as exon positions—to understand 
microsatellite tracts in context.  In this work, when we refer to multiple alleles at the same 
locus, we specify a microsatellite tract’s location by its chromosome and start coordinate. 
4.1.1.2 A brief history of microsatellites 
One of the first descriptions of microsatellites was inferred from amino acid 
sequences soon after the genetic code was completely defined (Khorana et al. 1966).  By 
screening trypsin-digested T4 phage-borne lysozyme in bacteria for pseudowild double 
frameshift mutations, codons for the frameshift mutants could be inferred.  In many double 
mutants examined, frameshift mutations occurred in a region with repeated 1 and 2 bp motifs 
by the insertion or deletion of a single motif.  Although the mutated DNA sequence was 
inferred from amino acid codons, the authors suggested that codons containing repeated 
sequences, i.e. microsatellites, could be mutational hotspots (Streisinger et al. 1966). 
Microsatellites were also observed in density gradient centrifugation experiments in 
the early 1970s (see, for example, Skinner and Beattie 1973).  In a typical centrifugation 
experiment, cesium salt density gradients resolved “satellite” bands distinct from the bulk of 
genomic DNA.  As different cesium salt-based solutions were studied, scientists realized that 
the behavior of satellite DNA bands were dependent on DNA sequence.  Careful analysis led 
to the observation that some density gradients were indicative of large DNA polymers 
composed of repeated short sequences (Skinner and Beattie 1973).  These initials 
observations are also the source of the term “microsatellite”.  Throughout the literature, 
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microsatellites have also been referred to as SSRs or STRs.  Along with minisatellites, they 
also comprise VNTR loci. 
In the 1980s, DNA sequencing of several loci—including the region between human 
δ and β globin genes and the cardiac muscle actin gene—led to first direct observations of 
AC microsatellites (Miesfeld et al. 1981; Hamada et al. 1982a).  Concurrently, Southern blot 
hybridizations using AC fragments revealed that these repeats were ubiquitous in the human 
genome as well as many other eukaryotic genomes (Miesfeld et al. 1981; Hamada and 
Kakunaga 1982; Hamada et al. 1982b; Jeang and Hayward 1983).  The prevalence of AC 
microsatellites throughout multiple genomes was initially assumed to be due to evolutionary 
conservation, which suggested a special function for these repeats (Hamada et al. 1982b).  
Some early studies sought to ascribe particular importance to AC microsatellites since they 
could adopt a Z-DNA conformation in vitro, as opposed to the more common B-DNA 
conformation.  The apparent conservation of AC microsatellites and their ability to adopt 
novel conformations in vitro led some scientists to believe that AC microsatellites—and 
perhaps all sequences capable of adopting the Z-DNA conformation—played a role in 
mutational hotspots, recombination, and gene regulation (Hamada and Kakunaga 1982; 
Hamada et al. 1982b).  Subsequent studies demonstrated that AC microsatellites modulated 
gene expression, which reinforced these assumptions.  Although CG microsatellites could 
also adopt the Z-DNA conformation in vitro, they did not seem to modulate gene 
expression—this discrepancy was attributed to structural differences favoring interactions 
with AC microsatellites (Hamada et al. 1984). 
While some researchers were attempting to attribute specific functions to AC 
microsatellites, others were beginning to realize that many microsatellite motifs were 
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ubiquitous in eukaryotic genomes.  Southern blots using A, G, AG, AC, and ACG 
microsatellite probes showed that each of these tracts could be found in phylogenetically 
diverse eukaryotic organisms.  Based on these observations, microsatellite tracts were 
proposed to be a result of stochastic indel and recombination mutations.  These mechanisms 
implied no conserved evolutionary role for microsatellites—ubiquitous AC tracts had no 
direct influence on gene expression (Tautz and Renz 1984). 
As the decade progressed, evidence accumulated that microsatellites were an 
abundant DNA class within eukaryotic genomes.  Microsatellite genomic frequency was 
significantly higher throughout eukaryotic genomes than would be expected by chance.  The 
same was not true in prokaryotic, organellar, or viral genomes (Tautz et al. 1986).  The 
abundance of eukaryotic microsatellite tracts necessitated a mechanism that could explain 
their emergence.  Possible mechanisms for microsatellite emergence are discussed in the 
following section. 
Microsatellites were also observed to undergo frequent frameshift mutations, 
pinpointing microsatellites as mutational hotspots within eukaryotic genomes.  Among the 
first direct observations of this instability was in early studies of spontaneous frameshift 
mutations in the Escherichia coli lacI gene, which were found to cluster in a CTGG 
microsatellite (Farabaugh et al. 1978).  A more in depth study of frameshift mutation 
characteristics in E. coli nearly a decade later studied an in-frame 40 bp AC microsatellite 
inserted in the lacZ gene.  Frameshift mutations were observed in almost 1.2% of E. coli 
plaques.  Mutation frequency rose in E. coli strains without functional methyl-directed MMR 
proteins, but remained unchanged in E. coli strains with impaired recombination machinery 
(Levinson and Gutman 1987a). 
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Evidence that microsatellites might be unstable in humans came soon after initial 
observations of microsatellite instability in E. coli.  Once PCR techniques using thermostable 
DNA polymerase had been developed, the same tools were almost immediately adapted for 
studies of microsatellite loci (Saiki et al. 1988).  A study of 10 AC microsatellite loci within 
a population of unrelated individuals and multi-generational families revealed polymorphism 
at every locus assayed (Weber and May 1989).  Another study of the intronic microsatellite 
in the cardiac muscle actin gene first described by Hamada and Kakunga produced similar 
results in a multi-generational family pedigree and in unrelated individuals (Litt and Luty 
1989).   
The publications of Litt and Luty and Weber and May provided two important 
breakthroughs—microsatellites were polymorphic in human populations and they could be 
easily isolated for genotyping using PCR.  These findings led to an explosion in 
microsatellite research.  Scientists began studying the factors influencing microsatellite 
stability and their applications to various genomic analyses.  Microsatellites are currently the 
DNA sequence of choice for forensic science; are still used in genetic linkage studies; and 
have proven invaluable in understanding the genetic history of many species.  Microsatellite 
polymorphisms can also have dramatic phenotypic effects.  Microsatellite mutations have 
been linked to several neurodegenerative diseases and cancer, and have been shown to affect 
behavior in prairie voles and facial morphology in domesticated dogs.  In the rest of this 
section, we discuss the many facets of microsatellite research that emerged from these initial 
studies. 
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4.1.1.3 The birth of a microsatellite locus 
Although microsatellites are prevalent throughout eukaryotic genomes, there does not 
appear to be a single process by which they emerge.  One theory of microsatellite emergence 
relies on the observation that non-repetitive sequences between nearby direct repeats tend to 
be preferentially deleted via replication slippage, which would then create a tandemly 
repeated sequence.  This tandem repeat could then undergo further replication slippage, 
creating a microsatellite locus.  This could account for the microsatellite emergence in 
regions under no selective constraint (Levinson and Gutman 1987b). 
Based on observations of two separate microsatellites in the primate η-globin 
pseudogene, microsatellite emergence was also suggested to derive from substitutions that 
create adjacent copies of a microsatellite motif in previously non-repetitive sequence 
(Messier et al. 1996).  For example, the initial sequence ATGTGTGT could undergo 
transition mutations at its first or fifth base, leading to the sequences GTGTGTGT or 
ATGTATGT, respectively.  These substitution events would be exceedingly rare, and only 
observable on an evolutionary timescale.  Once a mutation has generated an unstable 
microsatellite tract, species sharing a common ancestor with the initial destabilization event 
will have microsatellite polymorphism that would be observable on much shorter timescales 
(Messier et al. 1996). 
Microsatellites may also emerge via rare replication slippage or indel events in 
regions with very short tandem repeat tracts or even in the absence of any repeated sequence 
(Schlötterer and Tautz 1992; Zhu et al. 2000a).  Several different groups have proposed this 
theory with various forms of supporting evidence.  In its first iteration, slippage was 
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proposed to occur as an initiating event at very short repeat tracts (Schlötterer and Tautz 
1992).   
Several years later, an analysis of mutations found in the Human Gene Mutation 
Database synthesized the microsatellite emergence theories of Messier, et al. and Schlötterer 
and Tautz.  In analyzing the database, researchers observed that both substitutions and 
insertions created short microsatellite tracts capable of undergoing replication slippage.  
Between 3% and 16% of observed substitutions created microsatellites with 2 repeats—the 
specific rate depends on the motif length.  Substitutions rarely extended any microsatellite 
tract to three repeats.  In contrast, >70% of 2 – 4 bp insertions were copies of adjacent 
sequence, the majority of which were not already part of a microsatellite tract of any length.  
Although no specific mechanism is proposed, the authors suggested that tandem insertions of 
non-microsatellite sequence might be due to a slippage-like process.  Although substitution-
derived short microsatellite tracts are much more common, the vast majority of insertion 
mutations create short microsatellite tracts (Zhu et al. 2000b).   
The contribution of SNPs, insertions, and replication slippage to microsatellite birth 
has also been demonstrated by a comparative analysis of microsatellite loci in human and 
chimpanzee reference genomes.  In this study, both insertions copying adjacent sequence and 
substitutions creating adjacent repeats were observed as a means of microsatellite emergence.  
This analysis produces a similar observation to Zhu et al.—microsatellite loci resulting from 
duplicative insertions of non-microsatellite sequence are common, particularly for short 
motif lengths.  Leclercq et al. also suggest NHEJ as a mechanism for indel slippage—
Leclercq et al.’s term for insertions of non-microsatellite sequence.  In this model, indel 
slippage occurs after a DSB in DNA sequence either through stable base mispairings that are 
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subsequently filled in, or after a DSB is blunt-ended and ligated back together (Leclercq et al. 
2010). 
4.1.2 Microsatellite instability 
4.1.2.1 Mechanisms of microsatellite instability 
4.1.2.1.1 Unequal crossing over 
Recombination was initially thought to play a role in microsatellite instability through 
a mechanism described as unequal crossing over (Smith 1974).  In this process, microsatellite 
regions can pair with each other and recombine due to microhomologies within their tracts.  
If the chromosomes do not pair exactly, the resulting recombinant chromosomes will have an 
expanded microsatellite allele, and a correspondingly contracted microsatellite allele (Figure 
4.1, page 90).  Heterozygous SNPs near the recombination site could serve as a means of 
determining whether an unequal crossing over event occurred.  At least one early paper 
characterizing microsatellite sequences throughout eukaryotic genomes suggested unequal 
crossing over as a mechanism that could explain some variation at microsatellite loci (Tautz 
and Renz 1984). 
4.1.2.1.2 Replication slippage 
Replication slippage was proposed as a mechanism that explained microsatellite 
instability in one of the first papers that considered frameshift mutations in coding sequence 
(Streisinger et al. 1966).  Replication slippage products at AT microsatellite tracts had 
previously been observed under very specific conditions, but this behavior had yet to be 
established as a general feature of cellular DNA (Kornberg et al. 1964).  Replication slippage 
can occur when DNA polymerase dissociates from a nascent and template strand during 
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DNA replication.  Once the polymerase dissociates, the two strands are then free to dissociate 
from one another as well.  The free strands can re-anneal to one another out-of-phase, since 
complementary bases in the microsatellite tract that are in the incorrect position still allow for 
correct realignment.  If the nascent and template strands re-anneal out-of-phase, a bulge will 
be present in one of the strands.  If the bulge is in the nascent strand, the nascent 
microsatellite tract will be expanded relative to the template microsatellite tract.  If the bulge 
is in the template strand, the nascent microsatellite tract will be contracted relative to the 
template microsatellite tract.  Once the strands re-anneal and DNA polymerase re-associates, 
replication continues as usual (Figure 4.2, page 91).  Replication slippage can occur in DNA 
sequences of any length, since it only relies on local dissociation between strands (Schlötterer 
and Tautz 1992).  Replication slippage has been frequently been proposed as the primary 
means of microsatellite instability (see, for example, Tautz and Renz 1984; Schlötterer and 
Tautz 1992; Eichler et al. 1994). 
There are several intriguing characteristics of microsatellite mutation via replication 
slippage.  Replication slippage is not a recombinant process, and can therefore occur any 
time a cell undergoes DNA replication.  This is in stark contrast to unequal crossing, which 
would primarily occur during meiosis (Andersen and Sekelsky 2010).  Replication slippage 
would not affect nearby heterozygous SNPs.  Replication slippage also provides a 
mechanism for microsatellite mutation for haploid chromosomes—this is especially relevant 
for microsatellites in sex chromosomes in men.  Finally, replication slippage can only 
progress through insertions or deletions of complete motifs. 
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4.1.2.1.3 Microsatellite instability is primarily due to replication slippage 
Several lines of evidence support replication slippage as the primary driver of 
microsatellite instability.  In bacteriophage-borne AC microsatellites in E. coli, observed 
replication slippage mutations are specific to the microsatellite tract; are only observed as 
insertions or deletions of complete motifs, usually only a single motif; and the frameshift 
frequency is tract length-dependent (Levinson and Gutman 1987a).  These characteristics are 
consistent with replication slippage, but they do not rule out unequal crossing over as another 
driver of microsatellite instability.  Replication slippage was also demonstrated to be a 
primary driver of microsatellite instability in studies of in vitro microsatellite extension.  
PCR amplification of initial short microsatellite primers led to their expansion into much 
longer species in the absence of any means of recombination (Schlötterer and Tautz 1992).  
The only possible mechanism for microsatellite mutation in this study was replication 
slippage.   
Evidence ruling out unequal crossing over as a primary driver of microsatellite 
instability came from studies of microsatellite tracts in Saccharomyces cerevisiae.  In S. 
cerevisiae, mitotic recombination around regions of microhomology rarely occurs—the rate 
had been previously measured to be ~10-10 for a 26 bp non-microsatellite sequence.  The 
observed rate of microsatellite mutation was six orders of magnitude higher than this mitotic 
recombination rate (Henderson and Petes 1992).  In addition, mitotic recombination in S. 
cerevisiae largely depends on the RAD52 protein.  The rates of microsatellite instability were 
identical in S. cerevisiae strains with and without a functional RAD52 protein, indicating that 
microsatellite mutation is independent of a primary driver of mitotic recombination in S. 
cerevisiae (Henderson and Petes 1992; Wierdl et al. 1997). 
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In several studies evaluating the role of MMR proteins on replication slippage repair, 
the mutation rates of microsatellite loci in mitotically and meiotically reproducing S. 
cerevisiae were compared.  Despite dramatically higher recombination rates during meiosis, 
microsatellite mutation rates were identical to those of mitotically reproducing S. cerevisiae 
(Strand et al. 1993; Wierdl et al. 1997).  This suggests that unequal crossing over plays 
almost no role in microsatellite instability. 
Studies of microsatellite mutation rates of the human Y chromosome both reinforce 
replication slippage as the driver of microsatellite instability and suggest that there is no role 
for unequal crossing over.  Two independent studies compared Y chromosome microsatellite 
mutation rates to established autosomal microsatellite mutation rates.  Both studies found that 
Y chromosome microsatellite mutation rates were indistinguishable from autosomal 
microsatellite mutation rates, despite the near-complete absence of recombination on the Y 
chromosome (Heyer et al. 1997; Kayser et al. 2000).  This provides further support that 
microsatellite mutation is largely, if not entirely, independent from recombination or unequal 
crossing over. 
Population genetic evidence also supports replication slippage over unequal crossing 
over as the driver of microsatellite instability.  In a larger study on the origin of modern 
humans, phylogenies based on microsatellite polymorphisms were considered using two 
mutation models—the stepwise mutation model and the infinite alleles model.  The stepwise 
mutation model assumes that each mutation at a microsatellite locus consists of the insertion 
or deletion of one motif; therefore, identical alleles need not be derived from a single 
common ancestor.  This behavior is consistent with replication slippage.  The infinite alleles 
model assumes that each allele is derived from a single common ancestor, and is consistent 
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with unequal crossing over.  In comparing the separation of continental population groups, it 
is apparent that the phylogenies assuming a stepwise mutation model are more consistent 
with phylogenies generated from other polymorphism data than phylogenies assuming an 
infinite alleles model for microsatellite mutation (Jorde et al. 1995). 
Initial studies of microsatellite instability demonstrate a marked bias towards 
microsatellite mutations in the paternal germline.  Since paternal germlines undergo many 
more cycles of cell division than maternal germlines, this observation is consistent with 
replication slippage as the major driver of microsatellite instability (Weber and Wong 1993).  
Additional observations of somatic instability at microsatellite loci support the absence of a 
role for unequal crossing over, since somatic instability is almost completely independent of 
recombination (see, for example, Chong et al. 1995; Salipante and Horwitz 2006).  Finally, 
an exhaustive study of more than 2,400 microsatellite loci in over 85,000 Icelanders failed to 
show a correlation between microsatellite mutation rates and local recombination rates (Sun 
et al. 2012). 
4.1.2.2 Replication slippage repair 
4.1.2.2.1 MMR proteins 
Replication slippage intermediates are frequently repaired by post-replicative MMR 
machinery before they can be propagated to subsequent generations.  Efficient repair of 
frameshift intermediates in newly replicated DNA was first demonstrated in E. coli using 
bacteriophage-borne frameshift intermediates.  The E. coli MMR system is methyl-directed, 
which ensures that MMR targets newly synthesized DNA.  Frameshift and substitution 
mutation intermediates were repaired with equal efficiency; and frameshift repair is impaired 
in E. coli cells with defective MutL (Dohet et al. 1986).  Subsequent analysis of AC 
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microsatellite slippage in E. coli confirmed that microsatellite mutation rates increase 
dramatically in the absence of MutL and MutS, the primary proteins involved in MMR 
(Levinson and Gutman 1987a). 
Homologs for E. coli MutL and MutS were subsequently identified in S. cerevisiae.  
Initial studies of MMR mutations in S. cerevisiae demonstrated a dramatic increase in 
plasmid and chromosomal microsatellite instability in the absence of the MutL homologs 
PMS1 and MLH1, as well as in the absence of the MutS homolog MSH2.  Some of these 
same studies demonstrated no further increase in microsatellite instability in PMS1/MLH1 
double mutants, indicating that they represent the same MMR pathway (Strand et al. 1993; 
Greene and Jinks-Robertson 1997; Sia et al. 1997b; Tran et al. 1997).  Mutations to MSH2, 
MLH1, PMS1, and PMS2 increase the rate of slippage mutations and substitutions (Strand et 
al. 1995; Sia et al. 1997b).  The same is not true for mutations to the MutS homolog MSH3—
substitution rates are largely unchanged in MSH3 mutants while slippage rates increase by up 
to 40 – 50 fold (Strand et al. 1995; Greene and Jinks-Robertson 1997; Sia et al. 1997b).  
Mutants of a third MutS homolog—MSH6—increases the rate of replication slippage and 
substitution, although slippage mutations are not as prevalent as they are in other MMR 
mutants.  However, MSH3/MSH6 double mutants reproduce the dramatically increased 
slippage rate observed in MSH2, PMS1, and MLH1 mutants.  This rate is maintained in 
MSH2/MSH3/MSH6, MSH2/MSH6, and MSH2/MSH3 mutants, indicating that MSH3 and 
MSH6 are epistatic to MSH2 mutations.  This also indicates that there are probably at least 
two MMR complexes.  While both complexes appear to contain PMS1, MLH1, and MSH2, 
either complex only contains MSH3 or MSH6 (Johnson et al. 1996; Greene and Jinks-
Robertson 1997; Sia et al. 1997b).  Although MMR appears to maintain its preference for 
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repairing newly synthesized DNA in eukaryotes, the mechanism by which this is 
accomplished is unclear (Sia et al. 1997a). 
Many human MMR proteins were characterized after rampant microsatellite 
instability was observed in HNPCC and other colorectal cancers (Aaltonen et al. 1993; Ionov 
et al. 1993; Parsons et al. 1993; Thibodeau et al. 1993; Perucho et al. 1994).  The MutS 
homolog hMSH2 was the first MMR protein characterized in humans (Leach et al. 1993; 
Fishel et al. 1994).  The following year the MutL homologs hMLH1, hPMS1 and hPMS2 
were identified in HNPCC patients, suggesting these genes were involved in MMR in 
humans (Nicolaides et al. 1994; Papadopoulos et al. 1994).  The MutS homolog hMSH6 was 
identified in complex with hMSH2 after it was determined that both proteins were necessary 
to restore proper MMR function to MMR-deficient tumor cells (Drummond et al. 1995; 
Palombo et al. 1995).  Finally, hMSH3 was identified in studies of endometrial cancers 
exhibiting microsatellite instability, but without mutations to other known MMR genes 
(Risinger et al. 1996). 
4.1.2.2.2 MMR efficiency and sensitivity 
MMR efficiency and sensitivity depends on the size of the loop generated in a 
frameshift intermediate.  In an extensive study of microsatellites of varying motif lengths in 
S. cerevisiae, the behavior of the MSH3 and MSH6 MMR complexes were readily 
distinguished.  In MSH6 mutant S. cerevisiae cells, replication slippage rates were up to 30 
times higher than wild-type for 1 and 2 bp loops, while no change was observed for longer 
loops.  In contrast, MSH3 mutant cells exhibited replication slippage rates up to 130 times 
higher than wild-type for loops up to 8 bp long (Sia et al. 1997b).  By comparing the 
replication slippage rates of MSH2 mutant and wild-type S. cerevisiae colonies, MMR 
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appears to correct more than 99.9% of all 1 bp loops.  MMR becomes less effective as loop 
size increases—MMR efficiency is ~80% for loops of up to 13 bp, while no MMR-
dependent correction is observed in loops larger than 16 bp (Sia et al. 1997b).  Interestingly, 
MSH3 complexes appear to be more efficient at repairing deletions than insertions, which 
suggests that it favors template loops to loops in newly synthesized DNA (Strand et al. 1995; 
Johnson et al. 1996; Sia et al. 1997b). 
While MMR correction efficiency is highly dependent on loop size, and therefore 
motif length, it appears to be independent of tract length.  In studies of plasmid-borne AC 
microsatellites in S. cerevisiae with tract lengths ranging from 15 to 99 bp, overall correction 
efficiency is above 97%, although deletions are corrected more often than insertions (Wierdl 
et al. 1997).  MMR efficiency appears to have some dependency on motif composition and 
sequence context.  In a study of slippage events in wild-type S. cerevisiae, mutations 
occurred more frequently in microsatellites with C motifs than those with A motifs, and 
similarly sized microsatellites with identical 1 bp motifs mutated at distinctly different 
frequencies (Greene and Jinks-Robertson 1997).  
4.1.2.2.3 DNA proofreading 
A role for DNA proofreading in replication slippage repair has also been suggested.  
In S. cerevisiae strains with mutant DNA-Pol δ or DNA-Pol ε, replication slippage at short A 
microsatellite tracts increased between 3 – 300 fold relative to wild-type slippage rates.  
Since both DNA-Pol δ and DNA-Pol ε have 3’5’ exonucleolytic proofreading activity, this 
would imply a role for DNA polymerase-dependent replication slippage repair.  In DNA-Pol 
ε/MSH2 double mutants, A microsatellites with tract lengths of 4 or 5 bp were significantly 
less stable than either single mutant for either gene (Tran et al. 1997).  As microsatellite tract 
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lengths increased, the role of exonucleolytic proofreading rapidly diminishes.  DNA 
polymerase mutations do not appear to have an impact on replication slippage rates for 
microsatellite tracts longer than 8 – 10 bp (Strand et al. 1993; Tran et al. 1997).  In general, 
DNA proofreading appears to play a very limited role in replication slippage repair. 
4.1.2.3 Factors influencing microsatellite instability 
4.1.2.3.1 Motif length 
Microsatellite mutations typically insert or delete one complete motif from a 
microsatellite tract, although mutations involving more motifs are possible (see, for example, 
Levinson and Gutman 1987a; Henderson and Petes 1992; Strand et al. 1993; Brinkmann et 
al. 1998).  Microsatellite instability also has a well-characterized dependence on motif 
length.  Early studies in plasmid-borne C and AC microsatellites in S. cerevisiae 
demonstrated that microsatellites with 1 bp motifs had a slightly elevated mutation rate 
relative to those with 2 bp motifs (Henderson and Petes 1992).  That same year, in vitro 
microsatellite primer extension assays demonstrated that microsatellites with 2 bp motifs 
grew more rapidly than those with 3 bp motifs, implying that 2 bp motifs are less stable 
(Schlötterer and Tautz 1992).  Evidence for the motif length dependence of microsatellite 
stability in chromosomal DNA came later.  Studies of polymorphism at microsatellite loci 
grouped by motif length within human populations demonstrated that in general, the 
mutation rate for microsatellites with 2 bp motifs is highest, followed by those with 3 bp 
motifs, and then those with 4 bp motifs.  Disease-causing loci with 3 bp motifs were found to 
be the least stable (Chakraborty et al. 1997).  A study of microsatellite instability in 
microsatellites with 2 and 4 bp motifs in MMR deficient cell lines produced similar results 
(Lee et al. 1999).  This observation was reinforced by studies of de novo microsatellite 
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mutations in Drosophila melanogaster, which showed that microsatellites with 2 bp motifs 
mutated ~6 times more often than those 3 bp motifs, and ~8 times more often than those with 
4 bp motifs (Schug et al. 1998).  Recent studies examining several hundred to over a hundred 
thousand microsatellite loci in human populations make it clear that this behavior is 
universal—microsatellites are more stable as their motif length increases (Pemberton et al. 
2009; Gymrek et al. 2012).  This behavior was also demonstrated in comparisons of the 
human and chimpanzee genomes at microsatellite loci with motif lengths from 1 to 4 bp 
(Kelkar et al. 2008).  Some studies have a shown a higher mutation rate in highly 
polymorphic 4 bp marker loci as compared to highly polymorphic 2 bp marker loci (Weber 
1990; Sun et al. 2012). 
4.1.2.3.2 Tract length and repeat count 
Tract length and repeat count were among the earliest factors demonstrated to effect 
microsatellite instability.  In some of the first observations of spontaneous frameshift 
mutations of short A microsatellite loci in E. coli, the mutation rate increased dramatically 
with each additional motif (Streisinger and Owen 1985).  In another early study of 
microsatellite instability, 40 bp AC microsatellite loci in E. coli were shown to be more than 
twice as unstable as 22 bp AC microsatellite loci (Levinson and Gutman 1987a).  Studies in 
S. cerevisiae of chromosomally integrated microsatellites with 1 bp motifs also demonstrated 
decreased stability even for small changes in tract length—A microsatellites exhibit a 30-fold 
destabilization when they expand from 9 bp to 15 bp (Tran et al. 1997).  This observation is 
reinforced in S. cerevisiae studies of plasmid-borne AC microsatellites with tract lengths 
ranging from 15 to 99 bp—in wild-type cells, mutation rates increased by more than two 
orders of magnitude within range of tract lengths studied (Wierdl et al. 1997).  A separate 
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study of microsatellites in the S. cerevisiae genome suggested that microsatellite instability 
was dependent on a microsatellite tract’s length, but not its repeat count (Pupko and Graur 
1999). 
Studies of microsatellite variation in natural populations also demonstrate the 
relationship between repeat count or tract length and microsatellite instability.  Early 
analyses of polymorphism at AC microsatellite loci in human populations demonstrated that 
loci with higher average repeat counts tended to have more alleles, indicating increased 
instability (Weber 1990).  Later studies of microsatellite instability in human populations 
showed a positive correlation between the mutation rate of a microsatellite locus and its 
geometric mean, arithmetic mean, or maximum uninterrupted repeat count (Brinkmann et al. 
1998; Pemberton et al. 2009).  The same phenomena has been demonstrated in D. 
melanogaster populations—microsatellite loci with high maximum repeat counts have 
greater variance in their repeat length distributions (Goldstein and Clark 1995; Schug et al. 
1998; Bachtrog et al. 2000).  However, some studies were not able to reproduce this effect in 
worldwide collections of D. melanogaster or in human Y chromosome father-son pairs 
(Schlötterer et al. 1997; Kayser et al. 2000).   
Phylogenetic studies of microsatellite loci in human populations also demonstrate a 
strong relationship between allele count or tract length and microsatellite tract instability (Jin 
et al. 1996).  Studies estimating microsatellite polymorphism or mutation rates from large 
populations or sets of microsatellite loci demonstrate that longer microsatellites are more 
polymorphic and have higher mutation rates (Gymrek et al. 2012; Sun et al. 2012).  Longer 
microsatellite tract lengths and higher repeat counts also clearly destabilize microsatellite loci 
in comparisons of human and chimpanzee genomes (Kelkar et al. 2008).  The relationship 
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between microsatellite tract length and variability has even been demonstrated in Arabidopsis 
thaliana (Cao et al. 2014). 
There is some debate about whether replication slippage can only occur once a 
microsatellite locus has exceeded a threshold repeat count or tract length.  Initial studies on 
microsatellite emergence suggested that the transition from non-repetitive sequence to 
microsatellite sequence occurs once substitutions introduce a minimum number of 
consecutive repeats (Messier et al. 1996).  Subsequent studies of the over-representation of 
repeat tracts for each equivalence class in the S. cerevisiae genome suggested a minimum 
tract length of 8 bp (Rose and Falush 1998).  A study of microsatellite polymorphism within 
the genomes of 179 individuals from the 1000 Genomes Project indicated that extreme 
instability at microsatellite loci was dependent on repeat count.  A minimum of 9 repeats was 
necessary for replication slippage to occur for microsatellites with 1 bp motifs, 5 repeats for 
those with 2 bp motifs, and 4 repeats for those with motif lengths of 3 and 4 bp (Ananda et al. 
2013). 
Other studies suggest that there is no minimum threshold for replication slippage at 
microsatellite loci.  In a study paralleling Rose and Falush, analysis of all repeats in the S. 
cerevisiae genome grouped by motif length indicated that microsatellites were over-
represented for all repeat counts greater than two.  As microsatellite repeat counts increase, 
the over-representation simply becomes more pronounced (Pupko and Graur 1999).  Studies 
suggesting a base rate of replication slippage independent of threshold repeat counts would 
also support this perspective (Zhu et al. 2000b; Leclercq et al. 2010).  The absence of a 
threshold for replication slippage at microsatellite loci is also consistent with studies of short 
microsatellite repeats in S. cerevisiae, as well as observations of frameshift mutations at short 
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microsatellites with 1 bp motifs within the APC gene of cancer patients with and without 
MMP (Huang et al. 1996; Greene and Jinks-Robertson 1997). 
4.1.2.3.3 Motif composition 
Although microsatellite motif composition plays a role in microsatellite instability, 
the exact nature of this relationship is unclear.  Early studies of microsatellite tract synthesis 
in vitro demonstrated markedly increased instability for AG microsatellites as compared to 
AC microsatellites, despite their equivalent GC content.  The same is also true for 
microsatellites with 3 bp motifs.  Although motifs with higher GC content tend to be more 
stable, this is not consistent for all motifs—AGG microsatellites are among the least stable 3 
bp motifs (Schlötterer and Tautz 1992).  Mutation rate estimates for microsatellites with 2 bp 
motifs in global populations of D. melanogaster conflict with the findings of Schlötterer and 
Tautz—AC microsatellites are the least stable, followed by AG microsatellites, then AT 
microsatellites.  This observation confirms that the GC content of a microsatellite motif does 
not appear to affect microsatellite tract instability (Bachtrog et al. 2000).  In contrast, studies 
using HTS data from 13 strains of A. thaliana suggested that GC content was inversely 
correlated with microsatellite stability (Cao et al. 2014). 
The effect of motif composition on microsatellite instability is no clearer in studies of 
microsatellites in the human genome.  In comparisons of microsatellite loci in the human and 
chimpanzee reference genomes, A repeats are less stable than C repeats.  In contrast to what 
is observed in D. melanogaster, AT microsatellites are the least stable of all 2 bp motifs in 
the human genome.  This study also demonstrates variability in microsatellite instability 
among 3 and 4 bp motifs, but the relationship is even murkier than it is for 1 and 2 bp motifs.  
Overall, the GC content of a motif did not appear to affect microsatellite instability (Kelkar et 
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al. 2008).  However, in another study of microsatellite loci in ~1,000 human DNA samples, 
GC content was found to affect microsatellite instability for 4 bp motifs—increased 
heterozygosity at microsatellite loci was correlated with higher GC content in microsatellite 
motifs (Pemberton et al. 2009).  In a study of microsatellite variation at loci with motif 
lengths of at least 2 bp using HTS data, most variation occurred in microsatellites with AC or 
AT motifs (McIver et al. 2011).   
The relationship between motif composition and microsatellite instability may also 
depend on repeat count.  Although A and C microsatellites have different levels of instability 
for shorter tract lengths, they are nearly equally unstable at loci with more than 17 repeats.  
In addition, while AC microsatellites are less stable than AG microsatellites for repeat counts 
less than 12, they are more stable for repeat counts greater than 15 (Kelkar et al. 2008).   
Although it is clear motif composition affects microsatellite instability, there is no 
consensus on how that effect is realized.  Studies are inconsistent with regards to the effect 
motif GC content plays on microsatellite stability, if indeed it plays a role at all (Bachtrog et 
al. 2000; Kelkar et al. 2008; Pemberton et al. 2009; Cao et al. 2014).  Studies of 
microsatellite loci in the same organism do not report consistent relative stabilities for motifs 
with the same length but different compositions.  Among microsatellite with 2 bp motifs in 
humans, one study suggests that AT motifs are the least stable, while another observes more 
instability at AC motifs (Kelkar et al. 2008; McIver et al. 2011). 
At least two theories attempt to explain the relationship between motif composition 
and microsatellite instability.  These theories are not mutually exclusive.  The first theory 
suggests that MMR efficiency may vary for different motifs in a species-dependent manner.  
This motif-dependent MMR efficiency may itself be due to variation in GC content in 
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different species (Bachtrog et al. 2000).  This phenomenon may also be due to the stability of 
frameshift intermediates of different motifs.  Since AT loops may be more stable than AC or 
AG loops, AT microsatellites may be less stable (Kelkar et al. 2008). 
4.1.2.3.4 Sequence identity 
Microsatellite instability is highly dependent on sequence identity.  In one of the first 
studies of microsatellite instability in humans, interrupted microsatellite loci were 
significantly more stable than uninterrupted microsatellite loci.  Moreover, the best predictor 
of instability at an interrupted microsatellite locus was the length of its longest uninterrupted 
microsatellite tract (Weber 1990).  In an analysis of de novo microsatellite mutations in 
parent/child trios, mutations in interrupted microsatellite alleles were less frequent than 
mutations at uninterrupted alleles.  Akin to the results from Weber, the geometric mean of 
the longest uninterrupted repeat count at a microsatellite locus was the best predictor of its 
instability (Brinkmann et al. 1998).  In subsequent analyses of de novo microsatellite 
mutations in father/son pairs on the human Y chromosome, the only mutations observed were 
in uninterrupted microsatellite tracts with at least 11 repeats (Kayser et al. 2000).  Two later 
studies evaluating instability at thousands of microsatellite loci continued to demonstrate a 
marked difference in the stability of interrupted and uninterrupted microsatellites.  Neither 
study sought to determine if instability was correlated with the tract length or repeat count of 
the longest uninterrupted portion of an interrupted microsatellite tract (McIver et al. 2011; 
Sun et al. 2012). 
The dependence of microsatellite instability on sequence identity is reinforced in 
phylogenetic studies of microsatellite loci in the human genome.  One study described two 
distinct subpopulations at a single microsatellite locus with drastically different levels of 
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polymorphism.  One subpopulation had an uninterrupted AC repeat and was highly 
polymorphic, while the other subpopulation had an interrupted repeat and was nearly 
monomorphic.  This discrepancy was driven primarily by the sequence identity of the AC 
repeat, and not population genetic factors such as lineage age or a recent population 
expansion (Jin et al. 1996). 
Studies of microsatellite loci known to play a role in disease incidence also 
demonstrate the dramatic increase in microsatellite stability at interrupted microsatellite 
alleles.  In several studies of predisposing alleles in SCA1, ~98% of unaffected individuals 
possessed a stabilizing CAT variant motif in the CAG microsatellite tract whose expansion 
leads to the disorder, as did all unexpanded alleles in affected individuals (Chung et al. 1993; 
Jodice et al. 1994; Chong et al. 1995).  All pathogenic expansions in individuals with SCA1 
were at uninterrupted CAG microsatellites (Chung et al. 1993).  A similar study of AGG 
variant repeats in the FMR1 CGG microsatellite tract whose expansion leads to Fragile X 
indicates that all pathogenic alleles have lost at least one variant repeat.  Similar to Weber 
and Brinkmann et al., allele instability was related to the length of the uninterrupted CGG 
tract within the microsatellite locus (Eichler et al. 1994). 
The relationship of microsatellite instability to sequence identity remains true in non-
human species.  In two studies of the role of variant repeats on AC microsatellite stability in 
S. cerevisiae, interrupted microsatellites are significantly more stable than uninterrupted 
repeats (Heale and Petes 1995; Petes et al. 1997).  A population genetic analysis of 
microsatellite loci in D. melanogaster also demonstrated increased stability in interrupted 
microsatellite tracts.  The same study also found that the longest uninterrupted microsatellite 
tract is more stable than would be expected based on the uninterrupted repeat count 
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(Goldstein and Clark 1995).  Finally, an evaluation of HTS sequencing data from multiple A. 
thaliana strains demonstrates a strong correlation between sequence identity and 
microsatellite variability (Cao et al. 2014). 
4.1.2.3.5 Insertions and deletions in microsatellite tracts 
Several studies have reported conflicting results regarding a bias towards insertions or 
deletions at microsatellite loci.  In a study of spontaneous frameshift mutations in short A 
microsatellite tracts in E. coli, deletions were 2 to 4 times as common as insertions 
(Streisinger and Owen 1985).  In early studies of microsatellite instability in a bacteriophage-
borne 40 bp AC microsatellite tract in E. coli, deletions were also 3 times as common as 
insertions (Levinson and Gutman 1987a).  Later studies in S. cerevisiae demonstrated higher 
rates of deletions in a 10 bp A microsatellite tract than insertions in a longer 12 bp A 
microsatellite tract, suggesting a bias towards deletions at microsatellite loci (Tran et al. 
1997). 
A deletion bias—particularly at short microsatellite tracts—is inconsistent with the 
observed abundance of microsatellite tracts throughout many eukaryotic genomes.  
Fortunately, there is ample evidence of insertions being favored at microsatellite loci.  In an 
early study of spontaneous frameshift mutations in a 12 bp CTGG tract in E. coli, insertions 
are more than 4 times as common as deletions (Farabaugh et al. 1978).  In studies of plasmid-
borne 33 bp AC microsatellites in S. cerevisiae, small insertions were significantly more 
common than small deletions.  The same behavior is observed in S. cerevisiae colonies with 
mutant DNA-Pol δ and DNA-Pol ε (Strand et al. 1993; Petes et al. 1997).  Further 
characterization of insertion biases in S. cerevisiae demonstrated a significant small insertion 
bias in wild-type strains, but a bias towards small deletions in strains with mutant MSH3 
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(Strand et al. 1995).  Another study of tract instability in S. cerevisiae did not find any 
deletion bias in MSH3 mutant strains (Petes et al. 1997).  A study of de novo microsatellite 
mutations in father/son pairs at human Y chromosomal loci also describes an insertion bias at 
several microsatellite loci with 2 and 4 bp motifs (Kayser et al. 2000). 
Several other studies suggest that there is no bias towards insertions or deletions at 
human microsatellite loci.  In a study of somatic mutations at 24 microsatellite loci in 
patients with colon adenocarcinoma, insertions and deletions occurred with the same 
frequency (Di Rienzo et al. 1998).  In MMR defective human cells, insertions and deletions 
occur with equivalent frequencies.  This result suggests that any bias in mutations rates 
observed—at least at human microsatellite loci—could be due to biased MMR efficiency in 
repairing template and nascent frameshift intermediates (Lee et al. 1999).  In a study of de 
novo microsatellite mutations at 4 bp microsatellite tracts, there is similarly no observation of 
a bias in per-generation microsatellite mutation rates (Sajantila et al. 1999). 
In an attempt to reconcile these conflicting observations, two studies examined 
microsatellite insertion/deletion biases at microsatellite tracts of varying lengths.  In S. 
cerevisiae, a study of plasmid-borne AC microsatellite loci with lengths from 15 – 99 bp 
demonstrated that while the rate of single motif insertions rises as tract length increases, the 
rate of single motif deletions appears to decrease dramatically as tract length increases.  In 
addition, large deletions are significantly more frequent for longer tract lengths (Wierdl et al. 
1997).   In a study of over 100 4 bp microsatellites in human families, deletions appeared to 
increase exponentially as tract length increased, while the rate of insertions appeared to be 
independent of tract length (Xu et al. 2000).  Both of these studies suggest that reported 
insertion/deletion biases might be related to the balance of insertions and deletions specific to 
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an observed tract length or subset of tract lengths, rather than an indication of a universal 
insertion or deletion bias. 
4.1.2.3.6 Other factors affecting microsatellite instability 
Microsatellite orientation could play a role in microsatellite instability if leading or 
lagging strand DNA replication were more prone to slippage or produced frameshift 
intermediates that were poorly recognized by MMR proteins.  Plasmid-borne microsatellites 
in S. cerevisiae allow control of microsatellite tract orientation relative to the origin of 
replication.  In two separate studies, instability at 2 bp microsatellite tracts did not appear to 
depend on the tract orientation relative to the origin of replication (Henderson and Petes 
1992; Wierdl et al. 1997).  A study of CAG microsatellites in S. cerevisiae suggested that 
lagging microsatellites near an origin of replication are unstable compared to their leading 
strand counterparts in a motif-dependent manner (Maurer et al. 1996).  A similar study in 
CTG microsatellite tracts in E. coli demonstrated that insertions preferentially occurred when 
the microsatellite was in the leading strand, while deletions were more common if it was in 
the lagging strand (Kang et al. 1995).  There does not appear to be any reported orientation-
dependent effect on instability at human microsatellite loci. 
Although microsatellites with similar properties can have very different mutation 
rates within a genome, the effects of surrounding sequence context on microsatellite stability 
are not well defined.  An initial study of American alligator microsatellite loci suggested that 
high local GC content reduced allelic diversity at microsatellite loci (Glenn et al. 1996).  
However, an analysis of microsatellite loci in D. melanogaster showed no correlation 
between microsatellite stability and local GC content (Bachtrog et al. 2000).  An extensive 
analysis of microsatellite loci in HGDP-CEPH individuals also failed to demonstrate any 
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effect of surrounding GC content on microsatellite stability (Pemberton et al. 2009).  GC 
content appeared to have a weak effect on microsatellite stability in comparisons of human 
and chimpanzee genomes (Kelkar et al. 2008).  Similarly, an analysis of HTS data from 13 A. 
thaliana strains showed a significant correlation between surrounding GC content and 
microsatellite instability (Cao et al. 2014).  Variability in microsatellite stability due to 
surrounding sequence is largely unexplained, although some studies attribute a role to 
flanking GC content. 
Transcriptional activity may destabilize microsatellite loci.  In a study of a 
chromosomal AC microsatellite adjacent to the GAL1-10 promoter in S. cerevisiae, 
instability increased in experimental conditions that favored high levels of transcription 
(Wierdl et al. 1996).  Similar behavior is observed for plasmid-borne CAG microsatellites in 
E. coli, which seems to determine instability in concert with microsatellite orientation 
(Mochmann and Wells 2004).  In a comparison of microsatellite loci in the human and 
chimpanzee genomes, instability does not appear to differ between intergenic and intronic 
microsatellite loci, although this might be due to the active transcription of intergenic 
portions of the genome (Kelkar et al. 2008). 
4.1.2.3.7 Microsatellite instability summary 
Although microsatellites are known to be highly unstable, the effects of extrinsic and 
intrinsic microsatellite locus characteristics on stability are inconsistently defined.  It is clear 
that short microsatellite motifs are less stable.  Many studies also suggest that longer 
microsatellite alleles are less stable as well.  This observation is reinforced by several lines of 
evidence, including population genetic studies and direct observations of replication slippage 
in model organisms.  It is also very clear that sequence identity affects microsatellite 
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stability.  Observations in human disease, studies of variant repeats in model organisms, and 
population genetic studies all suggest that uninterrupted microsatellite loci are significantly 
less stable than their interrupted counterparts.  Moreover, many of these studies suggest that 
instability observed at interrupted microsatellite loci is highly correlated with various 
measures describing the length of the uninterrupted tract contained within the locus. 
Other factors affect microsatellite instability in unclear ways.  While it is clear that 
microsatellite motif composition has a significant effect on microsatellite stability, studies 
report contradictory results.  Some of these contradictions may result from organism-specific 
microsatellite instability biases, but even within the same organism, conflicting results have 
been reported.  Transcription, flanking GC content, and direction of replication may also play 
a role in microsatellite instability.  Finally, insertions and deletions may have length-
dependent biases as well. 
All of this suggests that a significant proportion of microsatellite instability is 
unexplained, and that previous studies have not produced consistent results regarding various 
factors known to affect microsatellite stability.  It might not be wise to generalize the same 
microsatellite mutation rates to similar microsatellite loci.  Microsatellites appear to have 
very different rates of instability, even when considering similar loci.  Until a better 
understanding of the interplay of various factors affecting microsatellite stability exists, it 
may be best to consider microsatellite mutation rates independently for each locus. 
4.1.2.4 Literature-estimated human microsatellite mutation rates 
Microsatellite mutation rates in humans have been estimated multiple times from 
different marker loci.  In the earliest direct study of de novo microsatellite mutation at 28 
microsatellite loci, the average mutation was determined to be 1.2 × 10−3  mutations per 
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locus per gamete per generation, while individual mutation rates for each locus ranged from 
0 to 8.0 × 10−3.  Evaluated by motif length, the mutation rate estimates were 2.1 × 10−3 for 
4 bp motifs and 5.6 × 10−4  for 2 bp motifs (Weber and Wong 1993).  These estimated 
mutation rate estimates are in agreement with estimates from two separate studies based on 
chromosome Y microsatellite loci, a study of autosomal microsatellite loci, and the average 
mutation rate of microsatellite loci from the first Généthon microsatellite linkage map 
(Weissenbach et al. 1992; Heyer et al. 1997; Brinkmann et al. 1998; Kayser et al. 2000).  A 
later study demonstrated that two of the loci analyzed by Weber and Wong accounted for 
more than half of all 4 bp microsatellite mutations.  If these loci were excluded, the average 
microsatellite mutation rate drops to 8.5 × 10−4 per locus per gamete per generation and 2 
bp motifs are nearly twice as unstable as 4 bp motifs (Chakraborty et al. 1997).  A study of 
microsatellite de novo mutations at 5 loci determined mutation rates ranging from 1.7 × 10−4 
to < 3.3 × 10−3  per locus per gamete per generation, with an average mutation rate of 6.7 × 10−4 (Sajantila et al. 1999).  A study of thousands of microsatellite loci in a large 
Icelandic cohort estimated mutation rates of 1.0 × 10−3 per locus per generation for 4 bp 
motifs and 2.7 × 10−4 for 2 bp motifs (Sun et al. 2012).  All of these studies use marker 
microsatellite loci that are known to be highly polymorphic, so these estimates might be 
higher than mutation rates for non-marker microsatellite loci. 
Several lines of evidence also demonstrate a clear bias for paternal transmission of de 
novo mutations in humans.  In studies of SCA1-affected families, expanded pathogenic CAG 
alleles were inherited from the father significantly more often than the mother, particularly in 
cases of juvenile-onset disease (Chung et al. 1993; Orr et al. 1993).  Analyses of de novo 
microsatellite mutations in pedigrees and families demonstrated that mutation events occur 3 
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– 5 times more often in the paternal germline as they do in the maternal germline (Weber and 
Wong 1993; Brinkmann et al. 1998; Henke and Henke 1999; Sajantila et al. 1999; Sun et al. 
2012).  Moreover, de novo microsatellite mutations derived from paternal germlines correlate 
strongly with paternal age—in one study, the germline microsatellite mutation frequency 
doubles in fathers from age 20 to 58 (Brinkmann et al. 1998; Sun et al. 2012). 
4.1.2.5 Operationally defining microsatellites 
We define microsatellites by their ability to undergo replication slippage.  The 
thresholds we define are motivated by some of the better defined characteristics of 
microsatellite instability described above.  We allow for any motif composition for 
microsatellite motif lengths between 1 and 6 bp.  Even though slippage seems to occur at 
microsatellites of any repeat count or length, all studies agree that the rate of replication 
slippage increases proportionally with microsatellite tract length.  We attempt to capture the 
greatest amount of microsatellite polymorphism in our study.  Therefore, we require a 
microsatellite tract to have a repeat count of at least 3, and a tract length of at least 8 bp.  
These thresholds are in line with previously described minimum tract lengths and repeat 
counts for replication slippage at microsatellite loci (Rose and Falush 1998; Ananda et al. 
2013).  We also limit our study to uninterrupted microsatellite loci.  Microsatellites could 
also be defined statistically, by considering whether adjacent, approximate copies of a repeat 
are closer together than might otherwise be expected (Benson 1999). 
4.1.3 Microsatellite distribution in the human genome 
Several studies have sought to characterize the microsatellite landscape of the 
reference human genome.  In an exhaustive study of uninterrupted microsatellites with motif 
lengths from 1 to 6 bp and tract lengths of at least 12 bp in build 29 of the human reference 
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genome, most chromosomes had a microsatellite density of ~12,000 to ~14,000 bp/Mb.  
Microsatellites with 1 bp motifs were uniformly distributed independent of genomic context, 
and exhibited a marked preference for A motifs than C motifs.  Microsatellites with 2 bp 
motifs are more common in introns and intergenic regions than they are in exons.  AC and 
AT motifs are the predominant 2 bp motifs, and CG motifs are exceedingly rare.  
Microsatellites with 3 bp motifs are more common in exons than they are in introns and 
intergenic regions.  AAT and AAC motifs are the predominant 3 bp motifs.  AAG and AGG 
motifs occur less frequently, but distinctly more often than ACC, AGC, or ATG motifs.  
There are very few CCG, ACG, or ACT motifs anywhere in the genome.  4 and 5 bp motifs 
are more common in introns and intergenic regions than they are in exons.  AAAT, AAAG, 
AAAC, and AACC motifs are the predominant 4 bp motifs, and several other 4 bp motifs 
rarely occur in the genome.  The most common 5 bp motifs are AAAAT and AAAAC.  6 bp 
motifs are more common in exons than they are in introns or intergenic regions, and the most 
common motifs are AAAAAT, AAAAAC, and AAAAAG (Subramanian et al. 2003). 
Another study of microsatellites in build 36.1 of the human reference genome that 
used TRF to identify tract lengths of at least 12 bp and 90% identity found ~1.2 million total 
microsatellite loci.  After filtering microsatellite loci in retrotransposons and those with 1 bp 
motifs, 376,685 loci remained.  Of those loci, only 1.0% are in exons, 7.4% are in UTRs, 
33% are in introns, and the remainder are in intergenic regions of the genome.  
Microsatellites are more commonly found in 5’ UTRs as compared to 3’ UTRs (McIver et al. 
2011).  Although the total length of the 5’ and 3’ UTRs in build 36.1 of the human reference 
genome is not reported, in build GRCh37 there are roughly 3 times as many bases in the 3’ 
UTR than there are in the 5’ UTR.  This would imply a significant enrichment of 
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microsatellites in 5’ UTR as compared to the 3’ UTR.  A further discussion on the 
microsatellite distribution in GRCh37 as part of this project can be found in section 6.1. 
4.1.4 Microsatellite relevance 
4.1.4.1 Microsatellite diseases 
4.1.4.1.1 Trinucleotide microsatellite expansion diseases 
4.1.4.1.1.1 Fragile X Syndrome 
The X-linked Fragile X syndrome was the first disease linked to a microsatellite 
expansion.  The only portion of the region linked to Fragile X that varied within an initial 
study population was the length of a CGG microsatellite in the 5’ UTR of the FMR1 gene.  
In normal individuals, the microsatellite appeared to have repeat counts ranging from 15 to 
65, while the microsatellite could not be accurately characterized in affected individuals due 
to its instability and length (Kremer et al. 1991).  CGG expansions upstream of the FMR1 
gene lead to methylation and transcriptional repression of the gene product in most affected 
individuals (Pieretti et al. 1991).  Later studies established that the disease risk for different 
haplotypes depended on the presence of at least two stabilizing AGG variant repeats within 
the CGG microsatellite tract.  In all cases, CGG microsatellite expansion was preceded by the 
loss of one or more variant repeats.  Stabilizing variant repeats also offered an explanation of 
a previously described “grey zone” of instability, where CGG microsatellites with identical 
tract lengths appeared to be stable in some families and unstable in others (Eichler et al. 
1994). 
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4.1.4.1.1.2 Fragile X and genetic anticipation 
Genetic anticipation is a characteristic shared by fragile X and many other 
microsatellite-linked disorders: microsatellite alleles expand from one generation to the next, 
which leads to earlier disease onset and more severe symptoms.  In fragile X, this was first 
studied in families where fathers with a fragile X pre-mutation allele appeared to be normal, 
as did their daughters, but their grandsons had the disease.  The repeat count in the 
pre-mutation allele explains this phenomenon—since the CGG repeat becomes less stable as 
it expands, successive generations have increased risk of Fragile X incidence after a 
threshold length is exceeded (Fu et al. 1991). 
4.1.4.1.1.3 SBMA 
Microsatellite expansions also cause the X-linked disorder SBMA, alternatively 
known as Kennedy Disease.  Investigations of a disease candidate region initially defined 
through linkage analysis revealed a CAG repeat in the first coding exon of the AR gene.  In 
unrelated individuals diagnosed with SBMA from diverse ethnic backgrounds, the CAG 
repeat count varied from 40 to 52; while in 263 unaffected controls, including family 
members of affected individuals, the CAG repeat count varied from 17 to 26 (La Spada et al. 
1991).  This indicated that the expanded CAG allele segregates with SBMA incidence, and is 
therefore responsible for the disease phenotype. 
4.1.4.1.1.4 Myotonic dystrophy 
Myotonic dystrophy is caused by mutations to two separate genes, both of which are 
microsatellite expansions.  The first form of the disease, DM1, is caused by an expansion of a 
CTG repeat in the 3’ UTR of the DMPK gene (Brook et al. 1992; Buxton et al. 1992; Fu et 
al. 1992; Mahadevan et al. 1992; Bowcock et al. 1994).  One reports link this mutation to 
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~98% of all cases of myotonic dystrophy (Fu et al. 1992).  Both DM1 age-of-onset and 
severity are correlated with repeat length, which are hallmarks of genetic anticipation (Brook 
et al. 1992; Buxton et al. 1992; Fu et al. 1992).  In normal individuals, the CTG repeat count 
ranges from 5 to 30, while in individuals with DM1, the repeat count is at least 50, but can 
exceed 1,000 in severely affected individuals (Brook et al. 1992; Fu et al. 1992; Mahadevan 
et al. 1992).  The expanded allele segregates perfectly with disease incidence in unrelated 
DM1 patients, and is never found in unaffected individuals (Buxton et al. 1992; Fu et al. 
1992; Mahadevan et al. 1992).  In addition, the CTG repeat exhibits somatic instability in 
DM1 individuals and is transcribed (Brook et al. 1992; Fu et al. 1992).  Transcription of the 
expanded allele suggests that DM1 is caused by a neofunctionalization of DMPK. 
Nearly a decade later, the mutation responsible for DM2 was identified as a CCTG 
microsatellite expansion in the first intron of the ZNF9 gene.  Although not a trinucleotide 
microsatellite disorder, DM2 is included here since it is related to DM1.  In normal 
individuals, the CCTG repeat count is ~26, and is stabilized by two variant repeats.  
Expanded alleles had at least 75 to >11,000 repeats, although it is unclear if they also contain 
variant repeats.  Unlike DM1, no correlation was observed between age-of-onset and repeat 
count, and there is no indication of genetic anticipation.  Like the DMPK CTG microsatellite, 
the ZNF9 CCTG microsatellite is somatically unstable, which could complicate the 
interpretation of the variant repeat status of affected individuals and age-of-onset correlation.  
The expanded allele perfectly segregates with the DM2 phenotype (Liquori et al. 2001). 
4.1.4.1.1.5 Huntington’s Disease 
After DM1, Huntington’s disease was the next disease that was linked to 
microsatellite expansion.  In normal individuals, a CAG microsatellite in the first exon of the 
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HTT gene has a repeat count between 11 and 34, while in affected individuals, repeat counts 
were at least 42.  The expanded repeat always segregated with Huntington’s disease 
incidence in patients from various ethnic backgrounds.  Longer alleles are correlated with 
earlier onset of disease symptoms, which indicates that Huntington’s disease exhibits classic 
signs of genetic anticipation.  Huntington’s disease is autosomal dominant and the mutant 
allele is expressed, which implies that the microsatellite expansion causes a 
neofunctionalization of the HTT gene (Macdonald et al. 1993). 
4.1.4.1.1.6 Spinocerebellar ataxias 
Many spinocerebellar ataxias are caused by microsatellite repeat expansions.  SCA1 
was the first spinocerebellar ataxia attributed to a microsatellite expansion.  In normal 
individuals, a CAG microsatellite in the second coding exon of ATXN1 has a repeat count 
ranging from 6 to 39.  Individuals with SCA1 have repeat counts from 41 to 81 (Chung et al. 
1993; Orr et al. 1993; Banfi et al. 1994).  SCA1 has at least one classic sign of genetic 
anticipation—longer alleles lead to early disease age-of-onset.  Expanded alleles were most 
likely to be paternally transmitted, particularly in juvenile onset SCA1 (Chung et al. 1993; 
Orr et al. 1993).  Two separate studies identified variant motifs that stabilized the CAG 
microsatellite in most normal individuals and in the normal alleles of SCA1 patients (Chung, 
et al. 1993; Chong, et al. 1995).  98% of normal individuals had at least one variant motif, 
while the remaining 2% had very short repeats (Chung et al. 1993).  Every individual 
affected with SCA1 had an uninterrupted repeat (Chung et al. 1993; Chong et al. 1995).  
Disease incidence segregates with the expanded allele, and all affected individuals in one 
study were heterozygous for the expanded allele, indicating autosomal dominant behavior 
(Orr et al. 1993).  The expanded SCA1 allele is expressed, which implies that a novel 
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function is gained by ATXN1 in SCA1 patients (Orr et al. 1993; Banfi et al. 1994; Chong et 
al. 1995).  Finally, uninterrupted SCA1 alleles exhibit significant somatic instability (Chong 
et al. 1995). 
Many spinocerebellar ataxias have been attributed to microsatellite expansions since 
the pathogenic SCA1 allele has been characterized.  SCA2 is caused by a CAG microsatellite 
expansion in the coding region of ATXN2.  Normal individuals have repeat counts between 
17 and 29, and variant repeats appear to stabilize the tract.  Typical of genetic anticipation, 
SCA2 age-of-onset decreases as pathogenic allele length increases.  Individuals affected with 
SCA2 have repeat counts between 36 and 52 in what appear to be uninterrupted 
microsatellite tracts, and the mutant allele is transcribed (Imbert et al. 1996; Pulst et al. 
1996). 
SCA3, also known as MJD, is caused by a CAG microsatellite expansion in the 
coding region of ATXN3.  Normal individuals have repeat counts between 13 and 36, while 
individuals with SCA3 have repeat counts from 68 to 79.  Unlike SCA1 and SCA2, variant 
alleles are present in both normal and affected individuals, although expansions in SCA3 
patients are limited to the 3’ side of the last variant motif.  Typical of other trinucleotide 
microsatellite disorders, SCA3 has classic hallmarks consistent with genetic anticipation, as 
repeat count is correlated with age-of-onset (Kawaguchi et al. 1994). 
SCA6 is caused by a CAG microsatellite expansion in the coding region of several 
isoforms of CACNA1A.  Normal individuals have a repeat counts from 4 to 16, while 
affected individuals have repeat counts from 21 to 27 (Zhuchenko et al. 1997).  SCA7 is 
caused by a CAG microsatellite expansion in the coding region of ATXN7.  Normal 
individuals have repeat counts ranging from 7 to 17, while affected individuals exhibit 
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extreme variability, with repeat counts from 38 to 130.  Expanded alleles are somatically 
unstable and are highly associated with paternal transmissions.  Finally, SCA7 age-of-onset 
increases in successive generations, which is a hallmark of anticipation (David et al. 1997).  
According to the National Ataxia Foundation, there are now 36 types of spinocerebellar 
ataxia.  Of these, ten appear to be caused by microsatellite expansions, including the five 
described above. 
4.1.4.1.1.7 Friedreich ataxia 
Friedreich ataxia is unusual among microsatellite-linked neurodegenerative disorders 
since it is autosomal recessive.  98% of Friedreich ataxia chromosomes are caused by an 
expansion of a GAA microsatellite in the first intron of the FXN gene.  The remaining 2% of 
chromosomes studied had point mutations that were heterozygous with allele expansions—
all other individuals with Friedreich ataxia were homozygous for the expanded microsatellite.  
In unaffected individuals, the GAA microsatellite has a repeat count between 7 and 22, while 
affected individuals had repeat counts of at least 200.  Since Friedreich ataxia is autosomal 
recessive, it exhibits no signs of genetic anticipation.  In fact, all tested parents of individuals 
affected with Friedreich ataxia were heterozygous for the expanded GAA microsatellite 
(Campuzano et al. 1996). 
4.1.4.1.1.8 DRPLA/HRS 
DRPLA, also known as HRS, is yet another neurodegenerative disorder cause by a 
microsatellite expansion.  DRPLA is caused by an expansion of a CAG microsatellite in the 
coding region of ATN1.  In unaffected individuals, the microsatellite repeat count ranges 
from 3 to 25; while in individuals with DRPLA, repeat counts range from 49 to >75 (Burke 
et al. 1994; Koide et al. 1994; Nagafuchi et al. 1994).  Some studies suggest that longer CAG 
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alleles are correlated with earlier age-of-onset and more severe forms of DRPLA, while the 
same may not be true for HRS, suggesting that anticipation may play a role in DRPLA 
(Koide et al. 1994; Nagafuchi et al. 1994).  Most studies suggest that the expanded allele 
perfectly segregates with incidence of DRPLA/HRS (Burke et al. 1994; Koide et al. 1994).  
In the study that did not show perfect segregation, some unaffected individuals possessing 
the expanded allele later developed symptoms of DRPLA, implying that long-term disease 
incidence could segregate perfectly with the expanded allele (Nagafuchi et al. 1994).  
Expanded alleles are typically paternally transmitted, and affected individuals are all 
heterozygous for the expanded allele (Burke et al. 1994; Koide et al. 1994; Nagafuchi et al. 
1994). 
4.1.4.1.1.9 OPMD 
OPMD has a few characteristics that distinguish it from other typical microsatellite 
expansion diseases where mutations occur in coding regions.  While most diseases have 
expanded CAG microsatellites coding for polyglutamine tracts, OPMD has an expanded 
GCG microsatellite, which codes for a polyalanine tract.  The OPMD GCG microsatellite is 
in the first exon of PABPN1.  98% of chromosomes in normal individuals have a repeat 
count of 6, while the remaining 2% have a repeat count of 7.  Affected individuals have very 
short expansions—one individual homozygous for a repeat count of 7 had autosomal 
recessive OPMD, while other individuals in the study population have repeat counts from 8 
to 13.  Individuals with repeat counts above 8 had a dominant form of OPMD.  All alleles 
observed in OPMD are comparatively stable (Brais et al. 1998). 
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4.1.4.1.1.10 Synpolydactyly 
Synpolydactyly is caused by expansions in a GCG microsatellite in the first exon of 
the HOXD13 gene.  The GCG microsatellite is interrupted, and the sequenced microsatellite 
expansions possess the same interruptions.  Affected individuals are heterozygous for 
insertions of 21, 24, and 30 bp, although some unaffected individuals also appear to be 
heterozygous for expanded alleles as well (Muragaki et al. 1996).  Of all the microsatellite 
diseases reviewed here, synpolydactyly is the only one where expanded alleles possess 
variant repeats, and it also has the most complex penetrance pattern, since disease incidence 
does not appear to perfectly segregate with the expanded allele. 
4.1.4.1.2 Microsatellites in cancer 
4.1.4.1.2.1 HNPCC and MMP tumors 
HNPCC, also known as Lynch syndrome, is defined by increased risk for a 
constellation of cancers.  Individuals with HNPCC are extremely prone to colorectal cancers, 
and are more likely to be diagnosed with endometrial, gastric, pancreatic, and other cancers.  
HNPCC cancers typically have diploid tumor genomes.  HNPCC has specific diagnostic 
criteria, known as the Amsterdam criteria, which distinguish it from other MMP tumors 
(reviewed in de la Chapelle and Peltomaki 1995).  The MMP phenotype was first observed in 
a majority of HNPCC tumors studied, and in a subset of sporadic colorectal tumors 
(Aaltonen et al. 1993; Ionov et al. 1993; Parsons et al. 1993; Thibodeau et al. 1993; Perucho 
et al. 1994).  A study of an HNPCC-derived tumor cell line demonstrated marked defects in 
the repair of microsatellite slippage mutations and substitutions (Parsons et al. 1993).  This 
phenotype would indicate that while MMP may be a hallmark of some tumors, somatic 
substitutions might be the primary contributor to tumor development and progression.  The 
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link established by Parsons, et al. between HNPCC and MMR motivated researchers to 
identify human orthologs to S. cerevisiae and E. coli MMR proteins.  A brief review of the 
various MMR genes in humans can be found in section 4.1.2.2.1. 
MMP is not limited to HNPCC and sporadic colorectal tumors.  In a study of 10 
ovarian tumors without conclusive HNPCC diagnoses, 50% had MMP (Orth et al. 1994).  
However, other studies of sporadic ovarian tumors did not reveal extensive MMP (Han et al. 
1993; Osborne and Leech 1994).  One of the studies undermining the role of MMP in ovarian 
tumor development did demonstrate that a significant portion of sporadic gastric and 
pancreatic tumors had MMP (Han et al. 1993).  A study of 33 primary small cell lung cancers 
also revealed that 45% had MMP (Merlo et al. 1994). 
4.1.4.1.2.2 Frameshift mutations in MMR proteins 
In addition to being a hallmark of MMP, microsatellite frameshift mutations can play 
a role in cancer incidence and progression.  Several studies have identified frameshift 
mutations in genes that are components of the MMR machinery.  An 8 bp A microsatellite in 
MSH3 was mutated in 39% of MMP colorectal tumors studied, while an 8 bp C 
microsatellite in MSH6 was mutated in 30% of the same tumors.  The mutations were 
insertions or deletions of single motif, leading to frameshift mutations that could disrupt 
MMR function, particularly if they are complemented by nonsense or frameshift mutations in 
the second allele of the appropriate gene.  These mutations are not limited to colorectal 
tumors, as they are found in other MMP tumors studied (Malkhosyan et al. 1996; Miyaki et 
al. 1997).  Similar microsatellite tracts in other genes remain unchanged, indicating that these 
mutations are selected for in the course of tumor development (Malkhosyan et al. 1996). 
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4.1.4.1.2.3 Frameshift mutations in tumor suppressor genes 
TGFβRII, a gene responsible for controlling cellular proliferation, was the first tumor 
suppressor gene to be identified as a common target of microsatellite frameshift mutations.  
In a study of 111 HNPCC tumors, 90% had insertions or deletions of 1 – 2 bp in a 10 bp A 
microsatellite, while no frameshift mutations were observed in non-MMP tumors (Markowitz 
et al. 1995; Parsons et al. 1995).  Most tumors studied appeared to have frameshift mutations 
in both alleles.  In sequence analysis of a selection of tumors heterozygous for the frameshift 
mutation, a complementary mutation was found in the second TGFβRII allele.  As was the 
case for frameshift mutations in MSH3 and MSH6, the TGFβRII A microsatellite tract 
mutates more frequently than other similar microsatellites, suggesting that this mutation 
provides a selective growth advantage for the tumor (Parsons et al. 1995). 
IGFIIR is another tumor suppressor gene that is mutated in some MMP tumors.  In a 
study of a 92 diverse MMP tumors, 13% had mutations in IGFIIR, while no mutations were 
observed in non-MMP tumors.  Most of these mutations occurred in an 8 bp C microsatellite, 
while one mutation occurred in an interrupted CT microsatellite.  Mutations to IGFIIR and 
TGFβRII are nearly mutually exclusive—of 31 tumors with mutations in either IGFIIR or 
TGFβRII, only three had mutations in both.  In total, more than one third of MMP tumors 
had a mutation in either gene.  Once again, similar microsatellites in other genomic locations 
do not have recurrent mutations in MMP tumors, suggesting a selective growth advantage is 
provided by the IGFIIR frameshift mutation (Souza et al. 1996). 
A study of the pro-apoptotic BAX gene revealed that >50% of MMP colorectal 
cancers studied had frameshift mutations in an exonic 8 bp C microsatellite.  These mutations 
were typically insertions or deletions of a single motif.  No BAX protein was detected in cell 
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lines with BAX mutant microsatellites, indicating that these mutations were homozygous, 
hemizygous, or had a complementary mutation on the second BAX allele.  BAX frameshift 
mutations did not occur in non-MMP tumors.  Microsatellite tracts in other regions of the 
genome with composition similar to this BAX microsatellite do not have recurrent frameshift 
mutations, suggesting that the BAX frameshift mutation provides a selective advantage in 
tumor development (Rampino et al. 1997). 
Frameshift mutations in other tumor suppressors may also provide selective growth 
advantages to MMP tumors.  In a study of 49 MMP colorectal tumors, 39% of tumors had a 1 
bp deletion in a 9 bp A microsatellite in TCF4.  Similar microsatellite tracts did not have the 
same mutation frequency in MMP tumors (Duval et al. 1999).  In two studies of MMP 
tumors, EPHB2 was found to have frequent frameshift mutations in a 9 bp A microsatellite—
40% of MMP colorectal cancers had the mutation, as did 39% of MMP gastric tumors and 
14% of endometrial tumors.  All of the colorectal frameshift mutations were somatic; and 
both colorectal and gastric EPHB2 appeared to confer a selective advantage to the tumor 
(Alazzouzi et al. 2005; Davalos et al. 2007).  In a study of 15 sporadic gastrointestinal MMP 
tumors, 1 bp deletions in a 9 bp A microsatellite in the BLM gene occurred in 27% of the 
cases and did not occur in any non-MMP gastrointestinal tumors (Calin et al. 1998; Calin et 
al. 2001).  In a study of 75 MMP gastric and colorectal cancers, 31% were found to have 
frameshift mutations in a 9 bp A microsatellite in RAD50 and 21% had mutations in the 
above-mentioned BLM microsatellite.  All BLM and RAD50 mutations were heterozygous 
(Kim et al. 2001).  The roles of TGFβRII, BAX, MSH3, MSH6, IGFIIR, and BLM were 
reinforced in a study of 63 MMP colorectal tumors of various types, which had frequent 
recurrent frameshift microsatellite mutations in each gene.  Many of these mutations, 
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including the BLM frameshift, were correlated with specific clinical and pathological 
parameters, reinforcing their roles in tumor development and progression (Calin et al. 2000). 
Microsatellite frameshift mutations are not limited to MMP tumors.  The APC tumor 
suppressor gene is frequently mutated in both MMP and non-MMP tumors.  In a study of 101 
sequenced APC mutations in colorectal cancer, frameshift mutations at short microsatellite 
loci were identified in both MMP and non-MMP tumors.  In MMP tumors, 81% of APC 
frameshift mutations were insertions or deletions of 1 – 2 bp at microsatellite loci with 1 and 
2 bp motifs and tract lengths ranging from 3 bp to 10 bp.  In non-MMP tumors, 37% of APC 
frameshift mutations were insertions or deletions of 1 – 4 bp at microsatellite loci with 1 and 
2 bp motifs and tract lengths ranging from 3 bp to 13 bp.  Every tumor screened had 
truncated APC protein product (Huang et al. 1996).  While frameshift mutations at 
microsatellite loci are more common in MMR tumors, they may play a role in many different 
types of tumors. 
There is also an apparent association between CAG microsatellite expansions in the 
AIB1 gene and breast cancer risk in BRCA1 carriers.  The relative risk of breast cancer 
incidence was 1.29 in individuals the BRCA1 mutation and two AIB1 alleles with repeat 
counts of at least 29.  The same effect is not observed in BRCA2 carriers, indicating a 
specific effect that distinguishes between these two high-risk breast cancer mutations 
(Kadouri et al. 2004). 
4.1.4.1.3 FALS/FTD 
FALS/FTD is the third most common neurodegenerative disease and is autosomal 
dominant.  Many cases of FALS/FTD are due to an expansion of a GGGGCC microsatellite 
tract in C9ORF72.  C9ORF72 has at least three transcript variants, two that contain the 
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microsatellite in the first intron, and one that contains the microsatellite in the promoter 
(DeJesus-Hernandez et al. 2011).  In normal individuals, the repeat count ranges from 0 to 
23; while in affected individuals, the repeat count ranges from 30 to >1600 (DeJesus-
Hernandez et al. 2011; Renton et al. 2011).  In a Finnish cohort study, this expansion was 
observed in ~46% of familial FALS/FTD cases and 21% of sporadic cases (Renton et al. 
2011).  One third of FALS/FTD patients of European descent also have the expanded allele 
(Renton et al. 2011).  The expansion almost perfectly segregates with the FALS/FTD disease 
phenotype—only 0.4% of unaffected individuals have the mutant allele (Renton et al. 2011).  
The expanded microsatellite is haplotype-specific, although normal individuals can have the 
risk haplotype without the expanded allele (DeJesus-Hernandez et al. 2011).  The GGGGCC 
expansion in C9ORF72 is the most common cause of FALS/FTD that has been identified to 
date (DeJesus-Hernandez et al. 2011; Renton et al. 2011). 
4.1.4.1.4 Microsatellite disease summary 
The current model of the role of microsatellites in human disease is composed of two 
broad categories.  The first is composed of neurodegenerative diseases caused by 
microsatellite expansions, typically at trinucleotide motifs.  Microsatellite mutations in these 
diseases are highly penetrant and segregate strongly with disease incidence.  These 
expansions occur in a variety of genomic contexts and do not have a single pathogenic 
mechanism.  Many of these diseases exhibit genetic anticipation—age-of-onset becomes 
earlier in successive generations, and can be accompanied by increasingly severe disease 
symptoms.  The second category of diseases is composed of frameshift mutations in tumor 
suppressor genes.  These mutations typically occur in short microsatellites with 1 bp motifs.  
Many of them truncate protein products, implying that these mutations must either be 
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homozygous, hemizygous, or complemented by a nonsense mutation in the second allele of 
the gene.  Some of these tumor suppressor genes may also be dosage dependent.  These 
categories are probably not exhaustive—there is no reason to assume that they are the only 
mechanisms by which microsatellite mutations cause disease.  A summary of the 
microsatellite loci linked to human disease can be found in Table 4.1 on pages 92-93. 
4.1.4.2 Microsatellites in forensic analysis 
Forensic DNA analysis relies on microsatellite genotyping for DNA evidence in 
convictions, exonerations, and identifying human remains.  Microsatellites are particularly 
useful for these purposes since they can be observed in short DNA fragments (< 300 bp) and 
can be amplified from samples with non-human contamination.  These two factors are 
particularly important when unidentified human remains are found in unprotected gravesites 
or have decayed significantly.  Microsatellites were first used to identify the remains of an 8-
year old murder victim in 1991.  This was accomplished by comparing the victim’s 
microsatellite genotypes to her parents’ at 6 microsatellite loci.  Identity was established by 
calculating the likelihood that any person would have genotypes consistent with Mendelian 
inheritance by chance using established microsatellite allele frequencies for the loci used 
(Hagelberg et al. 1991).  Microsatellite genotypes have also been used to identify the remains 
of victims after enormous disasters, including plane crashes (Olaisen et al. 1997). 
Microsatellite analysis can occasionally aid in victim identification even when living 
parents are not available.  In 1991, a shallow grave was discovered in Yekaterinburg, Russia 
with remains of what was thought to be the last Tsar and Tsarina of Russia, three of their 
children, and three servants, all of whom were murdered on July 17, 1918.  Microsatellite 
genotyping of the 75-year old remains established that five of the victims at the gravesite 
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were two parents and their children, and that the three other victims were unrelated to any of 
the others.  Since living relatives of the Tsar’s family were separated by several generations, 
the bloodlines of the Tsar and Tsarina were confirmed using mitochondrial DNA (Gill et al. 
1994). 
A 14-locus microsatellite panel for use in forensic investigations was first proposed in 
1993, with a match probability of < 1 × 10−14 (Kimpton et al. 1993).  As of 2004, there are 
13 CODIS core loci in the FBI’s NDIS, with a match probability < 1 × 10−13 (Jobling and 
Gill 2004).  Federal, state, and local authorities use NDIS to identify suspects using DNA 
evidence isolated from crime scene samples.  The same information can be used to exonerate 
wrongly convicted individuals.  Although there are some initial attempts to genotype CODIS 
microsatellites using HTS data, forensic genotyping still relies on PCR and capillary 
electrophoresis (Bornman et al. 2012). 
4.1.4.3 Paternity testing 
Microsatellite genotypes are frequently used to establish paternity or patrilineal 
descent.  One particularly interesting example was the use of Y chromosome microsatellite 
loci in combination with other DNA markers to establish that Thomas Jefferson likely 
fathered at least one child with his slave, Sally Hemings.  In particular, male-line descendants 
of Thomas Jefferson’s uncle and of Eston Hemings Jefferson—one of Sally Heming’s 
purported sons with Thomas Jefferson—share the fairly unique Jefferson Y chromosome 
(Foster et al. 1998).  Estimating the average rate of de novo microsatellite mutations in true 
descendants is essential when establishing paternity.  Several studies have estimated 
microsatellite mutation rates on the Y chromosome for use when establishing paternity for 
male offspring (Heyer et al. 1997; Kayser et al. 2000). 
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The most successful application of HTS microsatellite genotypes to date has been 
surname recovery from chromosome Y microsatellite loci from whole genome sequencing 
data.  By comparing microsatellite genotypes to those available from public genetic 
genealogy databases and assuming that chromosome Y microsatellites and surnames are both 
patrilineal, some family pedigrees and specific individuals could be identified.  This was 
particularly true when other demographic information was available for a person, such as 
birth year and state of residency.  Genetic privacy will continue to decrease as the amount of 
public microsatellite genotypes and other polymorphism data linked to surnames increases 
(Gymrek et al. 2013).  
4.1.4.4 Microsatellite-based genetic linkage maps and identifying disease loci 
One of the first studies describing extensive microsatellite polymorphism within a 
human population also suggested leveraging this polymorphism in linkage studies (Litt and 
Luty 1989; Weber and May 1989).  This achievement was first realized by creating a genetic 
linkage map of the human genome with an average resolution of 5 cM (Weissenbach et al. 
1992).  Several years later, average resolution was increased to 1.6 cM, allowing highly 
accurate linkage mapping of both monogenic and complex human diseases (Dib et al. 1996).  
Many of the diseases described above in section 4.1.4.1.1 were first characterized by 
identifying particular haplotypes and genomic regions that had strong linkage with disease 
incidence in families (see, for example, Burke et al. 1994; Muragaki et al. 1996; Brais et al. 
1998).  With the development of SNP arrays and GWAS, linkage mapping in human diseases 
is less common than it once was.  However, linkage maps remain a powerful means of 
relating phenotypes to genomic regions in organisms without published reference genomes. 
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4.1.4.5 Microsatellites in population genetics 
Microsatellites have found several interesting applications within population genetics.  
Microsatellite polymorphism has been used to assign individuals from geographically distinct 
regions to their continents of origin with 88% accuracy.  Within European, American, and 
Oceanian continental subgroups, individuals tend to form clusters corresponding to their 
population of origin.  African populations have greater microsatellite allele diversity than 
other continental subgroups, supporting the hypothesis of an African origin for humans.  This 
same study provided two other key insights regarding microsatellite diversity in population 
genetics.  First, most microsatellite alleles are neither continent- nor population-specific—on 
average, individuals from different continental subpopulations share 27% of their alleles, 
while individuals from the same continental subpopulation share 36% of their alleles.  
Second, microsatellite genotypes are not informative enough to recover deeper lineages, such 
as primate lineages (Bowcock et al. 1994).  This study suggests that microsatellites might be 
an effective means of resolving relatively short evolutionary timescales within a particular 
species (Jorde et al. 1997). 
Several later studies reinforce the findings of Bowcock, et al., particularly with 
regards to recovering continental subgroups from microsatellite data and the enormous 
amount of microsatellite polymorphism relative to other genetic markers.  In two studies on 
microsatellite diversity and the origin of modern humans, it was again suggested that there is 
little genetic differentiation between continental subpopulations—microsatellite diversity is 
nearly the same within and between population subgroups.  Microsatellite instability is high 
enough that the same allele will emerge multiple times in disparate human populations, 
violating the infinite alleles model.  Continental subgroups could still be resolved despite the 
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high level of diversity (Jorde et al. 1995; Jorde et al. 1997).  Many studies also echo the 
observation of Bowcock, et al. with regards to the resolution provided by microsatellite 
loci—they are most effective for recovering relatively recent lineages, and are not suited for 
inter-species evolutionary analyses (Heyer et al. 1997; Jorde et al. 1997; Schlötterer et al. 
1997).  Since microsatellite mutation rates are higher than mutation rates for other genetic 
markers and are highly variable among loci, care needs to be taken when considering them in 
analyses that require mutation rate estimates or that attempt to distinguish subpopulations 
based on the presence of unique alleles.  One strategy that has been employed with some 
success it to use short microsatellite loci that are more likely to have population-specific 
alleles due to their lower mutation rates (Brinkmann et al. 1998).  Another strategy is to 
employ statistical tests that do not implicitly assume a constant mutation rate (Jorde et al. 
1997). 
Population genetics studies using microsatellite loci have been used to infer 
interesting details about human history.  The Kaingang people exhibit decreased 
microsatellite diversity as compared to other populations, which implies a population 
bottleneck in indigenous American populations around the time of the colonization of the 
Americas (Di Rienzo et al. 1998).  This observation is reinforced by a genome-wide 
microsatellite study of indigenous American populations (Wang et al. 2007).  Additionally, 
in comparisons of two models for human demographic history, microsatellite variation seems 
to imply that humans underwent rapid population growth since the human-chimpanzee 
speciation event (Di Rienzo et al. 1998).  A later study estimated a microsatellite mutation 
rate from loci with 2 bp motifs, which was used to infer that the human-chimpanzee 
speciation event occurred 3.75 – 6.57 million years ago (Sun et al. 2012).  
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Population genetic insights from microsatellite loci are not limited to humans.  A 
study of natural D. melanogaster populations lent additional support to the African origin 
hypothesis for the species.  The same study was also able to identify at least one selective 
sweep within a specific D. melanogaster subpopulation, with weaker evidence for selective 
sweeps in other populations (Schlötterer et al. 1997). 
4.1.4.6 Recovering cellular lineages using microsatellite loci 
Several studies have leveraged the considerable somatic instability of some 
microsatellite loci to infer the cellular lineages, and by extent, developmental history, of 
animals and tumors.  One of the first efforts to infer tumor development from microsatellite 
mutations evaluated cancer progression in HNPCC patients.  Based on the recovered lineages 
inferred from microsatellite genotypes in hundred-cell samples, consecutive studies 
suggested that tumors exhibit behavior consistent with clonal evolution along multiple 
lineages (Tsao et al. 1998; Tsao et al. 1999).   
Subsequent proof-of-concept studies sought to demonstrate that cellular resolution of 
tumor and developmental lineages could be obtained from somatic microsatellite mutations.  
In a study of 84 cells genotyped at 31 G microsatellites in a single mouse, sufficient 
resolution was obtained to suggest that liver development pattern occurred at a lobular level, 
although resolution was insufficient for developmental inferences in other organs (Salipante 
and Horwitz 2006).  By creating artificial “clones” from cultured MMR deficient cells, a 
second study was able to recover accurate lineages based on a few hundred microsatellite 
loci.  The same study suggested that in MMR proficient cells, hundreds of thousands to 
millions of microsatellite genotypes might be necessary to recover complete lineages 
(Frumkin et al. 2005).   
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Inferences based on microsatellite-based cellular lineages have provided some limited 
insight into organ and tumor development.  A study of microsatellite phylogenies from a 
subset of murine cell types suggested that cell types are not derived from distinct, clonal 
lineages and that nearby myosatellite cells share longer developmental paths than distant 
myosatellite cells (Wasserstrom et al. 2008).  Microsatellite lineages were also used to 
provide insight into the dynamics of murine colonic stem cell crypts: crypts are monoclonal, 
there is no evidence of an immortal strand within colonic stem cells, and proximal colonic 
crypts are more closely related to each other than distal crypts (Reizel et al. 2011).  
Microsatellite lineages allowed for tumor age estimation in a murine lung tumor, 
demonstrated that nearby tumor cells are more closely related to each other, and established 
the particular tumor as having a monoclonal origin (Frumkin et al. 2008). 
4.1.4.7 Phenotypic variation due to microsatellites 
4.1.4.7.1 Variation due to exonic microsatellite polymorphism 
Phenotypic variability due to microsatellite polymorphism is not limited to human 
disease.  In a study evaluating the effect of microsatellites coding for polyproline and 
polyglutamine stretches within GAL4 on transcriptional activity, the lengths of the respective 
amino acid tracts were correlated with expression.  In HeLa cells, transcriptional activity was 
positively correlated with glutamine tracts of up to 40 units.  In the same system, a series of 
10 consecutive prolines was found to produce maximal transcriptional activity—subsequent 
proline tract expansions led to reduced activity (Gerber et al. 1994).  In several studies, 
variation in adjacent glutamine and alanine repeats in RUNX2 accounted for a significant 
amount of variance in the craniofacial shape of different dog breeds, and in Carnivora more 
generally (Fondon and Garner 2004; Fondon and Garner 2007; Sears et al. 2007).   
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4.1.4.7.2 Variation due to non-exonic microsatellite polymorphism 
Variation in non-coding microsatellites also contributes to phenotypic variation.  
Soon after the discovery that AC microsatellites were ubiquitous in eukaryotic genomes, AC 
microsatellites were inserted into enhancer sequences to determine their effect on gene 
expression.  As compared to controls, transcription from an enhancer with an AC 
microsatellite was 2 – 10 times higher than control enhancers.  Transcriptional activity 
decreased as the AC microsatellite length increased (Hamada et al. 1984).  A more direct 
phenotypic effect of non-exonic microsatellite variation modulating gene expression was 
described in an analysis of the sociobehavioral effects of microsatellite variation in prairie 
voles.  Differences in the distribution of the avpr1a gene product in the prairie vole brain 
depend on variation in several long microsatellite tracts in the 5’ regulatory region of the 
gene.  Males with longer microsatellite alleles spend more time caring for their pups and 
exhibit stronger monogamous tendencies than prairie voles with shorter alleles.  There were 
no general changes in male anxiety that could explain these changes, indicating that tract 
length variation likely accounted for specific social behaviors (Hammock and Young 2005). 
4.1.5 Microsatellite genotyping methods 
4.1.5.1 Southern blot detection and genotyping of microsatellite loci 
The Southern blot was essential to the discovery of widespread microsatellite 
sequences throughout mammalian genomes.  Southern blots demonstrating strong 
hybridization between an AC microsatellite tract in E. coli and DNA from HeLa cells 
provided the first evidence that AC microsatellites were common throughout the human 
genome (Hamada and Kakunaga 1982).  Subsequent blotting experiments using bacterial and 
viral DNA as probes provided the first evidence that AC microsatellites were a ubiquitous 
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component of eukaryotic genomes (Hamada et al. 1982b; Jeang and Hayward 1983).  Only a 
few years later, this observation was extended to many more microsatellite motifs in several 
eukaryotic genomes using the same methods (Tautz and Renz 1984).   
Southern blotting has also been used to assess the variability of disease-associated 
microsatellites.  In some of the initial experiments characterizing the mutations causing 
SCA1, candidate genes were screened for microsatellites by Southern blot using a CAG 
probe.  Once ATXN1 was identified as a candidate gene for SCA1, the CAG repeat 
variability was established by Southern blotting after a restriction digest to isolate the 
appropriate DNA fragment (Orr et al. 1993).  The same approach was taken to assess the 
instability of the Fragile X-linked CGG repeat (Kremer et al. 1991). 
4.1.5.2 PCR amplification of microsatellite loci 
PCR amplification of microsatellite loci is currently the most widespread method to 
isolate microsatellites for downstream analysis.  PCR methods for isolating microsatellite 
loci were developed almost simultaneously by two separate groups (Litt and Luty 1989; 
Weber and May 1989).  Almost every experiment described in this section that isolated 
microsatellite sequences for genotyping started with PCR amplification.  Although PCR 
amplification can be followed by Southern blot genotyping, most current microsatellite 
genotyping methods involve one of the following three techniques. 
4.1.5.2.1 PAGE genotyping of microsatellite loci 
When primers specific to a particular microsatellite locus can be designed, PAGE is 
an effective means of calling genotypes at a locus.  PAGE genotyping was used in the first 
applications of PCR to microsatellite loci (Litt and Luty 1989; Weber and May 1989).  
PAGE comparison of microsatellite genotypes has been used to analyze normal and mutant 
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alleles at disease-associated microsatellite loci and in MMP tumors (see, for example, Fu et 
al. 1992; Mahadevan et al. 1992; Thibodeau et al. 1993).  PAGE was also the initial 
technique of choice in early forensic analyses of microsatellite loci (Hagelberg et al. 1991; 
Gill et al. 1994; Olaisen et al. 1997).  Initial studies of tumor evolution also relied on PAGE 
to call microsatellite genotypes (Tsao et al. 1998; Tsao et al. 1999). 
4.1.5.2.2 Capillary electrophoretic microsatellite genotyping 
Capillary electrophoresis allows for significant automation of microsatellite 
genotyping, and has higher throughput than PAGE or Southern blot genotyping methods.  
Current forensic microsatellite genotyping is typically performed using capillary 
electrophoresis (Jobling and Gill 2004).  Many of the more recent microsatellite genotyping 
studies described earlier in this section called microsatellite genotypes using capillary 
electrophoretic data.  With these techniques, studies of thousands of microsatellite loci have 
been possible on an enormous Icelandic cohort (Sun et al. 2012).  Capillary electrophoresis 
has also been the genotyping technique of choice in microsatellite genotyping studies using 
single cells (see, for example, Frumkin et al. 2005; Salipante and Horwitz 2006). 
4.1.5.2.3 Microsatellite genotyping from first-generation DNA sequencing data 
Maxam-Gilbert sequencing led to the first direct observations of microsatellite 
sequences (see, for example, Miesfeld et al. 1981; Hamada et al. 1982a).  Sanger sequencing 
has been an essential tool in analyzing disease-linked microsatellite loci.  In particular, 
Sanger sequencing of selected affected and normal individuals in various disease studies led 
to the discovery of stabilizing variant repeats or otherwise interrupted microsatellite tracts 
(see, for example, Chung et al. 1993; Eichler et al. 1994; Muragaki et al. 1996). 
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4.1.5.3 HTS methods for microsatellite genotyping 
4.1.5.3.1 HTS microsatellite genotyping challenges 
In order to genotype microsatellite loci using HTS data, several issues must be 
addressed.  Any microsatellite genotyper must first define what it considers a microsatellite 
locus.  Every published method for HTS microsatellite genotyping so far appears to rely on 
TRF to define microsatellite loci.  TRF is capable of identifying interrupted microsatellites 
with statistical signal for repetitiveness.  However, some shorter microsatellite motifs that 
have a demonstrated ability to undergo slippage may go undetected.  While this choice may 
be appropriate for some applications, it will be unsuitable for others. 
With the exception of lobSTR, microsatellite genotypers do not directly identify 
microsatellites in sequencing data.  Other genotypers rely on identifying microsatellites by 
comparing read positions to known microsatellite regions once alignment is complete.  Direct 
microsatellite detection in sequencing data depends on the base-calling quality of the 
sequence within the microsatellite read.  The only current microsatellite genotyper to 
consider base-calling quality is RepeatSeq.  There does not appear to be a single algorithm 
that directly detects microsatellites in sequencing data and considers base-calling quality in 
detected microsatellites. 
Microsatellite alignment is very sensitive to insertions and deletions.  Alignment 
algorithms such as BWA have ad hoc rules for aligning insertions and deletions, as well as 
about sequence variation more broadly, that limit their ability to map microsatellites with 
large mutations relative to the reference genome (Li and Durbin 2009).  Even methods that 
use more sophisticated mappers such as BWA-MEM or Bowtie2 may not have alignment 
parameters that are appropriate for microsatellite loci.  Any microsatellite genotyper that 
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relies on an alignment algorithm’s general indel detection framework to correctly map 
microsatellite reads may not be able to accurately map microsatellite reads with large 
slippage events. 
A well-documented problem that is present any time a microsatellite locus is 
amplified is PCR slippage (Litt and Luty 1989; Weber and May 1989; Gymrek et al. 2012; 
Highnam et al. 2013).  Furthermore, while the average rate of slippage may be modeled 
accurately by a few parameters describing the locus, slippage could vary considerably 
between similar microsatellite loci.  Even with the characteristics affecting microsatellite 
instability described in section 4.1.2.3, microsatellite stability is still not completely 
understood.  If this unpredictability is true for slippage in vivo and in vitro, any averaged 
PCR slippage estimate will be inaccurate for a significant portion of microsatellite loci.  At 
the very least, metrics should be provided describing how well a proposed genotype fits with 
a genotyper’s error model.  With this information, users can make informed choices about 
whether the proposed genotype is consistent with the slippage model proposed.  Generalized 
error models could significantly impair the sensitivity and specificity of any microsatellite 
genotyper, which would be particularly damaging when attempting to identify de novo 
microsatellite mutations. 
In certain systems, such as exome capture, microsatellite capture may be significantly 
impaired.  Some studies have already described decreased capture efficiency for non-
reference indel alleles in exome capture data (Iossifov et al. 2012).  It is reasonable to expect 
that these same challenges will exist when considering microsatellite indels specifically.  
Moreover, in order to genotype microsatellite loci, alleles must be completely contained 
within sequencing reads.  Therefore, longer microsatellite alleles may have lower coverage 
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than shorter alleles at the same locus if read lengths are a limiting factor.  Both of these 
concerns suggest that coverage biases among microsatellite alleles at a locus must be 
accounted for to obtain accurate microsatellite genotype calls. 
Finally, regardless of how a genotyper defines a microsatellite, some true 
microsatellite mutations will escape detection.  No published algorithm accounts for mutation 
events that move microsatellites outside their respective detectable ranges.  Furthermore, 
microsatellite can exist in CNVs, which would invalidate any bi-allelic genotype call.  In 
these situations, it is necessary to have some sense of what the expected coverage at a 
microsatellite locus should be.  Only then can a genotyper assess whether coverage is 
sufficient to suggest that two alleles—and only two alleles—are being detected. 
4.1.5.3.2 TRF-derived microsatellite genotypers 
Since the development of HTS, several groups have designed microsatellite 
genotypers that leverage this data to call microsatellite genotypes either in great depth or 
across hundreds of thousand to millions of loci.  Nearly every current HTS microsatellite 
genotyper relies on TRF to define reference microsatellite loci.  Therefore, before describing 
the advantages and disadvantages of some of the most recent microsatellite genotyping 
methods, a brief overview of how TRF defines microsatellite loci is in order. 
TRF uses a probabilistic model to detect two or more contiguous, approximate copies 
of the same motif.  TRF detects motif lengths up to several hundred bp, so it will detect 
microsatellite, minisatellite, and satellite DNA.  It accomplishes this by scanning an input 
sequence for matches of DNA kmers and comparing the distance between consecutive 
matches, as well as any intervening matches to other kmers.  TRF looks to identify regions of 
the genome where a repeated pattern occurs more often than would be expected by chance, as 
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characterized by several distributions.  By setting a window size, kmer length, and a 
tolerance for mismatches and indels, candidate tandem repeats can be identified.  If the 
putative tandem repeat contains at least two copies of the putative motif, TRF will report the 
repeat with information including the motif length, motif, and sequence identity.  TRF 
performance on sample datasets demonstrates some inconsistency in detecting 
microsatellites—five previously annotated microsatellites in a human gene were not detected 
by TRF, while another 13 previously unknown microsatellites in the same gene were 
identified by TRF (Benson 1999). 
4.1.5.3.2.1 lobSTR 
The most successful HTS microsatellite genotyping algorithm to date, lobSTR splits 
genotyping into three stages: sensing, alignment, and allelotyping.  lobSTR statistically 
senses microsatellites by measuring the sequence entropy of overlapping windows within a 
sequencing read using 2 bp kmers.  A lower entropy score corresponds to more repetitive 
sequence.  By setting a specific entropy threshold, lobSTR identifies both interrupted and 
uninterrupted putative microsatellite sequences with high specificity and sensitivity.  lobSTR 
then determines the microsatellite motif length using a fast Fourier transform to identify 
strong periodic signals within the repetitive region.  Finally, lobSTR sets the most common 
kmer of the appropriate motif length within the repetitive region as the consensus motif 
(Gymrek et al. 2012). 
lobSTR uses BWA to align microsatellite reads to a customized reference set of 
microsatellite flanking sequences separated by motif equivalence class (Li and Durbin 2009).  
The reference microsatellite set is determined using a TRF scan of the reference genome.  
The minimum amount of flanking sequence on either side of a microsatellite typically 
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required by lobSTR to accurately map a microsatellite locus is 8 – 9 bp.  The resulting 
alignments determine the position and tract length of a microsatellite in a read, since the 
lobSTR sensing step cannot define exact microsatellite boundaries.  After an initial alignment 
step, lobSTR realigns reads in the candidate region using the Needleman-Wunsch local 
realignment algorithm (Needleman and Wunsch 1970; Gymrek et al. 2012). 
lobSTR calls “allelotypes” by considering the reads aligned at a particular 
microsatellite locus and a model of expected stutter noise.  The expected stutter noise model 
can either be generated in the course of sample preparation, or a standardized model can be 
used.  For each read, lobSTR calculates the likelihood that it represents a true genotype or 
whether it is a product of slippage noise, taking into account the distance between the 
observed tract length and the putative allele lengths.  lobSTR’s noise model is based on a 
logistic regression modeling of the slippage probability and a Poisson regression modeling of 
the distance of a read from a hemizygous reference.  The logistic regression model uses four 
parameters when estimating slippage probability: motif length, tract length, flanking GC 
content, and sequence identity.  However, lobSTR does not detect any relationship between 
tract length and noise rate.  The Poisson regression on the distance of a read from a 
hemizygous reference allele assumes that errors frequently arise from slippage events, and 
occasionally arise from non-microsatellite indels and substitutions (Gymrek 2013).  lobSTR 
noise models are inferred from hemizygous microsatellites on the Y chromosome in males.  
In addition to a noise model, lobSTR requires that each allele at a heterozygous locus have 
≥20% of total coverage at a locus, that the best allelotype has ≥50% of total coverage at a 
locus, and that allelotypes on sex chromosomes only have one allele (Gymrek et al. 2012). 
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lobSTR was initially validated using biological replicates from the same individual.  
In separate blood and saliva samples from a single person, and limiting calls to loci with at 
least 21X coverage, genotype discordance was 3%, while allelotype discordance was 2%.  
Most discordant microsatellite loci had slippage-prone 2 bp motifs, so miscalls may be due to 
high error rates.  Comparing Mendelian inheritance within a trio also validated lobSTR.  Loci 
with at least 15X coverage each trio member had a Mendelian inheritance rate of 99%.  
However, this coverage threshold limited lobSTR genotypes to ~1% of all loci in their 
reference set (Gymrek et al. 2012).  Even if we were to assume that every microsatellite locus 
had the highest microsatellite mutation rates reported in the literature, this de novo mutation 
rate is at least an order of magnitude too high.  lobSTR was subsequently used with moderate 
success to recover surnames from sequencing data based on chromosome Y STRs (Gymrek 
et al. 2013). 
lobSTR is a powerful tool for certain types of microsatellite analyses.  By focusing on 
somewhat long and interrupted microsatellite loci, it can compare genotypes within a 
population at loci that have frequent SNPs or indels.  The types of applications it has been 
applied to this far benefit greatly from the overall accuracy of the technique, since the focus 
has been on population information, or on Y chromosome microsatellites where there are no 
heterozygous calls to be made.   
lobSTR is not without its caveats.  Some versions consider microsatellites with 1 bp, 
while others do not.  lobSTR also has very limited coverage of microsatellites in exons.  The 
standard slippage model distributed with lobSTR was compiled by the Erlich lab from tens of 
thousands of Y chromosome microsatellite loci.  Therefore, variance in microsatellite 
slippage rates due to specific experimental protocols will not be detected.  The error model 
 79 
also assumes that locus instability can be estimated per locus by a logistic regression on four 
variables.  This assumption may describe the average locus slippage rate based on broad 
parameters, but it will not capture the variance in microsatellite slippage rate among similar 
microsatellite loci.  This variance can be stochastic, or it can be due to parameters not 
included in the model.  Finally, lobSTR’s own validation demonstrates that microsatellite 
allelotypes are correct ~99% of the time, which is sufficient for inferring “broad” information 
about microsatellites in the human genome.  This could be population behavior at a 
microsatellite locus, or a sense of microsatellite variation within the lobSTR reference set.  
lobSTR’s reported accuracy does not suggest it is capable of accurately identifying specific 
instances of microsatellite mutation or polymorphism, particularly de novo microsatellite 
mutations or microsatellite mutations that may be related to particular phenotypes or 
diseases. 
4.1.5.3.2.2 RepeatSeq 
The only other HTS microsatellite genotyper published that considers microsatellite 
slippage is RepeatSeq.  RepeatSeq takes data that has already been aligned using BWA or 
Bowtie2, and has been processed using GATK’s IndelRealigner.  RepeatSeq then identifies 
reads that completely contain microsatellites in its TRF-derived reference set of 
microsatellites with motif lengths from 1 to 5 bp.  RepeatSeq determines the most probable 
genotype at a locus by considering all possible allele combinations using Bayesian model 
selection, where each model is a possible genotype.  The noise parameters for RepeatSeq are 
derived from sequencing data from >100 inbred fly genomes.  The noise model is based on 
three parameters: reference microsatellite tract length, motif length, and average base-calling 
quality of the microsatellite tract.  The model is binned into a 5 × 5 × 5 array, which is used 
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to select an appropriate error rate for a locus.  RepeatSeq requires a minimum of two reads at 
a locus to call a genotype (Highnam et al. 2013). 
In early implementations of lobSTR and RepeatSeq, lobSTR appeared to have the 
most accurate microsatellite mappings, while RepeatSeq mapped more microsatellite loci.  
However, in their current implementations, lobSTR and RepeatSeq consider the same 
reference microsatellite set.  When calling genotypes in a parent/child trio, RepeatSeq’s best 
performance with regards to Mendelian inheritance is ~98% when minimum coverage for 
every individual is at least 17X.  In comparisons of lobSTR and RepeatSeq genotypes from 
the same sequencing data, genotypes were found to be ~88% concordant at loci where both 
pipelines made a genotype call.  At loci with discordant calls between the two pipelines, 
RepeatSeq was concordant with capillary electrophoresis validation ~62% of the time, while 
lobSTR was only concordant 10% of the time.  lobSTR also occasionally mapped more reads 
to the locus (Highnam et al. 2013). 
RepeatSeq has many of the same drawbacks as lobSTR when genotyping 
microsatellite loci.  While both methods allow for improved microsatellite genotyping from 
HTS data as compared to methods that do not consider microsatellite slippage, neither comes 
close to the accuracy necessary to detect some of the most meaningful microsatellite 
mutations.  Its error model is likely to be less accurate than lobSTR’s error model, 
particularly when a microsatellite allele in an individual deviates significantly from the 
reference.  Moreover, RepeatSeq is sensitive to whatever heuristics are employed by the 
upstream alignment algorithm, which might limit indel size and impair its ability to detect 
long microsatellite indels.  This is certainly the case with BWA (Li and Durbin 2009). 
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4.1.5.3.2.3 Other methods 
At least three other methods have been published that attempt to use HTS data to 
genotype microsatellites.  One method used reads aligned by BWA that have been filtered 
using a set of ad hoc parameters to provide robust allelotypes at ~1,000 informative 
microsatellite loci that also conformed to Mendelian inheritance (McIver et al. 2011).  This 
method did not have any error model accounting for slippage noise and was subject to the 
additional ad hoc parameters defined by BWA when detecting indels in sequencing data (Li 
and Durbin 2009).  Another HTS microsatellite genotyper was published that was designed 
to specifically call genotypes at CODIS loci.  This genotyper did not need an explicit error 
model since coverage was very high at the selected loci.  In addition, the targeted loci were 
mapped to a reference set of CODIS loci with all possible alleles, rather than aligning reads 
to the reference genome, obviating the need for gapped alignment.  In general, this method 
seemed to perform well as compared to typical CODIS genotyping via capillary 
electrophoresis, but it does not present a generalizable method for large-scale microsatellite 
genotyping (Bornman et al. 2012).  Most recently, STRViper, a method for calling genotypes 
at TRF-defined microsatellite loci by inferring insertions or deletions from the insert sizes of 
paired-end reads was published.  This method relies on high coverage and low variance in 
DNA fragment length, and has no noise model for stutter (Cao et al. 2014).  While it is able 
to detect large indels, it provides no direct observation that proves an indel near a 
microsatellite locus is actually a microsatellite indel.  In addition, it has no sensitivity to 
identify short microsatellite mutations whose indel magnitude is not distinguishable from 
insert size variance. 
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4.2 ASD 
4.2.1 ASD symptoms 
According to the DSM-5, ASD disorders are characterized by a constellation of 
symptoms.  Individuals diagnosed with ASD have persistent deficits in social communication 
and interaction, including deficits in social and emotional reciprocity; deficits in verbal and 
nonverbal communicative behaviors; and deficits in developing and maintaining 
relationships.  These individuals also have restricted patterns of behavior, interests, or 
activities.  This can include repetitive movements or speech patterns; inflexible adherence to 
routines; fixated interests; and hyper- or hyporeactivity to sensory input (American 
Psychiatric Association 2013). 
ASD symptoms present in early development and must cause clinically significant 
impairment in important areas of social functioning.  ASD is distinct from intellectual 
disability or global developmental delay.  The DSM-5 recognizes 3 levels of ASD severity, 
which could suggest the need for anywhere from some support to very substantial support 
(American Psychiatric Association 2013). 
4.2.2 ASD diagnosis prevalence 
According to the latest study from the CDC using data from 11 ADDM sites, one of 
every 68 8-year old children will be diagnosed with ASD.  ASD incidence varies 
significantly by gender and ethnic affiliation.  Boys are 4.5 times more likely to be diagnosed 
with ASD than girls.  Non-Hispanic white children are ~30% more likely to be given an ASD 
diagnosis than non-Hispanic black children, and ~50% more likely to be given an ASD 
diagnosis than Hispanic children.  The median age of earliest known ASD diagnosis was 53 
 83 
months old, and did not vary significantly by gender or ethnic affiliation.  ASD diagnoses 
also vary geographically.  Some of the variation in diagnosis may be due to external factors 
such as access to healthcare and psychiatric services or differences in diagnostic practices 
(Centers for Disease Control and Prevention (CDC) 2014). 
4.2.3 The SSC dataset 
The SSC dataset was created in an effort to identify de novo genetic mutations that 
contribute to autism incidence.  Its focus is on recruiting simplex autism families with 
unaffected parents and siblings.  Simplex autism families have only child with autism, while 
multiplex families have more than one child with autism.  Children with autism in the SSC 
have at least one unaffected sibling, and typically exhibit moderate to severe symptoms of 
autism with few signs of intellectual disability.  The absence of recurrent autism phenotypes 
within SSC families suggest that this dataset is enriched for de novo mutations that are likely 
to play a role in autism incidence.  Each family has had blood samples drawn and frozen at 
RUSDR for use in various genetic analyses (Fischbach and Lord 2010).  In order to enrich 
the SSC for de novo mutations, simplex families are specifically recruited, and multiplex 
families are excluded from the dataset.  However, it remains possible that there are 
transmitted polymorphisms within the dataset that cause autism (Levy et al. 2011; Iossifov et 
al. 2012).  The SSC dataset is currently composed of 2,700 families. 
4.2.4 The genetics of autism 
ASD is among the most strongly heritable psychiatric illnesses.  In studies of ASD 
incidence among monozygotic twins, concordance ranges from ~60% to ~90% (Rosenberg et 
al. 2009; Hallmayer et al. 2011).  A well-supported genetic model for autism incidence 
suggests that there are two autism risk classes.  The first class consists of high-risk families 
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with transmitted causative mutations from affected parents to children with autism.  These 
transmitted mutations would likely act in a dominant fashion.  Based on the gender bias 
observed for autism, these mutations are primarily transmitted from unaffected mothers to 
their affected sons, and carry a ~50% risk of recurrence if a family has multiple sons.  These 
carrier females were thought to comprise <1% of all women, and the transmitted mutations 
would be novel relative to the maternal grandparents.  Based on autism incidence data from 
AGRE and IAN, the high-risk class comprises <1% of all families with autism (Zhao et al. 
2007). 
 The second risk class consists of the remaining >99% of the population, where autism 
incidence is driven by de novo mutations in parental germlines.  Based on the gender bias 
observed in autism, these de novo mutations are expected to have high penetrance in males 
and relatively poorer penetrance in females.  Due to the role played by de novo mutations, 
parental age should be positively correlated with autism incidence.  This model is consistent 
with self-reported autism incidence data from AGRE and IAN.  This model suggests that 
mutations to a single allele of a gene frequently lead to autism, which implies that some of 
the genes where these mutations occur could be susceptible to haploinsufficiency (Zhao et al. 
2007).   
The conclusions of this model were reinforced by a concurrent study demonstrating 
frequent de novo CNV mutations in families.  Most of the CNVs observed in children with 
autism were deletions, reinforcing the role of haploinsufficiency in autism etiology.  
Interestingly, none of the de novo mutations were seen more than twice in the dataset studied, 
suggesting that mutations at many loci throughout the genome contributed to autism 
incidence (Sebat et al. 2007).  These observations were reinforced in a study of de novo 
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CNVs in the SSC dataset.  In addition to reinforcing the observations of Sebat, et al., this 
study observed that CNVs in children with autism had higher gene content than CNVS in 
their siblings, and that deletions of genes only occurred in children with autism.  Females 
with autism tended to have de novo CNVs with higher gene content than males with autism, 
suggesting that females can tolerate a higher mutational load before exhibiting disease 
symptoms.  Once again, most de novo CNVs were unique, suggesting that there are many 
genes whose mutations can lead to autism (Levy et al. 2011). 
A large study of de novo SNVs in or near exons in the SSC demonstrated that 
children with autism were twice as likely as their unaffected siblings to have de novo 
mutations that disrupt gene function, such as frameshift indels, nonsense SNVs, and splice-
site SNVs.  These mutations were most commonly transmitted from the paternal germline, 
which accumulated mutations with advancing paternal age.  This study estimated that 
disruptive mutations to a set of 350 – 400 autism risk genes.  Additionally, disruptive 
mutations were observed significantly more often in FMRP-associated genes than would be 
expected by chance.  In unaffected children, disruptive mutations to FMRP-associated genes 
are exceedingly rare (Iossifov et al. 2012). 
Several smaller exome sequencing studies—primarily using SSC families that were 
not studied by Iossifov et al.—further elucidated the genetics of autism.  One study observed 
the same bias for paternal transmission and paternal age for de novo mutation incidence and 
estimated that mutations to any of 384 – 821 genes could lead to autism.  Unlike Iossifov et 
al., missense mutations were significantly more common in children with autism than in their 
unaffected siblings.  This study observed recurrent mutations in CHD8 and NTNG1, 
suggesting that mutations to these genes may be causal.  Many of the most severe de novo 
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mutations in this study occurred in an interconnected β-catenin/chromatin remodeling protein 
network, suggesting another pathway that could be enriched for genes whose mutations 
might lead to autism (O'Roak et al. 2012b).  Two other studies, only one of which used the 
SSC dataset, observed recurrent mutations in CHD8 as well and an increased de novo 
mutation load in older fathers (Neale et al. 2012; Sanders et al. 2012).  In the study that used 
the SSC dataset, de novo mutations in brain-expressed genes were more likely to occur in 
children with autism than in their siblings (Sanders et al. 2012). 
A targeted sequencing study using the complete SSC cohort at the time found 
recurrent mutations in six genes of a 44-gene target set.  Of the 27 de novo mutations 
observed, one third occurred in CHD8.  Children with autism who had CHD8 mutations also 
tended to have larger head circumferences than people without a CHD8 mutation.  Although 
this study identified specific loci that likely cause ASD, it was unable to determine whether 
mutations to these genes were sufficient to lead to autism incidence (O'Roak et al. 2012a). 
Most recently, a review was published synthesizing the observations of the studies 
described above that reinforced the significant role of de novo mutations in autism incidence.  
By combining the observations of Iossifov, et al., and Sanders, et al., a significant enrichment 
of missense mutations in children with autism relative to their siblings was observed.  The 
authors predict that there are 250 – 500 autism risk genes.  As of the time since the review 
has been published, common variants have yet to be associated with autism, suggesting that 
autism incidence is primarily driven by the two-class model of Zhao et al.  The authors also 
estimate that within the SSC dataset, 60% of autism cases arise from de novo mutations.  De 
novo mutations have only been observed in ~35% of children with autism in the SSC, which 
means that many undetected mutations remain to be identified (Ronemus et al. 2014).   
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Based on the observations of frequent deletions in CNV studies, the authors 
suggested that genes involved in autism incidence are dosage sensitive.  This dosage 
sensitivity of deleted genes, and by extension, disruptive SNVs and indels, could be realized 
in three ways.  First, disrupted genes may be particularly sensitive to decreased expression, 
i.e. are haploinsufficient.  Second, these genes may be monoallelically expressed, in which 
case, one disrupted copy could lead to many cells without an essential gene product.  Finally, 
these mutations could lead to dominant mutant alleles that negate the function of their normal 
counterparts (Ronemus et al. 2014). 
4.3 Summary 
Microsatellites are widespread throughout eukaryotic genomes and have dynamic, but 
poorly understood, mutation processes.  Their exceptional variability has made them 
invaluable as markers in various genomes, particularly in humans.  Microsatellite mutations 
are known to play a role in several devastating monogenic neurodegenerative diseases.  They 
are both a hallmark of MMP tumors and a contributory factor to tumor development in MMP 
and non-MMP tumors.  There is no reason to assume that the roles of microsatellites in 
human disease are limited to these two disease models. 
Microsatellite genotyping technology is at an impasse.  Low throughput technologies 
such as Sanger sequencing or capillary electrophoresis produce highly accurate and 
reproducible genotype calls that are suitable for de novo mutation detection.  However, their 
utility for studying microsatellite loci in an unbiased, genome-wide manner is limited since 
they require primers for specific loci.  Although some algorithms have been designed to 
leverage HTS data to call genotypes at hundreds of thousands—even millions—of 
microsatellite loci, their accuracy is insufficient for specific detection of de novo 
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microsatellite mutations.  Based on their reported Mendelian inheritances, true de novo 
mutations will be swamped by false positives. 
This is particularly unfortunate in the study of human diseases such as autism, where 
sporadic disease incidence seems to be driven by de novo mutations in parental germlines.  
Due to their well-documented instability, frequent mutations to microsatellite loci may play a 
significant role in disease incidence, particularly when they are uninterrupted by SNVs or 
indels.  This project aims to bring microsatellite genotyping to the next level—by employing 
sophisticated genotyping methods and leveraging population-level information, we aim to 
develop sufficient specificity to accurately call de novo microsatellite mutations from HTS 
data.  By demanding high specificity in our genotype calls, we expect that this approach will 
be useful for many applications beyond de novo mutation detection. 
The uSeq pipeline is the realization of this goal.  This pipeline takes sequencing data 
from thousands of individuals as input and detects uninterrupted microsatellites, which it 
then maps to a reference genome.  After filtering reads and creating microsatellite profiles for 
each individual, uSeq learns parameters from the data that are specific to the experimental 
protocol being used.  These parameters include per-allele, per-locus expected coverage 
estimates, locus-specific slippage error estimates, and allele-specific capture bias estimates.  
These estimates enable highly accurate and tailored genotype calling, which is accompanied 
by careful consideration of how each call fits with uSeq’s proposed genotyping model.  
These genotypes are then used to identify possible de novo mutations, which are filtered to 
ensure that only high-confidence bi-allelic trios are considered. 
There are several advantages to uSeq as compared to other HTS genotyping methods.  
uSeq considers vastly more microsatellite loci than the latest implementations of lobSTR and 
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RepeatSeq.  Although uSeq does not employ the same detection strategy as TRF, only a 
small percentage of TRF-derived reference loci do not overlap a uSeq reference 
microsatellite locus.  Over 99.9% of all trio genotype calls are consistent with Mendelian 
inheritance.  Detected alleles are also consistent when comparing exome and whole genome 
sequencing coverage from the same individuals.  Moreover, uSeq demonstrates excellent 
specificity when distinguishing true de novo mutations from noise, as determined by 
validation sequencing.  We are able to leverage uSeq’s ability to detect de novo microsatellite 
mutations to determine that children with autism are significantly more likely to have unique 
microsatellite de novo expansions than their siblings.  Although not statistically significant, 
we also observe several frameshift mutations in children with autism.  Many of these 
frameshift mutations are consistent with the protein networks and recurrent mutations 
described by other studies of sporadic autism.  We do not observe a single microsatellite 
frameshift mutation in unaffected siblings.  Other general indel detection pipelines applied to 
the SSC dataset were incapable of detecting the majority of uSeq de novo microsatellite 
mutations. 
 While the results of this study suggest a role for de novo microsatellite mutations in 
autism, there is a much broader point to be drawn from this project.  Microsatellite mutations 
should be expected to play a role in many complex human diseases and other sources of 
phenotypic variation.  They must be examined in an unbiased, genome-wide manner.  uSeq 
provides the means to further elucidate the role de novo mutations and polymorphism may 
play in a variety of different diseases in HTS-based population studies. 
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Figure 4.1: A schematic representation of unequal crossing over.  Two chromosomes with 
equal numbers of identical tandem repeats align out-of-phase and undergo recombination.  
This results in one shorter repetitive region and one longer repetitive region in the resulting 
chromosomes. 
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Figure 4.2: A schematic representation of replication slippage.  Once DNA polymerase dissociates from a nascent and template 
strand, the strands can dissociate from each other.  The strands can then re-anneal out of phase, creating a bulge in the nascent or 
template strand.  If the bulge is in the nascent strand (grey), the nascent microsatellite will expand relative to the template 
microsatellite.  If the bulge is in the template strand (black), the nascent microsatellite will contract relative to the template 
microsatellite.
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Disease Gene Context 
Primary 
 motif 
Genomic  
position 
 (GRCh37) 
Normal 
range1 
Affected 
range1 
Variant 
repeat 
Fragile X syndrome FMR1 5' UTR CGG 
chrX:146,993,569- 
146,993,629 15 - 65 200+ Y 
SBMA AR Exon CAG 
chrX:66,765,159- 
66,765,227 17 - 26 40 - 52 N 
DM1 DMPK 3' UTR CTG 
chr19:46,273,463- 
46,273,524 5 - 30 50+ N 
DM2 ZNF9 Intron CCTG 
chr3:128,891,420- 
128,891,502 ~26 75+ Y 
Huntington's 
disease HTT Exon CAG 
chr4:3,076,604- 
3,076,662 11 - 34 42+ N 
SCA1 ATXN1 Exon CAG 
chr6:16,327,865- 
16,327,955 6 - 39 41 - 81 Y 
SCA2 ATXN2 Exon CAG 
chr12:112,036,754- 
112,036,823 17 - 29 36 - 52 Y 
MJD/SCA3 ATXN3 Exon CAG 
chr14:92,537,355- 
92,537,378 13 - 36 68 - 79 Y 
SCA6 CACNA1A Exon CAG 
chr19:13,318,673- 
13,318,712 4 - 16 21 - 27 N 
SCA7 ATXN7 Exon CAG 
chr3:63,898,361- 
63,898,392 7 - 17 38 - 130 N 
Friedreich 
ataxia FXN Intron GAA 
chr9:71,652,201- 
71,652,220 7 - 22 200+ N 
DRPLA/ 
HRS ATN1 Exon CAG 
chr12:7,045,892- 
7,045,938 3 - 25 49+ N 
OPMD PABPN1 Exon GCG 
chr14:23,790,681- 
23,790,701 6 - 7 8 - 13 N 
Synpolydactyly HOXD13 Exon GCG 
chr2:176,957,786- 
176,957,827 NA NA Y 
MMP cancers MSH3 Exon A 
chr5:79,970,915- 
79,970,922 8 fs N 
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Disease Gene Context 
Primary 
 motif 
Genomic  
position 
 (GRCh37) 
Normal 
range1 
Affected 
range1 
Variant 
repeat 
MMP cancers MSH6 Exon C 
chr2:48,030,640- 
48,030,647 8 fs N 
HNPCC TGFβRII Exon A 
chr3:30,691,872- 
30,691,881 10 fs N 
MMP cancers IGFIIR Exon G 
chr6:160,485,488- 
160,485,495 8 fs N 
MMP cancers IGFIIR Exon CT 
chr6:160,505,170- 
160,505,181 12 fs Y 
MMP colorectal 
cancer BAX Exon C 
chr19:49,458,971- 
49,458,978 8 fs N 
MMP colorectal 
cancer TCF4 Exon A 
chr18:52,894,880- 
52,894,888 9 fs N 
MMP cancers EPHB2 Exon A 
chr1:23,240,246- 
23,240,254 9 fs N 
MMP cancers BLM Exon A 
chr15:91,304,139- 
91,304,147 9 fs N 
MMP cancers RAD50 Exon A 
chr5:131,931,452- 
131,931,460 9 fs N 
BRCA1 breast 
cancer AIB1 Exon CAG 
chr20:46,279,815-
46,279,865 ? 29+ Y 
FALS/FTD C9ORF72 
Intron/ 
promoter GGGGCC 
chr9:27,573,522-
27,573,544 0 - 23 30+ ? 
Table 4.1: Diseases caused by microsatellite mutations.  Since there is no specific microsatellite locus in APC that is mutated, it is 
not shown here.  References can be found in the main text. 
1Affected and normal ranges are given as repeat counts unless otherwise specified.
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5 Methods 
5.1 uSeq pipeline overview 
The uSeq pipeline can be broken down into two modules.  The individual module of 
the uSeq pipeline processes sequencing data from individuals within the study population and 
consists of four stages (Figure 5.1, page 170): 
1. Scan and condense microsatellites 
2. Align condensed reads to a condensed reference genome using BWA 
3. Convert file formats, reindex reads to the uncondensed reference genome, sort reads, 
and perform file management tasks 
4. Merge sequencing data from multiple lanes, mark PCR duplicates and create profiles 
for each observed microsatellite locus 
The first three steps of the individual module are run separately on every sequencing file 
provided for an individual. 
The population module of the uSeq pipeline merges the microsatellite profiles of the 
entire study population, estimates genotyping parameters, and calls genotypes.  This module 
also consists of four stages (Figure 5.2, page 171): 
1. Merge microsatellite profiles for the entire study population 
2. Identify loci with sufficient study-wide coverage for genotyping 
3. Generate per-locus, per-person expected coverage estimators 
4. Call genotypes while iteratively updating per-allele bias parameters and per-locus 
noise parameters using a population EM algorithm 
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Since the specific application discussed in this thesis is identifying de novo mutations, the 
genotypes are then used to identify strong Mendel violation candidates.  A complete 
discussion of how uSeq identifies strong de novo mutation candidates can be found later in 
the chapter, in section 5.4. 
uSeq also creates a condensed reference genome prior to processing sequencing data.  
The same microsatellite detection parameters must be used to scan the reference genome and 
the sequencing data that is aligned to it.  Once microsatellite loci have been identified in the 
reference genome, any steps necessary to generate the proper files for a particular short-read 
alignment algorithm—such as BWA—must be performed. 
5.2 uSeq Individual Module 
5.2.1 Microsatellite detection 
5.2.1.1 Microsatellite detection inputs 
Microsatellite detection is done using an algorithm of our own design.  The detection 
algorithm can take sequencing data in single- or paired-end FASTQ or BAM formats, or any 
other DNA sequence—such as a reference genome—in FASTA format.  If sequencing data is 
provided, additional parameters can be specified that truncate subsequences with poor base-
calling quality, limiting microsatellite detection to confidently called regions of sequencing 
reads.  The algorithm can also take user-defined parameters specifying minimum tract length, 
number of repeated motifs, and upper and lower boundaries for motif length.  If these 
parameters are not specified, uSeq uses default parameters.  In this study, the minimum tract 
length was 8 nucleotides, the minimum repeat number is 3, and motif lengths between 1 and 
6 bp were considered.  For the sequencing data used, portions of reads with base-calling 
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quality below 20 are trimmed using the method outlined in the original BWA manuscript (Li 
and Durbin 2009). 
5.2.1.2 A rapid algorithm for perfect microsatellite detection 
The detection algorithm is a FSM derived from the MTF transform, which was 
originally proposed as a locally adaptive data compression scheme, but whose properties 
enable it to detect locally repetitive patterns (Bentley et al. 1986).  The FSM has two states: 
putative microsatellite (M) and non-microsatellite (N).  As the algorithm proceeds along an 
input DNA sequence, S, the state machine transitions between states based on the local 
repetitiveness of S (Figure 5.3, page 172).  A FIFO dictionary of the k most recent 
overlapping kmers tracks local repetitiveness, where k is the maximum microsatellite motif 
length.  The FSM initializes with an empty dictionary in the N state.  At each position in S, 
the current kmer is compared to the dictionary kmers.  The dictionary then updates by adding 
the most recent kmer to the end of the dictionary, and removing the kth kmer from the 
beginning of the dictionary.  This dictionary update occurs regardless of the FSM state.  If no 
match is found in the dictionary, the FSM remains in the N state, and the next kmer is 
compared to every kmer in the dictionary.  If a match is found, the FSM transitions to the M 
state.  While in the M state, the FSM only checks i—the index position of the match that 
initiated the transition from the N state to the M state—and increments the match count, m, 
by one for every match.  Once the current kmer no longer matches the kmer at index i in the 
dictionary, the FSM reports the current repetitive sequence if it meets the specified 
microsatellite thresholds, and then returns to the N state.  Upon this transition, the tract 
length, start position, and motif length are easily extracted from the state machine: 
𝑡𝑡𝑡𝑡𝑡 𝑙𝑙𝑙𝑙𝑡ℎ (𝑡):𝑚 + 𝑘 + 𝑖 − 1 
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𝑚𝑚𝑡𝑖𝑚 𝑙𝑙𝑙𝑙𝑡ℎ (𝑢):𝑘 − 𝑖 
𝑠𝑡𝑡𝑡𝑡 𝑝𝑚𝑠𝑖𝑡𝑖𝑚𝑙 (𝑠): 𝑥 − 𝑡 + 1 
In the start position calculation, x is the start position of the kmer in S that first matched a 
dictionary kmer.  Repeat count can be readily calculated using t and m, and the microsatellite 
motif sequence is simply the substring of S starting at s with length m.  Below is the 
pseudocode for the microsatellite detection algorithm. 
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By using a smaller dictionary of the k most recent kmers instead of all possible kmers, 
we dramatically reduce the compute time necessary to find repetitive sequence.  If we are 
considering microsatellite motif lengths less than or equal to some value of k, instead of 
scanning 4k dictionary elements at every position in S, the algorithm scans 1 position in the 
M state or k in the N state, which reduces our computation time from ~O(4k) to ~O(k). 
This detection algorithm immediately and exactly determines microsatellite 
boundaries in a single step—unlike TRF or lobSTR—and is highly sensitive and specific 
within the parameters specified.  The detection algorithm is rapid—on a single 3.3 GHz 
CPU, GRCh37 microsatellite detection completes in ~10 minutes, and detection of 
microsatellites in 1 million 101 bp Illumina paired-end reads takes ~24 seconds. 
5.2.1.3 Microsatellite detection algorithm outputs 
The uSeq detection algorithm produces four additional files when it is provided with 
FASTA data as input.  The first file is a tab-delimited microsatellite database file that 
provides information for every microsatellite locus found in the FASTA file, and contains the 
following fields:  
1. Coordinate/chromosome 
2. Microsatellite tract start position 
3. Microsatellite tract stop position 
4. Tract length 
5. Motif 
6. 5’ flanking sequence 
7. 3’ flanking sequence 
8. Microsatellite snapshot 
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In addition to serving as a reference file for later steps in the uSeq pipeline, the 
microsatellite database provides an easy-to-navigate microsatellite reference for the input 
sequence.  The second file provides a very brief summary of the scanning output—the 
number of sequences processed, the number of microsatellites found, and how many 
sequences were printed as output.  The third file is a “condensed” version of the input 
sequence, with all detected microsatellites removed, which enables the input sequence to be 
used as a reference genome for microsatellite alignments from sequencing data.  This 
algorithm is described in section 3.3.  The final output file is the offset index, which enables 
the uSeq pipeline to reindex microsatellites from the condensed reference genome to the 
standard reference genome.  If the microsatellite database is the only desired output, the 
condensed reference genome and offset index can be suppressed. 
When provided with DNA sequencing data, three files are produced as output.  The 
first file is a FASTQ-formatted read database of all the reads taken as input, with the 
sequence ID line containing summary data on any microsatellites that were detected.  The 
microsatellite summary format is: 
<sequence ID>[|<motif>:<start>:<length>:<base quality>(|…)] 
The second file is a condensed FASTQ-formatted file, with all microsatellites removed, 
which is compatible to the condensed reference genome during alignment.  The third file is a 
separate header file of microsatellite summaries described above, which uSeq adds back to 
the reads after alignment.  This is necessary due to the variations in the formats produced by 
different versions of Illumina sequencing technology and in the formats taken as input by 
different alignment algorithms.  By default, the uSeq detection algorithm outputs all reads it 
receives as input.  This behavior can be suppressed, and only reads containing 
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microsatellites—and their mate pairs in paired-end sequencing data—will be output for 
alignment and downstream processing.  This can significantly reduce processing time. 
5.2.1.4 Limitations of the detection algorithm 
5.2.1.4.1 Detection of imperfect microsatellites 
The uSeq detection algorithm does not detect microsatellites interrupted by point 
mutations or indels.  As discussed in the introduction, convergent lines of evidence indicate 
that the vast majority of microsatellite instability takes place within uninterrupted 
microsatellite tracts (see, for example, Chung et al. 1993; Eichler et al. 1994; Chong et al. 
1995; Goldstein and Clark 1995; Petes et al. 1997).  Since our study is focused on identifying 
de novo mutations, our analysis is currently tailored to the detection, alignment, and 
genotyping of uninterrupted microsatellites. 
While we do not expect interrupted microsatellite loci to contribute significantly to de 
novo mutations, such loci may play a larger role in other microsatellite analyses.  In 
population genetic studies, certain haplotypes may have relatively stable interrupted 
microsatellites, which may serve as distinct markers for specific subpopulations (Jin et al. 
1996).  As shown in studies of microsatellites in disease, disease incidence is usually reduced 
in populations with stabilizing variant repeats (Chung et al. 1993; Eichler et al. 1994; Chong 
et al. 1995).  uSeq can detect uninterrupted microsatellite subsequences within longer 
interrupted microsatellite loci, but comparisons among microsatellite tracts irrespective of 
any interruptions might streamline microsatellite mutation analyses within a population. 
Interrupted microsatellite detection can be incorporated into future versions of uSeq.  
The simplest means of expanding detection would involve one of two strategies.  The first 
would be somewhat similar to the TRF microsatellite detection strategy—after perfect 
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microsatellites are identified, microsatellites with identical motifs that are closer to each 
other than would be expected by chance could be combined into longer microsatellite tracts.  
In addition, microsatellites could be extended if there are nearby motifs identical to those of 
the microsatellite tract separated by an SNV or short indel.  This behavior could be controlled 
by a matching probability and indel probability, as they are in TRF.  A model defining 
criteria for deciding whether nearby microsatellite tracts are parts of one contiguous 
microsatellite tract could be derived from the distribution of repetitive sequence within a 
reference genome, the observation of slippage at microsatellite loci within a population, or a 
combination of the two.  This strategy would require a second step to identify interrupted 
microsatellite loci after the initial scan for uninterrupted microsatellite loci. 
A second option for detecting interrupted microsatellite loci would be to allow for 
wildcard characters in the kmer dictionary used in uSeq’s microsatellite detection algorithm.  
This would allow the algorithm to detect near-perfect microsatellites with a tolerance for a 
certain number of mismatches per kmer.  Subsequent processing would ensure that these 
interruptions are contained within the microsatellite itself and do not extend the locus into 
adjacent flanking sequence.  Similar to the strategy above described in the previous 
paragraph, statistical analysis would be required to ensure that the tolerance for mismatches 
and indels maintains the essential biological traits of microsatellite loci. 
The SSC dataset could be used to learn more about the traits that distinguish 
functional microsatellites from highly repetitive regions that are otherwise stable.  This could 
be accomplished by comparing the frequency of de novo mutations at interrupted and 
uninterrupted microsatellite loci.  Factors affecting the stability of interrupted and 
uninterrupted microsatellite loci could include sequence context, motif length, motif 
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composition, and tract length.  Using a large study population, such as the SSC, large 
populations with interrupted and uninterrupted alleles at the same individual locus could be 
evaluated to gain insight in to the mechanisms influencing their stability. 
5.2.1.4.2 Microsatellites below detection threshold 
The microsatellite detection method used by uSeq sets minimum thresholds for tract 
length and repeat number.  Although, as discussed in the introduction, microsatellite slippage 
at shorter microsatellite loci appears to be rare, evidence from MMP tumors indicate that 
microsatellite mutations can occur in repetitive mononucleotide microsatellites with tract 
lengths as short as 2 bp (Huang et al. 1996).  uSeq can accommodate these microsatellites by 
simply adjusting detection parameters for minimum tract length and repeat number.  Since 
our study population is assumed to generally have intact MMR, we chose to set a threshold 
for minimum tract length at 8 bp.  Short microsatellites could be particularly relevant when 
evaluating microsatellite loci with reference tract lengths just exceeding the minimum 
thresholds set by uSeq.  In such cases, alleles below the detection threshold might be missed 
in some individuals.  Additionally, slippage noise introduced during sample preparation will 
be missed, which would lead to underestimates of noise rates during genotyping.  Both of 
these concerns are considered in detail with regards to the SSC dataset in sections 6.3.1 and 
6.3.4.4.  In general, these are issues worth considering when setting detection thresholds for 
microsatellite genotyping studies using uSeq. 
5.2.1.4.3 Incompatible microsatellite detection parameters 
In the current implementation of the uSeq microsatellite detection algorithm, certain 
combinations of input parameters are incompatible.  When uSeq is provided with a minimum 
motif length and maximum motif length, a and b, respectively, the minimum detectable tract 
 103 
length for a microsatellite of motif length j, where 𝑡 ≤ 𝑗 ≤ 𝑏, is 𝑏 + 𝑗.  When the minimum 
detectable tract length for any motif length is longer than the desired minimum detectable 
tract length, tmin, uSeq will warn the user.  uSeq will also provide the user the maximum 
value of b that would still enable detection of microsatellites with motif length j and a 
minimum tract length of tmin.  In future versions of uSeq, it would be straightforward to 
accommodate any tmin by allowing uSeq to scan input sequences with multiple dictionaries of 
different kmer sizes.  The current implementation of the uSeq detection algorithm does not 
have this feature implemented since the study-wide tmin exceeds the minimum detectable tract 
length for all specified motif lengths. 
5.2.2 Microsatellite alignment 
5.2.2.1 An alignment method robust to microsatellite indels 
As mentioned in the previous section, microsatellites found in the reference genome 
and in sequencing data are condensed during microsatellite detection.  The condensation 
approach aligns microsatellites solely based on their flanking sequence, which is intended to 
ensure that short read alignment is robust to microsatellite indels.  This approach also allows 
uSeq to use most popular BWT-based alignment algorithms, which are optimized for speed- 
and memory-efficiency and use paired-end information to improve alignment accuracy, 
without relying on their indel detection methods.  The uSeq alignment algorithm currently 
uses BWA; although any mapping algorithm with SAM/BAM formatted output can be used 
(Li and Durbin 2009).  uSeq is therefore able to maintain flexibility as sequencing 
technologies and alignment algorithms continue to evolve. 
The uSeq alignment algorithm is designed to complement popular short-read 
alignment algorithms—a standard alignment algorithm is used to account for non-
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microsatellite indels, while condensed microsatellite indels are considered separately by 
uSeq.  Many common strategies for detecting indels are inappropriate for detecting 
microsatellite indels.  Algorithms such as bwa aln may have thresholds designed to disfavor 
long or terminal indels—specifically, capping the possible number of indels per read and 
their lengths; not calling indels near the ends of reads; and allowing a maximum of k 
differences in an alignment, where k is determined as described in the BWA manuscript (Li 
and Durbin 2009).  These heuristics may be appropriate for non-microsatellite indels, but 
they are incapable of accommodating the more complex and dynamic behavior of 
microsatellite indels. 
Recently, newer algorithms applying a seed-and-extend approach to short-read 
alignment have emerged, including bowtie2 and bwa mem (Langmead and Salzberg 2012; Li 
2013).  These algorithms circumvent some of the limitations of earlier alignment algorithms 
by using a BWT to find exact matches within a sequencing read, which are then used to seed 
local realignments that can provide more accurate indel calls.  However, the gap-opening and 
gap extension penalties used in local realignment of non-microsatellite indels may be 
inappropriate for microsatellite indels.  Microsatellite indels are more likely to occur than 
non-microsatellites indels, and microsatellite stability is dependent on motif length, tract 
length, and motif composition, as discussed in section 4.1.2.3.  Within the context of local 
realignment, a variable gap-opening penalty that depends on the context of the gap may be 
more appropriate.  Microsatellites frequently have significantly divergent lengths from the 
reference genome and mutate in a step-wise fashion, which implies that standard gap 
extension penalties may need to be rethought for microsatellites.  For example, although 6 bp 
insertions in microsatellites with 1, 2, 3, and 6 bp motifs tend to occur at different 
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frequencies, a gapped alignment considering the length of an indel rather than the number of 
motifs inserted would score them equivalently. 
5.2.2.2 Mapping algorithm sensitivity 
The success of the uSeq’s alignment approach depends on the amount of flanking 
sequence surrounding an observed microsatellite, as well as its uniqueness within a reference 
genome.  To test the accuracy of the uSeq alignment algorithm, we evaluated the amount of 
flanking sequence necessary to map microsatellites found in GRCh37 with a BWA mapping 
quality score of at least 30, which would imply a high-quality match.  Flanking sequences 
from 20 to 80 bp long in intervals of 5 bp were obtained from each reference microsatellite 
locus.  The flank length of a reference microsatellite locus was split between its 5’ and 3’ 
flanking sequences in 5 bp increments.  For example, 20 bp flanks were split into 5/15, 
10/10, and 15/5 bp flanks for the 5’ and 3’ flanking sequence of a reference microsatellite.  
The flanks were mapped as single-end reads; therefore, they represent a lower bound on 
achievable mapping accuracy.  More than 75% of microsatellites in the human genome can 
be mapped with 40 bp of flanking sequence (Figure 5.4, page 173).  The SSC exome study 
uses 101 bp Illumina reads, which allows uSeq to accurately map most microsatellites with 
tract lengths shorter than 66 bp long.  The mean microsatellite tract length in hg19 is 12 bp.  
Additionally, nearly ~90% of microsatellites can be mapped with 80 bp of flanking sequence 
in single-end reads.  In the SSC exome study, uSeq uses paired-end data, which should 
provide significant improvements over this already considerable accuracy. 
5.2.2.3 Mapping algorithm precision 
uSeq will occasionally align reads to an incorrect position in the reference genome.  
To test the precision of the mapping algorithm, and to discern whether there are systematic 
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effects behind incorrect alignments, we simulated 16 million 101 bp paired-end reads from 
chr22 in GRCh37 using wgsim v0.2.3 with default parameters.  After reads were scanned and 
aligned to the entire condensed reference genome by uSeq, we obtained precision and recall 
metrics for different subsets of the data.  Recall refers to the percentage of correctly aligned 
reads that exceed a mapping quality threshold.  Precision is the percentage of reads above a 
quality threshold that are correctly aligned to the reference genome.  When considering all 
reads, including those without microsatellites, uSeq has a recall of 82.2% for reads with 
mapping qualities above 30, and precision of 98.7% (Figure 5.5, page 174).  Considering 
only microsatellite reads, uSeq has somewhat diminished precision and recall—for reads 
with mapping quality of at least 30, recall is 74.4% and precision is 96.8% (Figure 5.5, page 
174).  Most importantly for the SSC study, precision is 99.4% when analysis is limited to 
reference microsatellite loci, with recall of 79.1%, for reads with mapping quality scores of at 
least 30 (Figure 5.5, page 174).  Since uSeq aligns reads based on flanking sequence only, we 
expect similar precision in real data that will remain robust to the frequency and magnitude 
of microsatellite indels.  We would not expect standard alignment algorithms to maintain 
consistent precision and recall for unstable microsatellite loci. 
This simulation does not include any microsatellite indels, so reads aligned with uSeq 
are expected to be slightly less accurate than reads aligned to an uncondensed genome using 
BWA.  A comparison of mapping performance at microsatellite reference loci between uSeq 
and GATK using SSC exome sequencing data can be found in the section 6.2.7.  GATK 
follows an initial BWA alignment with its own indel realignment algorithm.  Therefore, any 
alignment improvement demonstrated for uSeq as compared to GATK would also represent 
an improvement for uSeq as compared to BWA. 
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5.2.2.4 Limitations of the alignment algorithm 
5.2.2.4.1 Undetected terminal microsatellites 
Undetected microsatellites at the 5’ or 3’ end of a sequencing read are a notable 
contributor to incorrect alignments in uSeq.  Since these microsatellites cannot be detected by 
uSeq, they cannot be condensed (Figure 5.6, page 175).  Successfully finding an alignment 
for a read with an undetected terminal microsatellite depends on the length of the undetected 
tract and its similarity to the microsatellite’s flanking sequence—some reads may align to an 
incorrect reference genome position and some may not align at all.  Based on our analyses 
described above, this does not substantially reduce uSeq’s precision at reference 
microsatellite loci.  The primary effects of undetected terminal microsatellites are slightly 
reduced coverage at some reference microsatellite loci and occasional spurious non-reference 
alignments, which would confound identification of novel, non-reference microsatellite loci. 
Over 98% of incorrectly aligned reads with detected microsatellites are within 75 bp 
of their correct position in the reference genome (Figure 5.7, page 176).  This suggests a 
potential refinement to our alignment strategy by implementing a local realignment step with 
a modified Smith-Waterman algorithm allowing for different gapping penalties at 
microsatellite loci in the region surrounding the candidate alignment position reported by 
BWA.  uSeq does not incorporate a local realignment step since the current focus of the SSC 
project is on reference microsatellite loci, where precision is already very high.  A local 
realignment approach would not improve precision for unmapped reads. 
5.2.2.4.2 Other limitations 
uSeq can neither detect nor align reads with interrupted microsatellites or 
microsatellites below its detection threshold.  The current alignment approach should 
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theoretically accommodate short and interrupted microsatellite loci as uSeq’s detection 
capabilities evolve.  However, unanticipated complications may arise which would require 
further development to maintain high precision and recall in uSeq’s alignment algorithm. 
5.2.3 Post-alignment processing 
5.2.3.1 Preparing alignments for reindexing 
After reads have been aligned and converted to an unsorted BAM file, alignment start 
positions are reindexed from the condensed genome to the uncondensed reference genome.  
Alignments are concurrently matched to their respective sequence IDs that were saved to a 
header file during detection to reincorporate any relevant microsatellite summaries.  If an 
alignment maps to the reverse complement of the reference genome (i.e. SAM flag bit 0x10 
is set to 1), the microsatellite summary is recalculated for the reverse complement of the 
originally observed tract.  Once an alignment has been matched to any relevant microsatellite 
summaries and any necessary recalibration has been performed, the alignment can then be 
reindexed to the uncondensed reference genome.  Before reindexing, the microsatellite 
summary from the uSeq detection algorithm is added to each alignment entry in the BAM 
file as an MU tag with the following format: 
MU:Z:<motif>:<start>:<length>:<base quality>[|…] 
Once any microsatellite information has been added to the alignment entry, the alignment 
length is recalculated.  If a sequence ID in the BAM file and header file are not identical, 
reindexing is immediately terminated and the user is notified of the error.  These steps are 
incorporated into Algorithm 5.4 on page 110. 
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5.2.3.2 Reindexing alignments to the uncondensed reference genome 
Uncondensed coordinates are derived from the start positions provided by BWA and 
the reference genome offset index generated by uSeq’s microsatellite detection algorithm.  
The offset index contains two vectors of equal length for each chromosome in the reference 
genome, which match positions in the condensed reference genome to the corresponding 
cumulative microsatellite bases detected in the uncondensed reference genome.  For each 
alignment with a unique mapping to the reference genome, a modified binary search finds the 
microsatellite locus immediately preceding the alignment’s start position.  The pseudocode 
for the modified binary search is below. 
 
Once the nearest preceding microsatellite locus has been identified, the number of 
offset bases needed to reindex an alignment from the condensed reference genome to the 
uncondensed reference genome is calculated.  If the alignment start position does not 
coincide with a microsatellite locus, the offset is simply the number of cumulative 
microsatellite bases preceding the read.  If the alignment is adjacent to a microsatellite tract, 
the offset includes the bases of the next microsatellite locus.  If an alignment starts within a 
microsatellite tract, any detected terminal microsatellites are factored into the offset 
calculation.  Pseudocodes for the two algorithms needed to calculate the offset are below. 
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5.2.3.3 Calculating read and microsatellite start positions 
The start position in the uncondensed reference genome is added to the alignment’s 
entry in the BAM file as an OP tag, which reports the position in the original genome as an 
integer.  Once the alignment start position has been determined, the start positions for any 
microsatellites within the alignment are calculated.  The start positions are added to the 
alignment entry as an MC tag with the following format: 
MC:Z:<coord>:<motif>:<start>:<length>[|…] 
Microsatellite start positions are reported for every microsatellite, including non-reference 
microsatellites and detected terminal microsatellites.  Detected terminal microsatellites are 
distinguished from microsatellites completely contained within a read by the motif’s case in 
the MC and MU tag—detected terminal microsatellite motifs are lowercase, while 
completely contained microsatellite motifs are uppercase.  The pseudocode is below for 
calculating start positions for the alignment and any microsatellites it contains. 
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5.2.3.4 Subsequent post-processing 
Once alignments are combined with their microsatellite information and have been 
reindexed to the uncondensed reference genome, they are then sorted by position in the 
condensed reference genome.  After sorting, read group IDs are added to each BAM file that 
uniquely identify reads from each sequencing file by the flowcell ID, lane number, and SSC 
individual ID.  The only files generated in post-processing are the reindexed, sorted BAM 
file and a counts file from the reindexing program.  At this point, any files remaining from 
detection and alignment are removed or compressed.  
5.2.4 Marking PCR replicates and profiling microsatellite loci 
5.2.4.1 Marking replicates 
Rather than refer to read pairs coming from the same genomic fragment as PCR 
duplicates, we prefer the term PCR replicates.  While most PCR replicate sets only contain 
two read pairs, more than two read pairs can be derived from one genomic fragment.  
Therefore, “PCR replicate” more accurately portrays the phenomenon being characterized. 
Prior to marking replicates, BAM files from each lane of sequencing data for a single 
individual are merged.  Merged BAM files are used to mark replicates since all lanes of 
sequencing data for any individual derive from a single library preparation.  PCR replicates 
can therefore occur in separate lanes or flow cells from the same individual within the SSC 
study. 
uSeq uses Picard’s MarkDuplicates to mark PCR replicates in the merged BAM file 
(http://picard.sourceforge.net).  uSeq has modified criteria for replicate removal that differ 
from the approach used by samtools rmdup, which keeps the alignment with the highest 
mapping quality score.  uSeq first checks to ensure that the PCR replicate alignments all 
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report the same tract length.  If all of the replicate alignments have concordant tract lengths, 
the alignment with the highest mapping quality is used for genotyping.  If any replicate 
alignment has a discordant tract length, no alignments are reported.  Since we assume that all 
alignments within a replicate came from the same genomic fragment, discordant tract lengths 
could only be observed if a subset of them underwent slippage during sample preparation or 
sequencing.  Since it is impossible to determine the original genomic tract length, none of the 
replicate alignments are considered.  PCR replicates represent another means of analyzing 
microsatellite slippage during sample preparation, which could be useful in future extensions 
of uSeq that focus on individuals or very small populations.  Therefore, uSeq reports 
summaries for every PCR replicate set in every individual.  The pseudocode for PCR 
replicate handling is below. 
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5.2.4.2 Managing overlapping read pairs 
In the course of designing and evaluating uSeq, we have observed many instances of 
overlapping read pairs that report the same microsatellite locus in both fragments.  uSeq has a 
specific set of rules it applies to these overlapping read pairs.  Since both microsatellite 
observations are derived from one sequencing library fragment, they should have identical 
tract lengths.  When this is true, the first observation of a microsatellite locus is reported from 
the overlapping read pair.  When an overlapping read pair has discordant tract lengths, 
neither read is included in the microsatellite profile, and the read pair is added to a BAM file 
containing all discordant overlapping read pairs.  The pseudocode for managing overlapping 
read pairs is below. 
 
5.2.4.3 Additional read filtering 
In addition to marking PCR replicates and resolving overlapping read pairs, several 
other criteria are considered as reads are incorporated into microsatellite profiles.  The 
following criteria are used to filter reads: 
1. Unmapped reads are excluded (during reindexing) 
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2. Alignments must exceed a minimum mapping quality threshold—the default for uSeq 
is 30 
3. Both alignments in a read pair must map to the same chromosome 
4. Terminal microsatellites are excluded 
5. Microsatellite motifs may only contain standard nucleotides (A, C, G, and T) 
6. If an alignment maps to a reference microsatellite locus, its motif must match the 
reference motif 
These filters are incorporated into Algorithm 5.8 on page 117. 
5.2.4.4 Flanking sequences 
When profiling microsatellite loci, uSeq also tracks the flanking sequence 
surrounding the microsatellite locus in each alignment.  This is particularly useful when 
distinguishing slippage events from SNVs or non-microsatellite indels that extend or contract 
microsatellite sequence.  If a microsatellite mutates via slippage, all alleles should have 
identical flanking sequence.  If a microsatellite mutation is not due to slippage, the 
microsatellite flanking sequence is likely to differ (Figure 5.8, page 177).  Each microsatellite 
profile reported by uSeq has at least two entries.  The first entry reports the observed tract 
lengths for all flanking sequences observed at the locus.  Subsequent entries report all 
observed tract lengths for every unique flanking species encountered at the microsatellite 
locus. 
Each microsatellite profile entry has an associated flank sequence and flank ID.  The 
first flank sequence is always  “all” and its flank ID is always “0”.  Each flanking species is 
described by the 5 bp on either side of the observed microsatellite and its flank ID is 
determined by the total coverage within the species—flanks with more coverage are closer to 
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“0”.  The flank sequence is padded with “#”s if a microsatellite starts or ends within 5 bp of a 
reads’ boundaries (e.g. ##AGAATGTT). 
5.2.4.5 Profiling microsatellite loci 
Once uSeq read filtering has completed, microsatellite profiles can then be 
assembled.  The profiler software maintains a profile for every microsatellite locus covered 
by at least one alignment, even if the locus is not found in the reference genome.  By default, 
uSeq will only report microsatellite profiles covered by at least two alignments.  The 
microsatellite profile is a tab-delimited file with the following fields: 
1. Coordinate/chromosome 
2. Start position 
3. Motif 
4. Reference tract length (0 for non-reference microsatellites) 
5. Total number of flanking species at a microsatellite locus 
6. Current flank ID 
7. Current flank sequence 
8. Total coverage supporting the current flank 
9. Comma-delimited read count distribution 
10. Comma-delimited supporting sequence IDs 
The read count distribution is one-indexed.  Therefore, the number at a particular index in the 
distribution provides the coverage for the allele tract length given by that index.  For 
example, if there are 5 reads supporting an 8 bp allele in a read count distribution, the 8th 
index position will have the number 5.  The complete pseudocode for profiling microsatellite 
loci is below. 
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5.2.5 uSeq implementation for large datasets on a distributed computing cluster 
5.2.5.1 uSeq component implementation 
The current implementation of the uSeq pipeline is tailored to process SSC data using 
SGE in a distributed cluster environment where each node has its own RAM and disk space.  
uSeq must be able to process large numbers of samples simultaneously and efficiently, so it 
has been designed to maximize processing speed while minimizing the number of threads 
used per operation, RAM used by each process, and disk space requirements.  Therefore, all 
of the sequence-processing components of the uSeq individual module are written in C++, 
which allows for effective memory management and rapid processing times.  All uSeq 
programs are single-threaded to maximize the number of samples that can be run on each 
node.  Users do have the option of running the alignment step using two threads for bwa aln, 
which is the current uSeq default.  The pipeline manager is implemented in Perl and handles 
maintenance operations such as logging, error reporting, file management, and tracking the 
time used by pipeline components. 
5.2.5.2 Data distribution 
Since the SSC data was processed on a distributed memory cluster, the uSeq pipeline 
individual module is designed with special attention to data distribution.  uSeq programs 
accessing a sequencing file are run on the node where the file is stored and most outputs are 
written locally.  This cuts down on computation time by eliminating many costly NFS 
operations that would be necessary to move, read, or write files between nodes.  Since data is 
stored throughout the cluster, uSeq maintains a master directory on one node, which 
primarily consists of symbolic links to files distributed throughout the cluster nodes.  The 
only files that are ever copied between nodes by uSeq are small files—such as count or log 
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files—and microsatellite profiles.  All microsatellite profiles are stored on the same node 
since they must all be accessed simultaneously in the uSeq pipeline population module. 
5.2.5.3 uSeq modifications for high-traffic computing clusters 
The cluster used by uSeq to process the SSC dataset is under constant use by many 
individuals within the CSHL community.  Therefore, uSeq must be controlled enough that it 
can run within a high-traffic cluster environment without wreaking havoc.  In addition to the 
adjustments described above, three additional adjustments to uSeq have been implemented.  
First, each component of the individual module is submitted as a separate job to the SGE 
system that manages cluster access.  This ensures that uSeq does not monopolize the cluster 
for hours at a time.  Second, when running uSeq on large populations such as the SSC, the 
number of individuals being processed simultaneously is capped.  This ensures that the 
number of uSeq-generated SGE jobs running on the cluster does not flood the system.  
Finally, uSeq limits the amount of virtual memory available to Picard’s MarkDuplicates.  In 
our experience, when this restraint is not specified, MarkDuplicates can take up significant 
amounts of RAM on a node. 
5.2.5.4 Pipeline accessory files 
The uSeq pipeline generates two accessory file types during execution that track the 
commands run by the pipeline and their respective outputs.  The first accessory file is the log 
file, which tracks the parameters passed to the uSeq individual module and its components.  
The log file also reports the system calls, SGE job submission commands, and file 
management tasks performed by any pipeline component.  If an error is encountered in a 
component, it will be reported in the appropriate log file.  Log files dramatically simplify 
error and file tracking in the SSC.  Errors that occur in one instance of uSeq in one individual 
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can be easily found, their sources can be readily identified, and the offending commands can 
be reproduced and debugged.  This allows uSeq to scale up to large populations while 
maintaining robust tracking of any errors. 
uSeq also maintains a counts file for each component in the pipeline, which reports 
the number of input and output reads, as well as any other relevant counts.  For instance, 
during reindexing, uSeq reports the number of reads that align to multiple genomic positions 
or that fail to align to any genomic positions.  Tracking input and output reads between 
pipeline components is another effective way of ensuring that the uSeq pipeline is running 
smoothly. 
5.3 uSeq population module 
5.3.1 Creating a population profile summary table 
In order to take specific advantage of the population level data from the SSC, uSeq 
must summarize and merge the microsatellite profiles of every individual within the 
population before making genotype calls.  The summarizer takes the master directory 
mentioned in the previous section as input, finds all microsatellite profiles in the directory, 
and synchronously proceeds through the microsatellite profiles of the entire population.  
Currently, the summarizer only reports reference microsatellite loci.  The output of the 
summarizer is a large tab-delimited matrix with as many rows as there are unique reference 
loci, and as many columns as there are individuals in the study population.  Each entry 
reports the total coverage for one individual at one locus within the population.  If a person 
has any coverage, the format of their entry is: 
<# tract lengths observed>;<tract lengths>;<coverage> 
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The tract lengths and their coverage are both comma-delimited lists.  If no coverage is 
observed for an individual at a locus, their entry is simply “0;;”.  Currently, the population 
profile summary does not consider individual flanks.  Due to the complexity of this 
information and the huge amount of data already being processed, we are still evaluating 
options to incorporate this information into the summary table. 
 In addition to the summary table, the uSeq summarizer produces two index files—a 
locus index for the table rows and a person index for the table columns.  The locus index is a 
tab-delimited file with the following fields: 
1. Coordinate/chromosome 
2. Start position 
3. Motif 
4. Reference tract length 
5. Number of people with any coverage 
6. Maximum individual coverage 
7. Aggregate coverage in population 
The person index file is another tab-delimited file with the following fields: 
1. SSC individual ID 
2. SSC family ID 
3. Relationship to proband 
While the locus index would remain largely identical independent of study design, the person 
index file is study-specific.  For instance, in a case-control study, it might simply contain an 
ID and affected status for every individual.  Additional information can be added to either 
index file as needed. 
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The summarizer is currently implemented stably in Python using code generously 
supplied by Dan Levy.  An implementation in C++ has been written, but has not been tested 
on the complete SSC population.  The Python implementation can process the entire SSC 
population in several days to approximately one week.  Recently, we have begun to compress 
profiles for each SSC individual to reduce their disk space footprint.  This modification 
nearly doubles the Python summarizer’s processing time.  Re-implementing the summarizer 
in C++ is intended to reduce the profiler’s running time, especially in larger study 
populations. 
5.3.2 Identifying well-covered loci 
Since uSeq relies on population information to make genotype calls, when there is 
insufficient study-wide coverage at a locus, uSeq does not attempt to call genotypes.  This is 
particularly relevant in targeted capture studies such as the SSC exome study.  Although 
sequencing coverage is targeted to exons, off-target coverage is frequently observed.  A 
discussion of off-target and on-target coverage at reference microsatellite loci in the SSC 
dataset can be found in the section 6.4.1.  In order to maximize uSeq’s genotyping accuracy, 
we limit the loci at which genotypes are called by requiring that a locus must be observed in 
at least 60% of the study population and have a maximum individual coverage of at least 25.  
These are not hard thresholds, and can be modified to consider any subsample of the loci 
observed within the population.  
 123 
5.3.3 Genotyping microsatellite loci 
5.3.3.1 Parameters modeled by uSeq 
The uSeq genotyper is designed to call high accuracy microsatellite genotypes with 
consideration for the specific challenges that complicate microsatellite analysis in exome 
sequencing data.  Microsatellite slippage errors during sample preparation are one 
complication that has received considerable attention in other published HTS microsatellite 
genotypers (Gymrek et al. 2012; Highnam et al. 2013).  In addition to estimating a per-locus 
error rate, uSeq also estimates per-allele, per-person coverage and per-allele bias.  The 
genotyper consists of the following stages (Figure 5.9, page 178): 
1. Estimate per-allele, per-locus coverage using SVD 
2. Initialize estimates of allele bias and locus noise rate 
3. Call genotypes using bias and noise estimates 
4. Use EM to update locus noise rate and allele bias estimates 
5. Calculate model likelihood with new estimates 
Steps 3 through 5 are iterative, and final genotypes are derived from the EM once the model 
likelihood has converged, i.e. the estimates for allele bias and locus noise rate appear to 
describe the population at the locus as well as our model allows. 
5.3.3.2 Per-allele, per-person expected coverage 
5.3.3.2.1 Motivations for an expected coverage estimator 
We recognized the need for an expected per-allele, per-person coverage estimator 
after our initial attempts to call microsatellite genotypes.  This was motivated by our 
knowledge of the limits of uSeq’s microsatellite detection; observed coverage variability in 
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sequencing data; and the possibility of microsatellite polymorphism occurring within CNVs.  
While uSeq may not detect interrupted or short microsatellites, that does not prevent them 
from occurring within the datasets being analyzed.  Similarly, even when both alleles are 
detected by uSeq, insufficient coverage may reduce our confidence that both alleles have 
been observed in an individual at a locus.  Finally, in its current implementation, uSeq is 
designed to make bi-allelic genotype calls.  These calls can only be considered accurate if 
there is no evidence of CNVs at the microsatellite locus.  Estimates of per-allele, per-person 
expected coverage capture our uncertainty about the observed coverage at a locus.  They also 
allow uSeq to distinguish stochastic coverage variability from other effects that would 
severely curtail our ability to call genotypes accurately. 
The need for a coverage estimator also became apparent during our initial attempts to 
call de novo mutations in the SSC dataset.  Occasionally, coverage among family members at 
a locus would be extremely variable.  In these situations, it is essential to distinguish whether 
this coverage variation is stochastic, systematic, or due to a CNV in one or more family 
members.  If the coverage variation were due to a CNV, uSeq would not be able to reliably 
detect any de novo mutations that have occurred at the locus. 
5.3.3.2.2 Designing a coverage estimator 
In the initial publications discussing the Illumina sequencing technology, the genomic 
distribution of read coverage is random, and can be modeled as a Poisson distribution with a 
rate equal to the mean coverage (Bentley et al. 2008).  Due to the overdispersion that is 
generally observed in sequencing data, a negative binomial model might be more appropriate 
(Anders and Huber 2010).  However, both models assume that sequencing reads are sampled 
randomly from the sequencing library, and that each position in the genome is roughly 
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equally likely to be sampled.  Exome sequencing violates these assumptions—reads in or 
near exons are much more likely to be sequenced.  Additionally, probe affinity will lead to 
non-uniform coverage among exons.  Therefore, estimating expected coverage is not simply 
a matter of considering randomly sampled sequences from a biased sequencing library. 
Our initial per-allele, per-person expected coverage was estimated by minimizing a 
least squares objective function for two vectors of parameters.  The first parameter vector 
contained per-person terms, which described each person’s average coverage.  The second 
parameter vector contained per-locus multipliers reflecting the capture efficiency of each 
locus.  While this approach had the benefit of simplicity, it did not perform well as an 
estimator.  The poor performance of the two-parameter model was due in part to complex 
coverage variability—coverage is non-uniform in SSC individuals and in well-covered loci 
(Figure 5.10, page 179).  This variation might be partially attributed to several sources, 
including variability in sample preparation or exome capture kits. 
5.3.3.2.3 Estimating expected coverage using SVD 
In an effort to better capture coverage variability at microsatellite loci in the SSC 
data, we used the SVD of the total allele coverage matrix to create a low-rank expected 
coverage estimator.  The allele coverage matrix is a 𝑚 × 𝑙 matrix, where m is the number of 
loci being genotyped and n is the population size.  Each entry in the matrix is the total 
coverage for an SSC individual at a microsatellite locus, split in half.  The values are split in 
half to give a per-allele coverage estimate, and depend on the assumption that most loci in 
most individuals of the SSC have two copies of each locus.  There is no reason to assume 
that SSC individuals have extensive CNPs. 
 126 
SVD is a means of separating an input matrix into the orthogonal singular values that 
define its composition, akin to principal components in PCA.  The greatest singular values 
contribute the most amount of variation to the matrix.  Due to their orthogonal nature, each 
singular value describes a distinct axis of variation within the dataset.  In our case, these 
singular values may represent any combination of a number of factors affecting the allele 
coverage matrix, including the number of reads sequenced in an individual, GC content at 
different loci, variations in sample preparation between technicians, or other systematic 
variability.  As the singular values decrease in magnitude, their contributions to variability in 
overall allele coverage become less significant.  These smaller contributions could be due to 
stochastic processes, such as Poisson sampling; or they could be due to biological effects that 
are specific to a small number of individuals within the population, such as CNPs.  We 
estimate per-allele, per-person expected coverage by creating a k-rank approximation of the 
input allele coverage matrix.  This will recover the k components that most strongly influence 
coverage variability, while limiting contributions from stochastic sampling or occasional 
biological variability. 
More specifically, SVD is a factorization of a 𝑚 × 𝑙 matrix M of the following form: 
𝑀 = 𝑈Σ𝑉𝑇 
U is a 𝑚 × 𝑚 matrix of the eigenvectors of MMT; V is a 𝑙 × 𝑙 matrix of the eigenvectors of 
MTM; and Σ is a 𝑚 × 𝑙 diagonal matrix of the square roots of the eigenvalues of U and V, 
which are called singular values.  The singular values in Σ are in descending order, and 
correspond to the magnitude of the effect of an eigenvalue and corresponding eigenvectors to 
the values observed in M.  All eigenvectors of U and V are orthogonal to each other.  We 
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derive 𝑀� , a k-rank approximation of the input matrix M, by taking the first k eigenvalues of Σ 
and the first k eigenvectors of U and V. 
5.3.3.2.4 Identifying significant singular values 
The SVD contains every singular value that contributes to our observed matrix—if 𝑀�  
were composed of every eigenvalue and eigenvector from the SVD of M, the two matrices 
would be equivalent.  Therefore, as we incorporate more eigenvalues into 𝑀� , we increase the 
risk of over-fitting our low-rank approximation, and reduce its effectiveness as a coverage 
estimator.  Determining the rank for our coverage estimator matrix requires an algorithm that 
identifies the threshold for significant eigenvalues in the SVD of any input matrix.  We 
determine the rank of our expected coverage matrix by comparing the singular values of our 
observed allele coverage SVD to the singular values derived from the SVD of a randomized 
matrix containing the same values as the allele coverage matrix.  Any singular values that 
exceed their randomized counterparts are considered significant.  The pseudocode for 
identifying significant eigenvalues is below. 
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5.3.3.2.5 Reducing expected coverage calculation time by partial SVD 
A complete SVD factorization of a very large matrix such as the SSC allele coverage 
matrix would be time-consuming and pointless.  Since we only need a k-rank approximation 
of the input matrix, we can cut down on the time needed to decompose our input matrix by 
performing a partial SVD.  Fortunately, SVD is a common tool for the analysis of very large 
matrices, and very talented mathematicians have designed fast and accurate partial SVD 
algorithms.  The uSeq genotyper is implemented in R, and therefore it is able to use IRLBA 
SVD decomposition (Baglama and Reichel 2014).  IRLBA is most famous for its use in the 
winning Netflix Prize algorithm, which used the algorithm to create an improved predictive 
model for Netflix’s movie recommendation and ratings system.  In the context of uSeq, 
IRLBA is used to calculate the partial SVD of the original allele coverage matrix and the 
randomized coverage matrices.  In the current implementation, uSeq only calculates the first 
50 singular values. 
5.3.3.2.6 Accurate recovery of expected coverage parameters 
We designed a simulation to test the ability of our expected coverage estimation 
algorithm to accurately recover input coverage parameters in the presence of stochastic noise 
and biological variation.  In our simulation, we took a k-rank matrix derived from a 
subsample of our real coverage data to be used as Poisson rate parameters.  In addition to 
Poisson sampling noise, we introduced CNVs, which would increase or reduce coverage for 
our test individuals at random loci.  We then compared the SVD-derived expected coverage 
estimators from our algorithm to the input Poisson rate parameters provided to the simulator 
(Figure 5.11, page 180).  We also ensured that the rank of the SVD was the same as that of 
the input Poisson rate matrix. 
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Our simulations demonstrate the success of our expected coverage estimation 
algorithm.  Even when 5% of loci in the simulation have CNVs, the expected coverage 
estimators are nearly equivalent to the input Poisson rate parameters.  The Pearson 
correlation coefficient between the expected coverage estimators and the input coverage 
parameters is >0.99, and the RMSE is 0.52 (Figure 5.12A, page 181).  This demonstrates the 
estimators’ robustness to stochastic sampling noise.  The relationship remains true for 
individuals at loci with CNVs—correlation is >0.99 and RMSE is 0.92 (Figure 5.12B, page 
181).  Therefore, the estimators are robust to considerable amounts of biological variation.  
In real data, we cannot compare our expected coverage estimators to input Poisson rate 
parameters, but we can compare them to our observed coverage.  We observe a strong 
correlation between simulated observed coverage and the expected coverage estimators, but 
we also observe that RMSE is much larger than it is for input Poisson parameters and 
expected coverage estimators (Figure 5.13, page 182).  In the context of the simulation, an 
increased RMSE is due to Poisson sampling.  In real data, we might expect to see somewhat 
lower correlation and higher RMSE than we observe in simulated data. 
There is one other demonstration of the power of our expected coverage estimation 
algorithm that came about due to a bug in an earlier version of the uSeq pipeline.  If we were 
to divide an individual’s observed coverage by their expected coverage estimator, we would 
expect to see that the resulting distribution would be distributed around 2, since most alleles 
have two copies plus some stochastic sampling variation.  In an earlier version of the 
pipeline, we observed that some individuals had significant deviations from this expected 
distribution in contiguous blocks of microsatellite loci throughout their genomes.  When we 
evaluated the sequencing data from individuals with these aberrant distributions, we found 
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that uSeq had deleted contiguous chunks of sorted, aligned reads, which made it appear as 
though these individuals had enormous deletions at microsatellite loci.  Due to the power of 
this expected coverage estimation algorithm, we were able to identify and correct the bug 
before it significantly damaged our analysis. 
5.3.3.2.7 Limitations of the current expected coverage estimation algorithm 
The expected coverage estimation algorithm relies on the assumption that the vast 
majority of the genomes in the sample are bi-allelic.  This is a safe assumption in the SSC 
dataset, but it would need to be reconsidered in some other studies, such as copy number 
unstable tumors.  The expected coverage estimation algorithm could be adapted to datasets 
with high frequency CNVs by incorporating data from an orthogonal copy number prediction 
algorithm.  Since uSeq focuses on short, dispersed microsatellite loci, it is incapable of 
accurate copy number prediction on its own.  The expected coverage estimator is designed to 
weigh the evidence supporting a bi-allelic state for every SSC individual at every locus, 
nothing more. 
5.3.3.2.8 Additional coverage estimation algorithm implementation details 
Currently, the coverage model estimates expected coverage for autosomes.  Sex 
chromosomes are not evaluated since their copy number varies by gender, although this 
could be easily accommodated in future versions of uSeq.  No coverage estimators are 
provided for the mitochondrial genome.  There is no reasonable assumption to be made 
regarding the copy number of an individual’s mitochondrial genome since the number of 
sequenced mitochondrial genome copies will vary among individuals. 
Once the low-rank SVD coverage estimator matrix has been derived, uSeq eliminates 
coverage outliers within the study population.  Families with at least one member who has 
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total coverage more than two standard deviations below the population mean total coverage 
are excluded.  In addition, families with at least one member who has poor correlation 
between their observed total coverage and their estimated expected coverage are excluded.  
The current threshold for poor correlation is 0.8.  In practice, these rules only exclude a 
handful of SSC families from further analysis. 
5.3.3.3 Per-allele capture bias and per-locus noise estimation 
5.3.3.3.1 Motivations for per-locus noise rate estimation  
Typically, HTS and sample preparation introduce noise in the form of base miscalls 
and more rarely, spurious indels.  In addition, replication slippage is possible at a 
microsatellite locus any time DNA is replicated, even during in vitro replication such as 
PCR.  While cellular DNA replication can correct slippage mutations via the MMR 
machinery, in vitro DNA replication has no equivalent mechanism for slippage repair.  
Therefore, microsatellite instability can be dramatically higher during sample preparation 
than it would be during cellular replication.  The factors underlying cellular microsatellite 
instability discussed in section 4.1.2.3 also affect microsatellite instability during PCR.  
Accurate estimates of microsatellite instability rates during sample preparation are one 
essential component of a good microsatellite genotyper. 
Microsatellite loci with similar properties can have variable stability during sample 
preparation.  The most popular microsatellite genotypers estimate noise rates for a 
microsatellite locus based on its general properties using fixed models that are independent 
of experimental setup.  This general approach might be adequate when genotyping 
microsatellites in individuals, but it can fall short when experimental conditions affect the 
slippage rate relative to the genotyper model; or when the properties accounted for by the 
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model are insufficient to accurately capture the slippage behavior of a particular locus.  The 
uSeq approach to modeling sequencing noise addresses both of these problems.  In large 
datasets such as the SSC, the population size at any locus is sufficient to estimate locus-
specific noise parameters.  These estimates will be much more sensitive to slippage 
variability among similar loci.  Additionally, uSeq always estimates noise rates using study-
specific coverage data.  Assuming consistent experimental protocols, uSeq will be able to 
estimate study-specific noise rates.  
Per-locus noise estimates could be even more fine-grained.  In theory, noise rates can 
vary among people at a locus.  Currently, uSeq assumes that there is no significant intra-
person variation in locus-wide noise.  Alleles at the same locus may also have different noise 
rates.  Since we have no clear means of distinguishing which allele produced a particular 
slippage product, uSeq only infers a locus-specific noise rate estimate, accounting for 
slippage mutations as well as base miscalls and spurious indels.  In addition, allele-specific 
error rates could be hampered for alleles with few observations within the study population.  
Locus-specific noise rate estimates are sufficient to call accurate genotypes and identify de 
novo mutations. 
5.3.3.3.2 Motivations for per-allele allele capture bias  
In our initial attempts to call de novo microsatellite mutations in the SSC, we 
observed that exome capture probes favored reference alleles at many loci.  This capture bias 
affected both the sensitivity and specificity of uSeq de novo calls.  In allele scatter plots of 
some microsatellite loci, it is immediately obvious that different alleles at the same locus are 
consistently recovered and sequenced with varying efficiency (Figure 5.14, page 183).  Per-
allele capture bias has also been observed for indels in the broader SSC study as well 
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(Iossifov et al. 2012; see Table S2).  Without an estimator for per-allele capture bias, accurate 
detection of de novo microsatellite mutations would be impossible. 
Like the per-locus noise rate estimates, per-allele capture bias estimates might not 
have generalizable patterns.  The bias can depend on any number of factors that are 
exceedingly complex or impossible to discern.  Possible contributors to capture bias may 
include the position of a microsatellite locus relative to the exome capture probe; the 
difference between the capture probe microsatellite tract length and the library fragment 
microsatellite tract length; or the ability of a non-reference microsatellite allele to maintain a 
secondary structure favorable to a stable interaction with the exome capture probe.  Capture 
bias may also be a general feature of microsatellite genotyping, independent of exome 
capture.  For example, long microsatellite alleles will have less coverage than short 
microsatellite alleles at the same locus because the sequencing read has fewer opportunities 
to completely contain the longer microsatellite allele.  This limitation would diminish as the 
read lengths possible in HTS become longer. 
5.3.3.3.3 A custom EM to estimate allele capture bias and noise parameters while calling 
microsatellite genotypes 
5.3.3.3.3.1 EM overview 
The uSeq genotyper uses a custom EM algorithm that simultaneously solves for 
MLEs for per-locus noise and per-allele bias parameters.  In a typical Gaussian EM, we 
assume that the observed data is derived from a mixture of several Gaussian distributions 
with unknown parameters.  The identity of the distribution from which a point is drawn is 
defined by an unknown latent variable.  Since we do not know which of the distributions a 
point is drawn from, we can only estimate the membership probability for each point in every 
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distribution—ideally, a point’s source distribution should have the highest membership 
probability.  The EM requires a log-likelihood function relating the distribution parameters 
and membership probabilities to our observed data.  This log-likelihood function provides 
MLEs for each unknown distribution parameter, which the EM iteratively updates, along 
with membership probabilities, until the model converges. 
Before the EM algorithm can begin, we must specify initial estimates for membership 
probabilities and distribution parameters.  Membership probabilities for each data point 
typically start as a discrete uniform distribution—in the absence of distribution parameter 
estimates, all distributions are equally likely to be the source of a data point.  Initial 
distribution parameter estimates may sometimes be intuitive, while other times they might be 
randomly selected.  The EM can also be repeated several times with different initial estimates 
for distribution parameters to ensure that their MLEs are global maxima, not local maxima. 
A single iteration of the EM consists of two steps: the E—or expectation—step, and 
the M—or maximization—step.  During the E step, membership probabilities for each data 
point are estimated.  The membership probability is influenced by the latest distribution 
parameter MLEs, as well as each distribution’s weight—the likelihood that any point is 
drawn from that distribution.  A distribution with low weight is unlikely to produce many 
observations.  During the M step, the distribution weights and MLEs for each distribution 
parameter are updated.  The distribution weights are simply the mean membership 
probabilities for every distribution.  The MLEs are calculated from the partial derivatives of 
the log-likelihood function for each distribution parameter.  The derivation of the log-
likelihood equation, MLEs, and membership probabilities will be elaborated on in our 
discussion of the custom EM we developed for the uSeq genotyper. 
 135 
The EM algorithm will iterate until it converges.  Sometimes, convergence can be 
determined by comparing MLEs in consecutive iterations; in which case the EM will cease 
once the difference between MLEs in consecutive iterations is below some threshold.  
Convergence can also be determined by comparing model likelihoods— once model 
likelihoods from consecutive iterations are within some threshold of each other, the EM will 
cease.  EM algorithms can also be forced to stop prematurely if certain parameter thresholds 
are exceeded or if a maximum number of iterations has been reached. 
5.3.3.3.3.2 An EM genotyper which incorporates sequencing noise and allele bias 
Let 𝑥 = {𝑥1, 𝑥2, … , 𝑥𝑁} be a set of non-negative integers describing the total observed 
coverage for a population of N people at a microsatellite locus.  Let A be any integer greater 
than zero, which defines the total number of alleles observed at the locus.  𝑥𝑎 ={𝑥1𝑎, 𝑥2𝑎, … , 𝑥𝑁𝑎} is a set of non-negative integers that define the allele coverage throughout 
the population for any allele a of the A alleles observed at the locus.  Finally, let 𝜆 ={𝜆1, 𝜆2, … , 𝜆𝑁} be the per-allele expected coverage estimate for each individual within the 
population, which is the SVD-derived per-allele, per-locus coverage estimator described in 
section 5.3.3.2.3. 
G is the set of possible genotypes at a locus.  Each possible genotype is referred to by 
its constituent alleles.  Since genotypes are bi-allelic, genotype annotation in the likelihood 
equation and MLEs will only refer to three alleles: a, b, and 0.  The purpose of the 0, or null, 
allele will be explained in section 5.3.3.4.1.  Alleles a and b refer to any two alleles in A.  
Therefore, the genotype 𝑙𝑎𝑎  refers to any homozygous genotype; 𝑙𝑎𝑎  refers to any 
heterozygous, non-null genotype; 𝑙𝑎0 refers to any genotype containing one null allele; and 
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𝑙00 refers to the genotype containing two null alleles.  The number of genotypes in G is 
given as 𝐴(𝐴 + 1) 2⁄ .   
Let 𝑡 = {𝑡1, 𝑡2, … , 𝑡𝑁} be a vector of vectors defining the copy number for all A 
alleles and all N individuals.  Each element 𝑡𝑖 = {𝑡𝑖1, 𝑡𝑖2, … , 𝑡𝑖𝑖}, provides the copy number 
of each allele for individual i.  Elements of 𝑡𝑖 are limited to 𝑡𝑖𝑎 = [0,1,2], and ∑ 𝑡𝑖𝑎𝑖1 ≤ 2.  
These restrictions enforce the assumption that any genotype is comprised of at most two 
alleles.  If a genotype has a single null allele, ∑ 𝑡𝑖𝑎𝑖1 = 1.  If it contains two null alleles, 
∑ 𝑡𝑖𝑎
𝑖
1 = 0.  An individual’s copy number vector defines their genotype, which is the latent 
variable in our EM. 
Let 𝑡 = {𝑡1, 𝑡2, … , 𝑡𝑁}  define a vector of membership probability vectors for all 
individuals in N.  Each element in t is a vector defining the membership probabilities of a 
particular individual for all possible genotypes.  The membership probability of individual i 
for genotype g is referred to as 𝑡𝑖,𝑔.  For any individual, ∑ 𝑡𝑖,𝑔𝐺𝑔 = 1. 
Each genotype has a weight describing its frequency at the locus.  Like genotypes, 
genotype weights are also referenced by the alleles they contain.  The vector 𝑤 contains all 
the genotype weights for the locus, and ∑ 𝑤𝑔𝐺𝑔 = 1. 
We choose to model each allele as an independent Poisson process—the Poisson 
allele coverage model.  This decision was motivated by the observation that homozygous 
genotypes for biased alleles tend to have lower coverage than homozygous genotypes for 
unbiased alleles (Figure 5.14B).  This would suggest that coverage at biased alleles is not 
reduced due to competition with unbiased alleles, but rather that the capture process itself is 
less effective.  By modeling alleles as separate Poisson distributions with rates modified by 
per-allele capture bias, uSeq is able to account for this behavior.  An alternative genotyping 
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model could use a Poisson distribution to model the total coverage at any locus, followed by 
binomial sampling from that total coverage when assigning reads to both alleles.  This model, 
referred to as the Poisson total coverage model, accounts for capture bias by modifying the 
binomial probability of a read being assigned to a particular allele.  When considering 
heterozygous genotypes, a comparison of simulated allelic coverage for the two proposed 
models demonstrates that the model choice is probably irrelevant.  The difference is dramatic 
when considering homozygous genotypes.  Since binomial sampling in the Poisson total 
coverage model has no effect on total coverage, it would be impossible to account for the 
observed decrease in total coverage for homozygous genotypes of biased alleles.  Of the two 
models, only the Poisson allele coverage model accounts for this behavior. 
The likelihood function of a genotype in any individual is defined as the products of 
the Poisson probability of the observed coverage for any genotyped alleles multiplied by the 
binomial probability of the observed noise coverage given 𝑝.  The Poisson rate for any allele 
a in individual i is defined as 𝑡𝑖𝑎𝜆𝑖𝛼𝑎.  Therefore, the likelihood of observing any genotype 
can be defined by the following equations: 
𝑃(𝑙𝑎𝑎|𝑥𝑖) = (2𝜆𝑖𝛼𝑎)𝑥𝑖𝑖𝑥𝑖𝑎! 𝑙2𝜆𝑖𝛼𝑖 � 𝑥𝑖𝑥𝑖 − 𝑥𝑖𝑎� 𝑝𝑥𝑖−𝑥𝑖𝑖(1 − 𝑝)𝑥𝑖𝑖 
𝑃(𝑙𝑎𝑎|𝑥𝑖) = (𝜆𝑖𝛼𝑎)𝑥𝑖𝑖𝑥𝑖𝑎! 𝑙𝜆𝑖𝛼𝑖 (𝜆𝑖𝛼𝑎)𝑥𝑖𝑖𝑥𝑖𝑎! 𝑙𝜆𝑖𝛼𝑖 � 𝑥𝑖𝑥𝑖 − 𝑥𝑖𝑎 − 𝑥𝑖𝑎� 𝑝𝑥𝑖−𝑥𝑖𝑖−𝑥𝑖𝑖(1 − 𝑝)𝑥𝑖𝑖+𝑥𝑖𝑖 
𝑃(𝑙𝑎0|𝑥𝑖) = (𝜆𝑖𝛼𝑎)𝑥𝑖𝑖𝑥𝑖𝑎! 𝑙𝜆𝑖𝛼𝑖 � 𝑥𝑖𝑥𝑖 − 𝑥𝑖𝑎� 𝑝𝑥𝑖−𝑥𝑖𝑖(1 − 𝑝)𝑥𝑖𝑖 
𝑃(𝑙00|𝑥𝑖) = 𝑝𝑥𝑖 
The purpose of the EM algorithm is to estimate the membership probabilities of each 
possible genotype in G for every individual in N, as well as the set of unknown parameters, 
𝜃 = {𝑤,𝛼,𝑝}.   
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We define the following likelihood function for our model, with parameters 𝜃: 
𝑙(𝜃) = ��𝑤𝑎𝑎�𝑡𝑖,𝑎𝑎𝑁
𝑖
𝑃(𝑙𝑎𝑎|𝑥𝑖)
𝑎∈𝑖
� × �� � 𝑤𝑎𝑎�𝑡𝑖,𝑎𝑎𝑁
𝑖
𝑃(𝑙𝑎𝑎|𝑥𝑖)
𝑎∈𝑖,𝑎∉𝑖𝑎∈𝑖 �
× ��𝑤𝑎0�𝑡𝑖,𝑎0𝑁
𝑖
𝑃(𝑙𝑎0|𝑥𝑖)
𝑎∈𝑖
� × �𝑤00�𝑡𝑖,00𝑁
𝑖
𝑃(𝑙00|𝑥𝑖)� 
The log-likelihood function of 𝑙(𝜃), 𝐿(𝜃), will then be: 
𝐿(𝜃) = � ln�𝑤𝑎𝑎�𝑡𝑖,𝑎𝑎𝑃(𝑙𝑎𝑎|𝑥𝑖)𝑁
𝑖
�
𝑎∈𝑖
+ � � ln�𝑤𝑎𝑎�𝑡𝑖,𝑎𝑎𝑃(𝑙𝑎𝑎|𝑥𝑖)𝑁
𝑖
�
𝑎∈𝑖,𝑎∉𝑖𝑎∈𝑖
+ � ln�𝑤𝑎0�𝑡𝑖,𝑎0𝑃(𝑙𝑎0|𝑥𝑖)𝑁
𝑖
�
𝑎∈𝑖
+ ln�𝑤00�𝑡𝑖,00𝑃(𝑙00|𝑥𝑖)𝑁
𝑖
� 
According to Jensen’s inequality, ln∑ 𝛽𝑖𝑦𝑖𝑖 ≥ ∑ 𝛽𝑖 ln𝑦𝑖𝑖 .  Using this property, we 
can set a lower bound for our log-likelihood equation (Equation 1): 
𝐿(𝜃) ≥ �𝑤𝑎𝑎�𝑡𝑖,𝑎𝑎 ln�𝑃(𝑙𝑎𝑎|𝑥𝑖)�𝑁
𝑖𝑎∈𝑖
+ � � 𝑤𝑎𝑎�𝑡𝑖,𝑎𝑎 ln�𝑃(𝑙𝑎𝑎|𝑥𝑖)�𝑁
𝑖𝑎∈𝑖,𝑎∉𝑖𝑎∈𝑖
+ �𝑤𝑎0�𝑡𝑖,𝑎0 ln�𝑃(𝑙𝑎0|𝑥𝑖)�𝑁
𝑖𝑎∈𝑖
+ 𝑤00�𝑡𝑖,00 ln�𝑃(𝑙00|𝑥𝑖)�𝑁
𝑖
 
This can be written more concisely as: 
𝐿(𝜃) ≥ �𝑤𝑔�𝑡𝑖,𝑔𝑁
𝑖
ln�𝑃(𝑙|𝑥𝑖)�
𝑔∈𝐺
 
In the rest of the discussion of the EM, 𝐿(𝜃) refers to the log-likelihood equation 
simplified by Jensen’s inequality.  After each iteration, the EM algorithm uses its current 
parameter estimates to calculate 𝐿(𝜃).  Values of 𝐿(𝜃) for consecutive iterations can then be 
compared to determine whether the EM has converged. 
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5.3.3.3.3.2.1 MLEs for 𝛼 and p 
Deriving MLEs for the parameters α and p requires the logarithms of each genotype 
likelihood function, which are given here: 
ln𝑃(𝑙𝑎𝑎|𝑥𝑖) = 𝑥𝑖𝑎 ln 2𝜆𝑖𝛼𝑎 − ln 𝑥𝑖𝑎! + 2𝜆𝑖𝛼𝑎 + ln � 𝑥𝑖𝑥𝑖 − 𝑥𝑖𝑎� + (𝑥𝑖 − 𝑥𝑖𝑎) ln𝑝+ 𝑥𝑖𝑎 ln(1 − 𝑝) ln𝑃(𝑙𝑎𝑎|𝑥𝑖) = 𝑥𝑖𝑎 ln 𝜆𝑖𝛼𝑎 − ln 𝑥𝑖𝑎! + 𝜆𝑖𝛼𝑎 + 𝑥𝑖𝑎 ln 𝜆𝑖𝛼𝑎 − ln 𝑥𝑖𝑎! + 𝜆𝑖𝛼𝑎+ ln � 𝑥𝑖
𝑥𝑖 − 𝑥𝑖𝑎 − 𝑥𝑖𝑎
� + (𝑥𝑖 − 𝑥𝑖𝑎 − 𝑥𝑖𝑎) ln𝑝 + (𝑥𝑖𝑎 + 𝑥𝑖𝑎) ln(1 − 𝑝) 
ln𝑃(𝑙𝑎0|𝑥𝑖) = 𝑥𝑖𝑎 ln 𝜆𝑖𝛼𝑎 − ln 𝑥𝑖𝑎! + 𝜆𝑖𝛼𝑎 + ln � 𝑥𝑖𝑥𝑖 − 𝑥𝑖𝑎� + (𝑥𝑖 − 𝑥𝑖𝑎) ln𝑝+ 𝑥𝑖𝑎 ln(1 − 𝑝) ln𝑃(𝑙00|𝑥𝑖) = 𝑥𝑖 ln𝑝 
The partial derivative of 𝐿(𝜃) with respect to 𝑝 can be solved for zero to provide its 
MLE: 
𝑑𝐿(𝜃)
𝑑𝑝
= 1
𝑝
��𝑤𝑎𝑎�𝑡𝑖,𝑎𝑎(𝑥𝑖 − 𝑥𝑖𝑎)𝑁
𝑖𝑎∈𝑖
+ � � 𝑤𝑎𝑎�𝑡𝑖,𝑎𝑎(𝑥𝑖 − 𝑥𝑖𝑎 − 𝑥𝑖𝑎)𝑁
𝑖𝑎∈𝑖,𝑎∉𝑖𝑎∈𝑖
+ �𝑤𝑎0�𝑡𝑖,𝑎0(𝑥𝑖 − 𝑥𝑖𝑎)𝑁
𝑖𝑎∈𝑖
+ 𝑤00�𝑡𝑖,00𝑥𝑖𝑁
𝑖
�
−
11 − 𝑝��𝑤𝑎𝑎�𝑡𝑖,𝑎𝑎𝑥𝑖𝑎𝑁
𝑖𝑎∈𝑖
+ � � 𝑤𝑎𝑎
𝑎∈𝑖,𝑎∉𝑖 �𝑡𝑖,𝑎𝑎(𝑥𝑖𝑎 + 𝑥𝑖𝑎)𝑁𝑖𝑎∈𝑖
+ �𝑤𝑎0�𝑡𝑖,𝑎0𝑥𝑖𝑎𝑁
𝑖𝑎∈𝑖
� = 0 
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Solving the above equation for 𝑝, our MLE is (Equation 2): 
?̂? = 𝐴
𝐵
 
𝐴 = �𝑤𝑎𝑎�𝑡𝑖,𝑎𝑎(𝑥𝑖 − 𝑥𝑖𝑎)𝑁
𝑖𝑎∈𝑖
+ � � 𝑤𝑎𝑎
𝑎∈𝑖,𝑎∉𝑖 �𝑡𝑖,𝑎𝑎(𝑥𝑖 − 𝑥𝑖𝑎 − 𝑥𝑖𝑎)𝑁𝑖𝑎∈𝑖
+ �𝑤𝑎0�𝑡𝑖,𝑎0(𝑥𝑖 − 𝑥𝑖𝑎)𝑁
𝑖𝑎∈𝑖
+ 𝑤00�𝑡𝑖,00𝑥𝑖𝑁
𝑖
 
𝐵 = �𝑤𝑎𝑎�𝑡𝑖,𝑎𝑎𝑥𝑖𝑁
𝑖𝑎∈𝑖
+ � � 𝑤𝑎𝑎
𝑎∈𝑖,𝑎∉𝑖 �𝑡𝑖,𝑎𝑎𝑥𝑖
𝑁
𝑖𝑎∈𝑖
+ �𝑤𝑎0�𝑡𝑖,𝑎0𝑥𝑖𝑁
𝑖𝑎∈𝑖
+ �𝑤00�𝑡𝑖,00𝑥𝑖𝑁
𝑖𝑎∈𝑖
 
Although A and B look complicated, the intuition for the MLE ?̂? is straightforward.  
The numerator, A, is the sum of the total noise coverage for each genotype multiplied by each 
individual’s membership probability for the respective genotype, weighted by the genotype 
frequency.  Similarly, the denominator, B, is the sum of the total observed coverage for each 
individual multiplied by their membership probability for every genotype, weighted by the 
genotype frequency.  In essence, the noise rate is related to the number of noise reads divided 
by the total coverage. 
The MLEs for any 𝛼𝑎 only depend on the partial derivative of 𝐿(𝜃) with respect to all 
genotypes that include the a allele.  We obtain the MLE by setting the partial derivative to 
zero and solving for 𝛼𝑎: 
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𝑑𝐿(𝜃)
𝑑𝛼𝑎
= 1
𝛼𝑎
�𝑤𝑎𝑎�𝑡𝑖,𝑎𝑎𝑥𝑖𝑎𝑁
𝑖
+ � 𝑤𝑎𝑎�𝑡𝑖,𝑎𝑎𝑥𝑖𝑎𝑁
𝑖𝑎∈𝑖,𝑎∉𝑖 + 𝑤𝑎0�𝑡𝑖,𝑎0𝑥𝑖𝑎𝑁𝑖 �
− 𝑤𝑎𝑎�𝑡𝑖,𝑎𝑎2𝜆𝑖𝑁
𝑖
− � 𝑤𝑎𝑎�𝑡𝑖,𝑎𝑎𝜆𝑖𝑁
𝑖𝑎∈𝑖,𝑎∉𝑖 − 𝑤𝑎0�𝑡𝑖,𝑎0𝜆𝑖
𝑁
𝑖
= 0 
Solving the equation for 𝛼𝑎, provides the following MLE (Equation 3): 
𝛼𝑎� = 𝑤𝑎𝑎 ∑ 𝑝𝑖,𝑎𝑎𝑥𝑖𝑎𝑁𝑖 + ∑ 𝑤𝑎𝑎 ∑ 𝑝𝑖,𝑎𝑎𝑥𝑖𝑎𝑁𝑖𝑎∈𝑖,𝑎∉𝑖 + 𝑤𝑎0 ∑ 𝑝𝑖,𝑎0𝑥𝑖𝑎𝑁𝑖𝑤𝑎𝑎 ∑ 𝑝𝑖,𝑎𝑎2𝜆𝑖𝑁𝑖 + ∑ 𝑤𝑎𝑎 ∑ 𝑝𝑖,𝑎𝑎𝜆𝑖𝑁𝑖𝑎∈𝑖,𝑎∉𝑖 + 𝑤𝑎0 ∑ 𝑝𝑖,𝑎0𝜆𝑖𝑁𝑖  
The intuition behind the MLE 𝛼𝑎� is also meaningful.  The numerator is the sum of 
each individual’s observed allele coverage multiplied by their respective membership 
probability, weighted by the genotype frequency.  The denominator is the sum of the 
expected allele coverage for each genotype in each individual, multiplied by their respective 
membership probability, weighted by the appropriate genotype frequency.  In its simplest 
sense, the allele bias is the observed coverage divided by the expected coverage. 
5.3.3.3.3.2.2 Initializing the EM 
The EM initializes with the assumption that every allele is unbiased, i.e. 𝛼𝑎 = 1 for 
all alleles.  All possible genotypes are assumed equally likely, and the noise rate for the locus 
is assumed 0.001.  Currently, the initial genotype frequencies and allele biases are not 
modifiable, but the initial noise estimate can be changed. 
5.3.3.3.3.2.3 E step 
During the expectation step, the current model is used to calculate membership 
probabilities for each person i and each genotype gj  (Equation 4): 
𝑡𝑖,𝑔𝑗 = 𝑤𝑔𝑗𝑃�𝑙𝑗�𝑥𝑖�∑ 𝑤𝑔𝑃(𝑙|𝑥𝑖)𝑔∈𝐺  
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5.3.3.3.3.2.4 M step 
Genotype frequencies are estimated as (Equation 5): 
𝑤�𝑔 = 1𝑁�𝑡𝑖,𝑔𝑁
𝑖
;𝑙 ∈ 𝐺 
The MLEs for α and p are as described in section 3.3.3.3.2.1. 
5.3.3.3.3.2.5 Determining EM convergence 
The EM converges when the current model log-likelihood is within some threshold of 
the log-likelihood for the model immediately preceding it.  In the current uSeq 
implementation, this threshold is 10.  The EM will stop prematurely under two conditions: 
1. The EM has not converged after a threshold number of iterations.  The default 
threshold is 25 iterations. 
2. The noise rate has exceeded some upper limit.  The default threshold is 0.4. 
The EM is forced to stop once the noise rate is so high as to make confident genotype calling 
impossible.  If 2 of every 5 reads may be the result of slippage noise, there is almost certainly 
no means of consistently calling accurate bi-allelic genotypes within the study population at 
the locus.  A high estimated noise rate does not necessarily mean a locus is unstable during 
sample preparation—it could also suggest that a locus has frequent somatic variations or 
CNPs.  The complete pseudocode for the EM genotyper is below. 
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5.3.3.3.3.2.6 Interpreting EM results 
Once the EM has converged or stopped prematurely at a locus, uSeq saves the noise 
rate MLE, a vector of allele capture bias MLEs, and an upper triangular matrix of the 
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genotype weights with dimensions 𝐴 × 𝐴 .  The rows of the genotype weight matrix 
correspond to first allele of a genotype, and the columns correspond to the second allele of a 
genotype.  Allele biases can take any non-negative value.  If an allele has a bias of 1, it is 
captured with the efficiency predicted by the per-allele, per-person expected coverage 
estimators at that locus.  A bias term below 1 indicates decreased capture efficiency for an 
allele relative to expected coverage estimators for that locus.  A bias term above 1 indicates 
increased capture efficiency relative to the coverage estimators for that locus. 
The EM also reports every individual’s membership probabilities for any genotype at 
the locus.  The complete membership probabilities for any locus are reported as a 𝑁 × 𝐴 × 𝐴 
array of 𝑁 upper triangular matrices—one for each individual.  The complete membership 
probabilities are unwieldy and most genotype probabilities are very low.  uSeq only reports 
the maximum membership probability for each individual, along with the alleles comprising 
the corresponding genotype.  The maximum membership probability is reported as the 
genotype confidence.  Genotype confidences close to 1 indicate confident genotype calls. 
5.3.3.3.3.3 Benefits of the EM approach 
An EM approach is appealing for several reasons.  EM iteratively updates its 
distribution parameter estimates, as it improves its membership probabilities and distribution 
weights.  This allows an EM to find MLEs even when initial parameter estimates are 
inaccurate.  The EM membership probabilities not only report the likeliest source distribution 
source for each data point, they also indicate any uncertainty regarding the source 
distribution.  This property is essential to uSeq’s ability to call microsatellite genotypes and 
report their confidences.  The EM convergence threshold can be set arbitrarily, which allows 
the user to balance accurate parameter estimates and additional computation time.  Similarly, 
 145 
the total number of iterations and distribution parameters can be capped in an EM.  These 
final two properties are particularly useful in uSeq, where a separate EM is required for each 
locus.  Since there are so many loci, the current EM implementation favors rapid 
convergence by limiting the maximum number of iterations and noise rate. 
5.3.3.3.4 Testing the uSeq EM genotyper 
5.3.3.3.4.1 Simulating biased microsatellite coverage 
We designed a single-locus simulation to test the uSeq EM genotyper’s performance.  
The simulator takes the following parameters as inputs: 
• Population size 
• Per-person, per-allele expected coverage 
• Number of alleles  
• Per-allele capture bias 
• Population allele frequencies 
• Null allele frequency 
• Locus-wide noise rate 
For each individual in the population, the simulator picks a random genotype based on the 
provided allele frequencies.  The simulator will then randomly remove alleles from 
individuals within the population based on the null allele frequency.  After the genotypes for 
each individual have been established, coverage is assigned to each genotyped allele from a 
Poisson distribution with a rate parameter defined by each person’s expected coverage, the 
capture biases for each allele, and each person’s copy number vector.  In every individual, 
the number of slippage events from each allele is assigned from a binomial distribution using 
each allele’s coverage and the locus-wide noise rate.  Slippage events are randomly assigned 
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to any allele except for the allele from which they are derived.  Simulated noise is 
independent of other typical sequencing errors since they are not expected to significantly 
affect the number of errors observed in any individual. 
The EM genotyper is provided the observed locus coverage and the per-allele 
expected coverage for each individual.  The simulator does not derive expected coverage 
parameters using the SVD described in section 5.3.3.2.  We previously demonstrated that 
input Poisson parameters and SVD-derived per-allele, per-person expected coverage 
estimators are highly correlated in simulation; therefore, we do not expect the source of the 
EM genotyper’s expected coverage estimators to affect its performance.  Given this input 
data, the EM predicts each allele’s capture bias, the locus-wide noise rate, and the genotypes 
of each individual.  The estimated biases and noise rate are compared to their respective input 
parameters.  The EM-derived genotypes are also compared to genotypes derived from a naïve 
genotyper that does not assume any capture bias. 
5.3.3.3.4.2 Simulated EM genotyper performance—single parameter set 
As a demonstration of the EM genotyper’s performance, we simulated a locus with a 
population of 5,000 individuals with two alleles, A and B.  Per-allele expected coverage for 
each individual is sampled from a Poisson distribution with a rate parameter of 10.  The 
allele frequency for A was 0.9 and the frequency for B was 0.1.  No null alleles were 
assigned.  The capture bias for A was 1, and the capture bias for B was 0.5.  As a reminder, 
the closer the allele bias is to 1, the less bias it has.  Finally, we specify a locus-wide noise 
rate of 0.03. 
The true genotypes and observed coverage assigned by the simulation can be found in 
Figure 5.15A on page 184, and genotypes called by the naïve genotyper are in Figure 5.15B 
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on the same page.  By comparing the two plots, the shortcomings of the naïve genotyper are 
readily apparent.  Even when the correct locus-wide noise rate is provided, genotypes are 
consistently called incorrectly—almost every BB genotype, many AB genotypes, and even 
some AA genotypes are called incorrectly. 
After applying the EM genotyper to the simulated data, we first compare the input 
slippage rates and bias to their EM-derived values.  The comparison is very favorable—the 
EM-inferred noise rate is 0.01, compared to the input noise rate of 0.03; the EM-inferred 
capture bias for A is 0.99, compared to 1; and the EM-inferred capture bias for B is 0.51, 
compared to 0.5.  The accuracy of the EM-inferred parameter estimates improves as the locus 
coverage and population size increase.  The genotypes provided by the EM genotyper are 
also visibly more accurate than the naïve genotypes (Figure 5.16B, page 185). 
A careful comparison demonstrates a clear improvement of the EM genotyper relative 
to the naïve genotyper.  We can define a summary table for both genotypes, where each row 
corresponds to the original, simulated genotypes, and each column corresponds to a genotype 
call using any genotyping algorithm.  This summary table reports a genotyper’s precision for 
each category of original genotypes, as well as any typical errors it makes in its genotype 
calls.  The summary tables for both genotypers, considering all genotypes, regardless of 
genotype confidence, can be found in Figure 5.17 on page 186.  87% of the naïve 
genotyper’s calls are correct.  It is most precise when the original genotype is AB and has a 
decreased precision for AA genotypes.  The naïve genotyper’s precision drops precipitously 
for BB genotypes—less than 10% of all BB genotypes are called correctly.  In contrast, the 
EM genotyper calls >98% of genotypes correctly.  Its precision is >99% for AA genotypes, 
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and >92% for AB genotypes.  The most dramatic improvement is for BB genotypes, which 
are called correctly >96% of the time. 
If we vary genotype confidence thresholds from 0 to 1, we can measure the sensitivity 
and specificity of both genotypers for confidence cutoffs.  We can do this graphically by 
comparing the ROC plots for both genotypers (Figure 5.18, page 187).  The naïve genotyper 
is comparatively mediocre job at distinguishing true positive and false positives genotype 
calls—maintaining an FPR below 5% requires a minimum confidence threshold of 0.988, 
which limits sensitivity to <50%.  In contrast, the EM genotyper requires a minimum 
confidence threshold of 0.996 to maintain an FPR below 5%, but TPR is a vastly improved 
82%.  A more general comparison of model performance can be obtained by comparing the 
AUC for both ROC curves.  The AUC measures the chance that the genotyper will provide a 
higher confidence for a randomly selected correct genotype call than for a randomly selected 
incorrect genotype call.  In this particular simulation, the AUC for the EM genotyper is 0.97, 
while the AUC for the naïve genotyper is 0.85, indicating a clear advantage in implementing 
the EM genotyper. 
The FPR is calculated as the number of false positives divided by the total number of 
negative calls (true negatives and false positives).  When the number of false positives and 
true negatives are low, the FPR can seem high even though the total number of false 
positives is low.  In this particular simulation, of the 5,000 total calls made by the EM 
genotyper, just 76 are incorrect.  Requiring an FPR of 5% in the EM genotyper allows for 
just three false positives, but we may be willing to be more permissive since the maximum 
false positive count is low.  This behavior can be accurately captured using a precision-recall 
curve (Figure 5.19, page 188).  This curve presents a more nuanced view of the precision 
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measured by the summary tables in Figure 5.17.  If we demand higher precision from the 
naïve genotyper, its recall drops dramatically—requiring at least 95% precision limits recall 
to <85%.  In contrast, the minimum precision of the EM genotyper is 98% when recall is 
100%. 
5.3.3.3.4.3 Simulated EM genotyper performance—multiple parameter sets 
While the EM genotyper’s performance for a single simulation is very encouraging, 
extensive tests with a wide range of parameters are necessary to establish its effectiveness.  
The EM genotyper has been tested on two simulation classes totaling over 5,000 parameter 
combinations.  The first simulation class explores every combination of the following 
parameters for a locus with 3 alleles (A, B, and C): 
• Population sizes of 100; 1000; 3,500; and 10,000 
• Mean per-allele, per-person coverage of 7, 12, 20, and 30 
• Allele frequencies for alleles A, B, and C 
o 60%, 26%, and 14% 
o 41%, 41%, and 18% 
o 70%, 30%, and 0% 
o 100%, 0%, and 0% 
• Null frequencies of 0, 0.01, and 0.001 
• Capture biases for alleles A, B, and C 
o 1, 0.8, and 0.3 
o 1, 0.6, and 0.6 
o 1, 0.3, and 0.8 
o 1, 0.8, and 0.8 
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o 1, 0.3, and 0.3 
• Locus-wide slippage rates of 0.001, 0.01, 0.05, and 0.1 
The second simulation class explores every combination of the following parameters for a 
locus with 5 alleles (A, B, C, D, and E): 
• Population sizes of 100; 1000; 3,500; and 10,000 
• Mean per-allele, per-person coverage of 7, 12, 20, and 30 
• Allele frequencies for alleles A, B, C, D, and E 
o 43%, 19%, 19%, 9.5%, and 9.5% 
o 35%, 35%, 15%, 15%, and 0% 
o 52%, 24%, 24%, 0%, and 0% 
o 30%, 30%, 30%, 0%, and 0% 
• Null frequencies of 0.01 and 0.001 
• Capture biases for alleles A, B, C, D, and E 
o 1, 0.8, 0.3, 0.3, and 0.3 
o 1, 0.8, 0.8, 0.8, and 0.3 
o 1, 0.8, 0.8, 0.8, and 0.8 
o 1, 0.3, 0.3, 0.3, and 0.3 
• Locus-wide slippage rates of 0.001, 0.01, 0.05, and 0.1 
Each combination of the 3-allele class was simulated three times, while combinations of the 
5-allele class were only simulated once.  We compared the performances of the naïve and 
EM genotypers by measuring their ROC AUCs for each parameter combination.  For the 3-
allele class, the mean ROC AUC for each combination was reported. 
 151 
The EM genotyper performs at least as well as the naïve genotyper for >92% of all 
parameter combinations in the 3-allele class (Figure 5.20A, page 189).  When the EM 
genotyper underperforms relative to the naïve genotyper, the locus-wide slippage rate is 
typically 0.1 or the mean per-allele, per-person coverage is 7, particularly when the biases for 
alleles B and C is 0.3 and both alleles have non-zero frequencies.  Within this set, the EM 
genotyper outperforms the naïve genotyper in ~75% of all combinations, despite frequent 
slippage, low coverage, and strong capture biases.  The relative performance of the EM 
genotyper is not strongly affected by population size.  These observations indicate that 
genotypes tend to be most accurate for common alleles and rare alleles with relatively weak 
bias without very high noise rates.  A rare allele may be genotyped incorrectly if its capture 
bias is particularly strong or if the corresponding locus-specific noise rate is especially high. 
Among all combinations in the 5-allele class, the EM genotyper performs at least as 
well as the naïve genotyper for >83% of all parameter combinations (Figure 5.20B, page 
189).  As was the case for the 3-allele class, the EM genotyper occasionally underperforms 
relative to the naïve genotyper when the noise rate is high or the mean per-allele, per-person 
coverage is low.  This is particularly true when biases are strong and many alleles have non-
zero frequencies. 
In general, the performance of uSeq’s EM genotyper is superior to the performance of 
a naïve genotyper.  The limitations of the EM genotyper are unsurprising—low coverage and 
noisy loci make genotyping more difficult, particularly when capture bias is strong.  When 
these characteristics are true at a locus, any genotyper would have trouble calling genotypes 
accurately.  Additionally, comparing the AUCs of the simulated ROC curves demonstrate 
that genotype confidence is a generally meaningful measure of genotype precision. 
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5.3.3.4 Interpreting uSeq genotypes 
5.3.3.4.1 The null allele 
In the definition of the uSeq EM genotyping algorithm, we introduced the concept of 
the null allele.  The null allele allows uSeq to indicate a lack of confidence that complete 
information has been observed at a locus, i.e. the observed coverage is less than expected, 
even when accounting for capture bias.  The EM may have a high confidence null allele for 
several reasons.  A null allele could be due to insufficient coverage because of stochastic 
processes.  A null allele could also be due to an undetected microsatellite in an individual—
perhaps they have a microsatellite allele whose tract length is below uSeq’s detection 
threshold or is interrupted by an indel or SNP.  A null allele could also be due to a deletion of 
the genomic region containing the microsatellite locus in an individual.  The genotypes called 
by uSeq are held to high standards—there must be strong evidence supporting any observed 
alleles, and there should be no evidence of undetected alleles at a locus.  In practice, many 
null alleles are the result of stochastic sampling.  The marginal frequency of the null allele 
throughout the population at a locus can provide strong evidence of a common undetected 
microsatellite or deletion. 
5.3.3.4.2 Measuring genotype goodness-of-fit with respect to uSeq genotype parameters 
uSeq leverages the richness of the SSC population to estimate per-allele, per-person 
coverage estimators and per-locus noise estimates.  These estimators allow uSeq to make 
highly accurate genotype calls, assuming an individual’s true genotype is bi-allelic.  If an 
individual does not have two alleles—either because they have a CNV or a somatic 
mutation—the per-locus noise rate may mistake a third or fourth microsatellite allele for 
sequencing errors.  Even in the absence of extensive noise, higher-than-expected coverage 
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could indicate the presence of a CNV within an individual.  It is not enough for a genotype to 
have high confidence and low null probability; the allelic and noise coverage must be 
consistent with a bi-allelic genotype at a microsatellite locus in an individual in our current 
genotyping model. 
The uSeq genotyper measures the evidence that a genotype is bi-allelic by calculating 
its goodness-of-fit with respect to the per-allele, per-person expected coverage estimator, the 
per-allele bias estimator, and the per-locus noise rate estimator.  Fundamentally, these values 
address two important concerns about uSeq’s final genotype calls—whether the allelic 
coverage is consistent with our expected coverage model and allele bias model, and whether 
the observed noise coverage is consistent with the total locus coverage and the per-locus 
noise rate.   
Allelic goodness-of-fit is measured using a two-sided exact Poisson test.  Since we 
expect the coverage for any allele to be sampled from a Poisson distribution, this test is 
appropriate.  The null hypothesis of the test is that the per-allele, per-person expected 
coverage; the allele capture bias; and the allele copy number define the Poisson rate for 
allelic coverage in any genotype, i.e.: 
𝐻0: 𝜆𝑜𝑎𝑜 = 𝜆𝑖𝛼𝑎𝑡𝑖𝑎 
for some person i and some allele a.  The null hypothesis is rejected when the observed 
coverage is too high or too low to assume that this rate defines the distribution that produces 
our observed coverage.  The threshold to reject the null hypothesis depends on the study size.  
When allelic goodness-of-fit is calculated for a heterozygous genotype, the reported 
goodness-of-fit is the product of each allele’s goodness-of-fit.  A genotype’s allelic 
goodness-of-fit provides an intuition regarding how well the uSeq genotyping model 
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describes the coverage observed at the locus.  A low allelic goodness-of-fit would indicate 
suspiciously high or low coverage, which could indicate the chance of a CNP or other 
genomic abnormality at the locus.   
 Noise goodness-of-fit is measured using a one-sided exact binomial test.  We chose 
this test since the uSeq genotyper assumes that noise reads are sampled from a binomial 
distribution from a population of xi reads with a rate of p, using the terms defined in the EM 
description in section 5.3.3.3.3.2.  The test’s null hypothesis is that the noise rate for an 
individual’s genotype is less than or equal to the locus-wide noise rate.  Since we do not want 
to penalize genotypes with fewer noise reads than expected, we do not use a two-sided test.  
The null hypothesis is only rejected if the observed noise coverage is too high to be explained 
by the locus-wide noise rate estimate.  Similar to allelic goodness-of-fit, the threshold for 
rejecting the null hypothesis depends on the study size.  A poor noise goodness-of-fit score 
would indicate that the best possible genotype for an individual at a locus is still too noisy.  
This could just be a matter of bad luck—perhaps the individual just happened to have 
excessive noise at the locus under consideration; but it could also indicate the presence of 
more than two alleles at the locus or the presence of a somatic mutation. 
5.3.3.5 Genotyper implementation 
The uSeq EM genotyper is currently implemented in R, which is in part due to the 
dependence of the expected coverage estimation algorithm on the R package IRLBA, and in 
part due to R’s statistical and graphical capabilities (R Core Team 2013).  For loops in R are 
notoriously slow, which affects the runtime of the uSeq genotyper.  Future genotyper 
implementations may rely on further optimization to reduce the number of for loops; 
implementing R for loops in C++ using Rcpp; parallelization using one of several R parallel 
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computing packages; or implementing the genotyper in an entirely different programming 
language, such as Python.  In the meantime, uSeq reduces genotyper runtime by splitting 
genotypes into 10,000 locus chunks that are processed in parallel.  This also maintains the 
genotyper’s scalability, since R limits the size of array and matrices.  The size of the SSC 
dataset would make it impossible to load genotype information for all people at all loci into R 
at once. 
5.3.3.6 Standard genotyper output 
Currently, genotyper output is stored separately for each chunk of loci in the RData 
format, which allows for storage of high-dimensional data structures such as lists of matrices 
or multi-dimensional arrays.  The RData file for each chunk contains the following 
information: 
• A vector of the number of EM iterations per locus 
• A vector of the per-locus noise rate 
• A list of vectors of per-allele capture biases per locus 
• A list of matrices of the final locus-wide genotype frequencies from the EM 
• A 3-dimensional genotype array 
The first dimension of the genotype array has one entry per locus, and the second dimension 
has one entry per SSC individual.  The third dimension consists of 11 fields, which report the 
following information for each genotype: 
1. First genotyped allele 
2. Second genotyped allele 
3. Genotype confidence 
4. Allelic goodness-of-fit 
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5. Noise goodness-of-fit 
6. Allele 1 coverage 
7. Allele 2 coverage 
8. Noise coverage 
9. Expected per-allele coverage estimator 
10. Expected noise coverage 
11. Marginal null probability 
Further improvements to genotyper output could involve reimplementation of the output 
format in HDF5, which is a popular set of libraries and file formats suited for the storage of 
large, complex datasets (The HDF Group 1997-2014).  HDF5 allows for efficient and 
flexible management of highly complex data, and has APIs for C++, Perl, Python, and R. 
5.3.3.7 VCF format for individuals 
Since uSeq considers genotypes on a population-level, its most intuitive format is the 
3-dimensional array described in the previous section.  To allow for comparisons with other 
genotypers, uSeq genotype calls for any individual can be obtained in a VCF version 4.1 file 
format (http://samtools.github.io/hts-specs/VCFv4.1.pdf).  Each VCF entry has four field 
types: required, information, format, and uSeq fields.  The format field describes the 
information found in the uSeq field.  The VCF format requires the following fields for each 
microsatellite genotype: 
1. Chromosome 
2. Microsatellite start position 
3. ID 
4. Reference sequence 
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5. Alternate sequence 
6. Phred-scaled genotype confidence 
7. Filter 
The ID and filter fields are not used in the uSeq pipeline, so they are both set to “.”.  
Depending on the genotype, the alternate sequence field can be set to “.”; it can contain a 
single non-reference sequence; or it can contain a comma-delimited list of each genotyped 
non-reference sequence.  The Phred-scaled genotype confidence is given as −10 log10(1 −
𝑙𝑙𝑙𝑚𝑡𝑦𝑝𝑙 𝑡𝑚𝑙𝑚𝑖𝑑𝑙𝑙𝑡𝑙).  A genotype confidence of 1 will produce an infinite Phred-scaled 
confidence.  To avoid confusion, the Phred-scaled genotype confidence is set to 100 when 
this occurs. 
The information field contains a semicolon-delimited list of short key-value pairs in a 
<key>=<value> format.  The keys and their meanings are as follows: 
1. END: microsatellite stop position 
2. RL: microsatellite reference tract length 
3. RU: microsatellite reference unit 
4. POP: total number of people with coverage 
5. SUM: total coverage throughout population 
6. TOP: maximum total coverage observed in any individual 
7. NR: log10 of the locus-wide noise rate 
The format field describes the colon-delimited data found in the uSeq field.  The 
format/uSeq fields provide the following information: 
1. GT: genotype indices 
2. GB: genotype alleles 
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3. GC: genotype confidence (not Phred-scaled) 
4. EC: expected per-allele coverage 
5. AF: allelic goodness-of-fit 
6. NF: noise goodness-of-fit 
7. AL1: allele 1 coverage 
8. AL2: allele 2 coverage 
9. ALN: noise coverage 
10. PNULL: Phred-scaled marginal null likelihood 
11. DP: total coverage 
12. SEEN: genotyped allele summary 
The genotype indices refer to the reference and alternate sequence fields in the VCF entry.  
The reference allele has an index of 0, and the alternate alleles start with an index of 1.  The 
genotyped allele summary reports the unique non-null alleles observed. 
5.4 Identifying potential de novo mutations 
A de novo mutation is any violation of Mendelian inheritance between two parents 
and their child.  A Mendelian inheritance pattern is any set of genotypes where a child 
inherits one allele from each parent.  When Mendel inheritance appears unlikely, there is a 
chance that a novel mutation has occurred in the child relative to their parents.  This mutation 
may have occurred in one of the parental germlines, or it may have occurred somatically 
during the child’s development.  Mendel violations can be classified into two categories: 
“commissions” and “omissions”.  A commission violation occurs when a child has an allele 
that is not observed in either parent.  An omission violation occurs when a child has two 
copies of an allele that is only observed in one parent (Figure 5.21, page 190).   
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Omission violations are exceedingly rare for SNVs, but may not be as unusual at 
microsatellite loci.  Omissions at SNV loci may be due to a missed allele from the second 
parent, an LOH event in the child, or an identical sporadic SNV occurring at the same 
position by chance.  The first explanation is usually the most likely, if coverage is not 
exceptionally high and capture efficiency is the same for all parental alleles.  LOH can be 
reinforced by nearby loci that are heterozygous between parents.  It is exceedingly unlikely 
that the same mutation observed in a parent occurred sporadically in their child.  Since 
mutation rates are high at some microsatellite loci, and microsatellite mutations are 
constrained to insertions or deletions of complete units, microsatellite omissions may occur 
more frequently.  This would be due to the increased likelihood of an identical sporadic 
mutation occurring in a child relative to one of their parents.  Therefore, omissions may 
represent true mutations at microsatellite loci more often than they do at SNVs. 
5.4.1 Calculating per-trio Mendel obedience scores 
The Mendel obedience score expresses the Mendelian behavior of any parent-child 
trio.  It is calculated as the Phred-scaled sum of the joint probabilities for all possible 
Mendelian inheritance patterns: 
−10 log10 � 𝑃(𝑀 = 𝑙𝑀)𝑃(𝑃 = 𝑙𝑃)𝑃(𝐶 = 𝑙𝐶)All Mendelian trios  
In this equation, 𝑃(𝑀 = 𝑙𝑀)  refers to the probabilities that the mother has a particular 
genotype, 𝑙𝑀 .  Similarly, 𝑃(𝑃 = 𝑙𝑃) and 𝑃(𝐶 = 𝑙𝐶) refer to genotype probabilities in the 
father and child, respectively.  The probabilities referred to in this equation are the 
membership probabilities for each genotype provided by the EM genotyping algorithm in 
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section 5.3.3.3.3.2.  Since the Mendel obedience score is Phred-scaled, the higher the score, 
the stronger the evidence that a particular trio contains a Mendel violation. 
As is expressed in the Mendel obedience score, the quality of a Mendel violation 
depends on the confidence of the underlying genotypes.  Even when the likeliest trio 
genotype violates Mendelian inheritance, other potential trio genotypes may still be 
consistent with Mendelian inheritance.  These alternative trio genotypes are represented in 
the Mendel obedience score.  Several alternative explanations exist for apparent violations of 
Mendelian inheritance that do not involve actual de novo mutations.  In the case of 
commission violations, the putative novel allele may actually have been in either parent, but 
simply went unobserved.  Novel alleles may also be the product of sample-induced slippage.  
In the case of omission violations, an allele that was only observed in one parent may have 
actually been in both parents, but it had insufficient coverage in one parent.  Alternatively, 
the child may have in fact inherited one allele from each parent, but one parental allele was 
not observed with sufficient coverage in the child. 
When a trio genotype appears to violate Mendelian inheritance, it is essential to 
distinguish a true de novo mutation from an artifact due to any of the several possibilities 
described above.  The Mendel obedience score is an effort to make that distinction—as 
Mendelian genotypes patterns within a trio become less likely, the score rises, indicating a 
higher likelihood that a de novo mutation is being observed.  The Mendel obedience score 
explicitly considers all possible Mendelian inheritance patterns, but it does not consider 
whether the most likely trio genotypes are bi-allelic and detectable.  For this reason, we 
incorporate additional metrics assessing trio genotype quality in order to get the most 
accurate set of possible de novo mutations. 
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5.4.2 Assessing per-trio kinship 
When identifying candidate de novo mutations, we assume that only one mutation 
event occurred within any trio at a locus.  De novo mutations that introduce two novel alleles 
at a locus will be exceedingly unlikely when compared to alternative explanations.  Possible 
alternative explanations are similar to those mentioned in the description of omission and 
commission violations described above.  
In the current implementation of uSeq, per-trio kinship is calculated as the maximum 
swapped Mendel obedience score within a trio.  In this calculation, the child in a trio is 
swapped with either parent and the Mendel obedience score is calculated.  Since parents must 
pass one allele to their children, the swapped Mendel obedience score tests to ensure that the 
child contains at least one allele that is seen in either parent.  The kinship score is not Phred-
scaled, so the closer it is it to 1, the more likely it is that a child has inherited at least one 
allele from a parent.  If a kinship score is close to 0, it is more likely that the child does not 
possess any alleles seen in their parents. 
A probabilistic measure of trio kinship can also be calculated without the need for 
calculating two swapped Mendel obedience scores.  This measure would be the sum of the 
joint probabilities for any parental genotype combination, multiplied by the child’s marginal 
probabilities for any allele observed in either parent for a particular genotype combination.  
Kinship probabilities close to 1 would be a strong indicator that at least one allele has been 
inherited from a parent. 
5.4.3 Other measures of trio genotype quality 
In addition to the Mendel obedience score, we implement additional measures of trio 
genotype quality to identify the strongest candidate de novo mutations.  They measure 
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whether every trio member fits the uSeq expected coverage, bias, and slippage models, 
whether all trio genotypes have been called confidently, and whether anyone within the trio 
has any evidence of a null allele. 
5.4.3.1 Trio genotype confidence 
De novo mutations can be filtered by trio genotype confidence.  The trio genotype 
confidence score is calculated as the product of the genotype confidences for each trio 
member: 
� max
𝑔𝑖∈𝐺
�𝑃(𝑖 = 𝑙𝑖)�
𝑖∈(𝑀,𝐹,𝐶)  
Low trio genotype confidence scores can be the result of low individual genotype 
confidences in any trio member.  This score allows us to discern potential Mendel violations 
that do not have one clear trio genotype.  Ambiguous trio genotypes can be excluded from 
further analysis, or can be studied separately to gain a better understanding of their unusual 
behavior. 
5.4.3.2 Trio allelic goodness-of-fit 
The trio allelic goodness-of-fit score is calculated as the product of each trio 
member’s allelic goodness-of-fit: 
� 𝐷𝑎𝑎𝑎𝑎𝑎𝑎,𝑖
𝑖∈(𝑀,𝐹,𝐶)  
The allelic goodness-of-fit for each trio member is represented as 𝐷𝑎𝑎𝑎𝑎𝑎𝑎,𝑖 .  Trio allelic 
goodness-of-fit is a means of determining how well the trio as a whole is in accordance with 
their expected coverage parameters and applicable allele bias estimates.  Low trio allelic 
goodness-of-fit could be an indication of a suspiciously high coverage in any trio member.  
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Trio genotypes with poor trio allelic goodness-of-fit can be used to filter de novo mutations, 
or they can be studied separately in an attempt to better understand why the expected 
coverage estimator does not fit the trio genotypes. 
5.4.3.3 Trio noise goodness-of-fit 
Like the trio allelic goodness-of-fit, the trio noise goodness-of-fit is calculated as the 
product of each trio member’s noise goodness-of-fit: 
� 𝐷𝑛𝑜𝑖𝑜𝑎,𝑖
𝑖∈(𝑀,𝐹,𝐶)  
Each individual’s noise goodness-of-fit is represented as 𝐷𝑛𝑜𝑖𝑜𝑎,𝑖.  Trio noise goodness-of-fit 
is an effective means of identifying trio genotypes that appear to have at least one member 
whose coverage is either too noisy or appears to have more than two alleles at a locus.  Trio 
genotypes with poor noise goodness-of-fit may be especially interesting to study further.  
Members of these trios may have novel CNPs or somatic mutations, or they may be derived 
from especially noisy loci.  By studying these trios in-depth, perhaps some insight could be 
gained into loci with particularly complex genotypes. 
5.4.3.4 Trio null probability 
The trio null probability is the probability that any individual within the trio has a null 
allele, regardless of whether it is their most likely genotype.  It is calculated as: 1 − � �1 − 𝑃𝑛𝑛𝑎𝑎,𝑖�
𝑖∈(𝑀,𝐹,𝐶)  
𝑃𝑛𝑛𝑎𝑎,𝑖  is the marginal probability that a trio member has a null allele.  The trio null 
probability is a means of determining whether any trio member is likely to be missing any 
information at a locus.  As discussed in section 5.3.3.4.1, low trio null probabilities are often 
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the result of stochastically low sampling for some trio members.  At loci with high null 
probabilities, these trios may represent good study cases for undetected microsatellite alleles. 
5.4.4 Mendel obedience score implementation 
De novo mutation detection is implemented in R, similar to the uSeq EM genotyper 
(R Core Team 2013).  It is also split into separate 10,000 locus chunks to reduce the time 
needed to calculate Mendel obedience scores.  It is subject to the same avenues for 
improvement as the EM genotyper.  The only additional limitation placed on the uSeq EM 
genotyper is the number of alleles considered when calculating Mendel obedience scores for 
each trio.  The Mendel obedience score is calculated for any combination of the six most 
common alleles within a trio.  There are 1,281 possible Mendelian genotype trio 
combinations from six alleles, which are considered for every trio at every locus.  As the 
number of alleles considered for each trio grows, the number of possible Mendelian genotype 
trios increases exponentially.  The time taken to calculate Mendel obedience scores will 
dramatically increase with the number of alleles considered. 
5.4.5 Mendel obedience output 
Mendel obedience scores are saved as 3-dimensional arrays in the RData format for 
each genotyping chunk.  The first dimension of each array contains one entry per locus, the 
second dimension contains one entry per family, and the third dimension contains 14 fields.  
The first eight fields contain the likeliest genotypes for each family member in order for the 
mother, father, proband, and unaffected sibling.  The remaining six fields are: 
9. Proband trio genotype confidence 
10. Sibling trio genotype confidence 
11. Proband Mendel obedience score 
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12. Sibling Mendel obedience score 
13. Proband kinship score 
14. Sibling kinship score 
5.4.6 Identifying strong candidate de novo mutations 
Potential de novo mutations can be filtered using any combination of the metrics 
defined in the preceding sections to produce a set of high-confidence de novo mutation calls.  
The appropriate thresholds for many of the metrics will be study dependent or can be 
arbitrarily set.  Specific thresholds that yield very good specificity and positive predictive 
value are discussed in the section 6.6.1. 
On occasion, sample mix-ups can occur within a dataset, which will make it appear as 
though a child has an excessively high number of de novo mutations relative to their parents.  
While there may be biological explanations for high de novo mutation rates, we currently 
take a conservative approach and exclude all families where either child has more than 20 de 
novo mutations.  Families with excessive numbers of de novo mutation rates can be studied 
separately to determine whether the increased rate is due to a sample mix-up, impaired MMR 
efficiency, or some cause. 
5.5 Experimental procedures 
5.5.1 SSC exome sequencing protocol 
SSC samples were collected at 13 clinical centers.  The institutional review board at 
CSHL approved the SSC study, and written informed consent was obtained from all subjects 
by SFARI.  Families selected for uSeq processing were solely composed of “quads”—two 
unaffected parents, a single proband, and an unaffected sibling.  Blood samples from each 
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family member were drawn and sent to RUCDR for DNA preparation.  Exome sequencing 
data from 875 families (3,500 individuals) were selected for analysis in the current study.  Of 
the initial 875 families, 173 were processed at the Genome Center at Washington University, 
while the remaining 702 families were processed at CSHL.  In total, 807 families passed 
expected coverage filters and passed the filters described in Iossifov et al. in 2012. 
A complete description of the exome capture and sequencing protocol can be found in 
(Iossifov et al. 2012).  Briefly, exome capture was performed using NimbleGen SeqCap EZ 
Exome v2.0, which targets 36.0 Mb of the GRCh37 build of the reference human genome.  
The standard NimbleGen protocol was slightly modified.  In particular, barcodes were ligated 
prior to capture to enable pooled sequencing of samples.  Following sample preparation, 
101bp paired-end sequencing was performed on Illumina’s HiSeq 2000 platform. 
5.5.2 Validation sequencing protocol 
Candidate de novo mutations were confirmed via PCR amplification of loci with 
putative mutations, followed by pooled HTS on the Illumina MiSeq instrument.  Steven 
Marks carried out all the validation primer design for this project.  Primers were designed 
using BatchPrimer3 with the following conditions: primers must be between 18 – 27 bp; 
amplicon lengths are ~300 bp; and ideal primer melting temperatures were 62º C.  Primers 
start within 400 bp of the de novo mutation, and were targeted to either the forward or 
reverse strand of the chromosome.  Following primer design, primers were validated using 
BLAST.  Some loci have putative de novo mutations in multiple families.  These de novo 
mutations were processed in separate validation sets to avoid confusion.  At the primer 
design stage, validation targets can be excluded for one of three reasons: 
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1. De novo mutation was previously submitted for validation after discovery in other 
pipelines 
2. No DNA was available for at least one family member in the trio 
3. Primers could not be designed for target locus 
Jennifer Troge performed all sample preparation and sequencing for the microsatellite 
validation protocol.  Mitchell Bekritsky and Jennifer Troge adapted the standard Wigler lab 
validation protocol for microsatellite loci.  Primers were synthesized by Integrated DNA 
Technologies (Coralville, IA, USA).  Primer pairs were resuspended to a 10 µM 
concentration.  Template DNA from whole blood cells was obtained for each family 
member.  Primer cocktails were prepared of 5 µL 2X HFPMM and 3 µL water in 25 5-person 
aliquots.  5 µL of the respective family primer pair was added to each 5-person aliquot.  1 µL 
of each individual’s template DNA was added to 9 µL of each family-specific primer 
cocktail.  PCR amplification of each individual was carried out under the following 
conditions: 
• 1 cycle at 98º C for 10 seconds 
• 24 cycles with the following conditions: 
o 10 seconds at 98º C 
o 15 seconds at 60º C 
o 10 seconds at 72º C 
• 1 cycle at 72º C for 10 minutes 
• Hold at 4º C 
Following PCR amplification, samples were pooled by family member (fathers, mothers, 
probands, and siblings) and 100 µL of each pool was purified using Qiaquick (Qiagen).  The 
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sample concentration of purified samples was determined by Nanodrop (ThermoFisher 
Scientific), and size distribution was ascertained on a Bioanalyzer (Agilent Technologies).  
DNA ends were then polished, 3’ adenylated, and ligated to barcoded Illumina sequencing 
adaptors using standard protocols.  The barcodes for each adaptor were designed in the 
Wigler lab.  Adaptor-ligated DNA was amplified for 5 cycles and purified.  Sample 
concentration was measured once more by Nanodrop, diluted to 20 ng/µL, and quantitated 
(Bioanalyzer).  After diluting to the appropriate concentration, pooled samples were loaded 
on an Illumina MiSeq and sequenced using 150bp paired-end reads. 
 Following sequencing, sample barcodes were deconvoluted, and each family member 
pool was processed via the individual component of the uSeq pipeline.  Since loci were 
amplified via targeted sequencing, PCR replicate sets are indistinguishable from DNA 
sequences deriving from distinct genomic fragments.  Therefore, we did not mark or filter 
our PCR replicates.  Once profiles have been assembled from each individual, putative de 
novo mutations were manually validated for each family member (mother, father, de novo 
child).   
A novel allele is observed if it is distinguishable from slippage noise at a locus in an 
individual’s profile.  A de novo mutation is considered valid if the novel allele is observed in 
the appropriate child and is not observed in either parent.  If a putative novel allele is not 
observed in a child, or is observed in the child and either parent, it is considered invalid.  If a 
novel allele is observed in a child, but has no clear interpretation in either parent, the 
validation status is unclear.  Additionally, if any trio member appears to have more than two 
alleles, the validation status is unclear.  Unclear validation results could be the result of 
somatic mutations in a trio member; sample mix-ups in exome or validation sequencing; or 
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excessive slippage during sample preparation.  Any trio with one or more individuals with no 
observed coverage or observed coverage below 200x was considered to have failed 
validation.  In contrast, observed coverage at validated loci is generally >2000X. 
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Figure 5.1: An outline of the individual component of the uSeq pipeline.  Reads and a 
reference genome are taken as input.  Both are scanned for microsatellites using user-defined 
parameters for a microsatellite locus.  All detected microsatellite loci are removed from the 
reads and reference genome.  Reads are aligned to the condensed reference genome and post-
processed.  Microsatellite profiles reporting the coverage for each allele at each detected 
locus are given as output. 
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Figure 5.2: An outline of the population component of the uSeq pipeline.  Microsatellite 
profiles from a study population are merged and loci with low population coverage are 
removed.  Per-allele, per-person expected coverage parameters are estimated using SVD.  
After expected coverage estimators are derived, an EM algorithm estimates locus-wide error 
rates and allele-specific capture bias parameters from population data to call genotypes.  
Genotypes are called for every study individual at every locus, with genotype confidence 
scores and metrics assessing each genotype’s fit to a bi-allelic genotype model. 
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Figure 5.3: An example of the uSeq microsatellite detector FSM, with a maximum kmer size 
of 4 bp.  Positions in the dictionary and in the input sequence are 0-indexed.  At each step, 
the current kmer (bolded in the data column) is converted to a code, which is compared to the 
kmer codes in the dictionary.  If the FSM is in the N state, no putative microsatellite has been 
detected, and all dictionary kmers are checked.  If the FSM is in the M state, a putative 
microsatellite index has been detected, and the current code is only compared to the initial 
matching index (in green).  Once the current code no longer matches the dictionary code at 
the matching index, the FSM returns to the N state, and the putative microsatellite is reported 
if it meets the detector thresholds.  The variable names and their values correspond to the 
variable names and calculations described in section 5.2.1.2. 
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Figure 5.4: Percent of microsatellite flanks that map with mapping quality ≥30 by total 
flanking sequence length.  Horizontal lines mark the mean percentage of high quality 
microsatellite alignments among all flank divisions for each flank length.  Flank divisions are 
described in section 5.2.2.2.  Vertical lines mark the range of high quality alignments among 
all flank divisions for each flank length.  Most microsatellites map with high quality to the 
reference genome even when flanks are as short as 25 bp.  For any flank length, the flank 
divisions do not significantly affect mapping success. 
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Figure 5.5: uSeq alignment mapping quality precision and recall.  The lines represent 
mapping quality precision and recall for all reads; reads with microsatellites only; or reads 
with reference microsatellites only, respectively.  The black dot indicates a threshold of 
mapping quality of at least 30.  Precision and recall were calculated for simulated reads from 
chr22 that were condensed and aligned by uSeq.  Correctly mapped reads either shared the 
start position of the simulated fragment, or were 100 bp less than the stop position of the 
simulated fragment.  Each point represents a mapping quality threshold, which range from 0 
to 60.  For reference microsatellite loci, precision of over 0.99 can be obtained with recall 
near 0.80 for reads with mapping qualities of at least 30. 
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Figure 5.6: Undetected terminal microsatellites can cause uSeq to misalign reads.  
Microsatellite tracts are highlighted in orange, and base mismatches in alignments are 
highlighted in red.  In both examples, the read is aligned incorrectly to the condensed 
reference genome.  In (A), a complete motif is contained in the read, which maps to the 5’ 
flanking region of the microsatellite with a single mismatch.  In (B), only one base in the 
read is from the microsatellite tract.  The base is a perfect match to the last base preceding 
the microsatellite. 
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Figure 5.7: Distance of misaligned microsatellite reads to the correct genomic position.  The 
maximum distance to the correct genomic position is >51 Mb.  Distance to the correct 
position was measured as the minimum absolute distance of a start position reported by uSeq 
to the simulated fragment’s start and stop positions.  Distances to correct genomic positions 
are only reported for reads with mapping quality scores ≥30.  Most of these misaligned reads 
with microsatellites are within 100 bp of their correct genomic positions. 
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Figure 5.8: Flanking sequence can distinguish between slippage and substitutions at 
microsatellite loci.  In both (A) and (B), a microsatellite sequence has an additional motif that 
extends the sequence by 1 bp.  In (A), the 3’ flanking sequences of the original microsatellite 
locus and the mutant microsatellite locus differ, suggesting the mutation occurred via a 
substitution immediately adjacent to the microsatellite.  In (B), the 3’ flanking sequences of 
the original and mutant microsatellite loci are identical, suggesting that a slippage mutation 
extended the microsatellite locus. 
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Figure 5.9: An outline of the uSeq genotyper, as described in section 5.3.3.  First, expected per-allele coverage is estimated for 
each individual at each locus using SVD.  Then, a custom EM iteratively calls genotypes and updates allele bias and locus error 
parameters until it reaches convergence.  Finally, genotype probabilities are used to calculate Mendel obedience scores, which can 
be used to identify potential Mendel violations.  Steps within the loop represent the EM genotyper algorithm. 
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Figure 5.10: Coverage within SSC exome sequencing data is highly variable and complex.  In (A), coverage variability is shown 
among all well-covered loci in a randomly selected SSC individual.  In (B), coverage variability is shown among all SSC 
individuals at a single well-covered locus.  The best-fitting negative binomial and Poisson distributions are shown for each 
distribution.  Neither distribution adequately models the coverage variability throughout a locus or an individual.  Parameters for 
the distributions were calculated using the ‘fitdistr’ function in the MASS package using R (Venables and Ripley 2002).
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Figure 5.11: Simulation test schematic for the SVD-derived expected coverage estimator.  
Poisson random deviates are generated from input Poisson parameters for per-allele coverage 
and CNVs randomly distributed throughout the entire test set.  The SVD-inferred Poisson 
parameters (A’) are compared to the input Poisson parameters (A) to determine estimator 
accuracy. 
  
 181 
 
Figure 5.12: SVD-inferred coverage estimator performance on simulated data.  In (A), a subset of 200,000 data points is shown 
from all 35,000,000 simulated data points.  In (B), a subset 200,000 of data points from simulations where simulated copy number 
is not 2 is shown.  In both plots, the line where input and expected coverage are equivalent is shown in black.  Reported Pearson 
correlation coefficients and RMSE are given for all data in (A), and for all data that is not copy number 2 in (B).  The high 
correlation and low RMSE of input Poisson parameters to SVD-inferred expected coverage estimators strongly suggests that our 
SVD algorithm is able to successfully approximate input Poisson parameters in from coverage data. 
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Figure 5.13: SVD-inferred coverage parameters compared to simulated observed coverage.  
Correlations and RMSE are shown for all data.  When limited to copy number 2 simulated 
data only, Pearson’s correlation is >0.99, while RMSE is 30.  Each line represents an 
idealized copy state, where the observed coverage is the product of a locus’s copy number 
state and its expected coverage.  Although our SVD approximation algorithm accurately 
estimates input Poisson parameters, the RMSE for observed coverage and expected per-allele 
coverage can be large. 
 183 
 
Figure 5.14: Biased and unbiased coverage in SSC data.  In (A), a locus with two alleles and no discernible bias is shown.  Points 
are plotted for each individual based on their coverage for both alleles, and are colored according to their most likely genotype 
assuming no allele bias.  Both alleles have similar coverage.  In (B), a locus with two alleles demonstrating significant bias is 
shown.  Points are plotted as in (A), although genotypes have different colors.  The 12 bp allele consistently has half the coverage 
of the 10 bp allele, which leads to extensive genotyping errors.  Most noticeably, probable 12|12 genotypes are frequently called as 
12|-1 (single null genotype), and many probable 10|12 genotypes are miscalled as 12|12. 
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Figure 5.15: Comparing simulated genotypes to naïve genotypes.  The genotypes in (A) are randomly assigned coverage in 
simulation using a per-allele expected coverage parameter and per-allele capture bias parameters.  Each point is colored according 
to its assigned genotype.  A naïve genotyper calls the genotypes in (B) without accounting for capture bias.  Each point is colored 
according to the estimated genotype.  Identically colored points in (A) and (B) are called correctly by the genotyper without a bias 
model.  By comparing (A) and (B), it is apparent that the genotyper without a bias model makes frequent erroneous B0 and A0 
genotype calls. 
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Figure 5.16 Comparing simulated genotypes to bias EM genotypes.  The genotypes in (A) are identical to those in figure 15A.  An 
EM genotyper that accounts for capture bias calls the genotypes in (B).  Each point is colored according to the estimated genotype.  
As in Figure 5.15, identically colored points in (A) and (B) are called correctly by the genotyper with a bias model.  By comparing 
(A) and (B), it is apparent that the genotyper incorporating a bias model calls more genotypes correctly than the genotyper without 
a bias model. 
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Figure 5.17: Summary table for the naïve and EM genotypers.  Each row in the summary table corresponds to the genotype 
assigned in simulation, and each column represents a genotype called by either genotyper.  All rows sum to 100%.  The text in 
each cell is colored to reflect whether the genotypes called by a genotyper are in agreement with the simulation-assigned 
genotypes.  Cells colored green represent correct calls, while cells colored in red represent incorrect calls.  Naïve genotyper 
performance is presented in (A), while EM genotyper is presented in (B).  The EM genotyper is considerably more accurate.  Most 
notably in this example, the EM genotyper calls many more AA and BB genotypes correctly. 
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Figure 5.18: ROC plots for the naïve and EM bias model genotypers.  Maintaining a low false positive rate is especially 
challenging in the naïve genotyper—the true positive rate drops dramatically even when the false positive rate is limited to just 
0.2.  The EM genotyper is able to maintain high sensitivity while maintaining a much lower false positive rate.  This behavior is 
reflected in each genotyper’s ROC AUC—the EM genotyper is more likely to give a correct genotype a higher confidence call 
than the naïve genotyper. 
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Figure 5.19: Precision-recall curves for naïve and EM genotypers.  In this simulation, the EM 
genotyper has perfect recall while maintaining precision >0.95.  The recall of the naïve 
genotyper is limited to ~0.8 if we demand precision >0.95.  The naïve genotyper has recall of 
just ~0.5 if we want precision comparable to what we observe in the EM genotyper with total 
recall (~0.98). 
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Figure 5.20: Performance of EM genotyper in parameter sweeps.  Performance improvement is measured as the difference in ROC 
AUC between the EM and naïve genotyper divided by the ROC AUC of the naïve genotyper.  A percent AUC improvement of at 
least 0% indicates that the EM genotyper performs at least as well as the naïve genotyper.  A percent AUC improvement below 
0% indicates that the naïve genotyper outperforms the EM genotyper.  In (A), performance is shown for a range of parameter 
combinations at simulated loci containing three alleles.  In (B), performance is shown for a range of parameter combinations at 
simulated loci containing five alleles.  In both parameter sweeps, the EM genotyper consistently outperforms the naïve genotyper.  
The naïve genotyper occasionally has a higher ROC AUC when the locus error rate is high; expected coverage is low; and allele 
bias is strong. 
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Figure 5.21: Patterns of Mendelian and non-Mendelian inheritance.  In (A), one parent is 
homozygous for A, while the other is heterozygous with alleles A and B.  The only possible 
Mendelian genotypes these parents can pass to their children are AA and AB.  In (B), the 
parents have the same genotypes in (A), but the child either has a novel C allele not seen in 
either parent, or the child inherits two copies of the B allele that is only present in one parent.  
Both patterns represent different types of non-Mendelian inheritance. 
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6 Results 
6.1 uSeq reference microsatellite loci 
The uSeq detection algorithm describes a novel set of reference microsatellite loci.  
These loci differ significantly from the TRF-based reference microsatellite sets used by other 
microsatellite genotyping algorithms such as lobSTR or RepeatSeq (Gymrek et al. 2012; 
Highnam et al. 2013).  uSeq detects perfect microsatellite loci with motif lengths between 1 
and 6 bp, with minimum tract lengths of 8 bp, and minimum of 3 repeats of the same motif.  
With these parameters, uSeq identifies 5,784,968 microsatellite loci in release GRCh37 of 
the human reference genome, comprising ~2.4% of all the bases in the reference genome.  
Microsatellite frequency varies by genomic context (Figure 6.1, page 230).  Of particular 
relevance to the exome sequencing performed as part of the SSC study, microsatellite 
frequency in exons is ~1.2%.  This depletion of microsatellites within the exon might 
represent an evolutionary adaptation to minimize the effects of microsatellite instability on 
gene function.  The microsatellite base frequency reported by uSeq is nearly double that of 
earlier microsatellite base frequencies (Subramanian et al. 2003). 
The genome-wide mean reference microsatellite tract length is ~12 bp, and the 
genome-wide median tract length is 10 bp.  While >98% of microsatellite loci have reference 
tract lengths ≤30 bp, some microsatellite loci have reference tract lengths >1,000 bp.  
Microsatellites in exons tend to be shorter than those in introns and intergenic regions—the 
longest exon microsatellites are just 69 bp (Figure 6.2, page 231).  Exon mean and median 
reference tract lengths are shorter than other genomic contexts—the mean exon microsatellite 
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tract length is ~10 bp, while the median is 9 bp.  In GRCh37 as a whole, the mean is ~12 bp 
and the median is 10 bp (Table 6.1, page 289).  Mean microsatellite tract lengths are 14% – 
30% shorter in exons for motif lengths whose slippage products would induce frameshift 
mutations.  In contrast, mean microsatellite tract lengths for 3 and 6 bp motifs are nearly 
indistinguishable from their genome-wide counterparts. 
The most common genome-wide motif lengths are 1, 2, and 3 bp, which comprise 
24% – 33% of all microsatellite loci in the reference set.  Motif length distributions do not 
vary widely among most genomic contexts (Figure 6.3, page 232).  There are two dramatic 
exceptions to this behavior: miRNAs are enriched for 2 bp motifs (21/35; 60%), and exons 
are enriched for 3 bp motifs (32,845/42,028; 78%).  While the interpretation of the 2 bp motif 
enrichment at miRNA loci is unclear, the enrichment of 3 bp motifs in exons is somewhat 
intuitive.  By favoring 3 bp motifs, most microsatellites in exons would maintain the proper 
coding frame if they underwent slippage mutations, minimizing the opportunities for highly 
deleterious frameshift mutations.  Tandem amino acid repeats in a protein primary sequence 
could still be composed of degenerate codons to minimize the number of slippage-prone 
sites.  However, many short microsatellites with 3 bp motifs still occur, suggesting that while 
the genome has selected against frameshift-prone exon microsatellites, there does not appear 
to be a similar effect on microsatellites that would induce in-frame indels.  The mechanism 
by which 3 bp motifs are enriched in exons—as opposed to leveraging the degeneracy of the 
genetic code to minimize the occurrence of all microsatellite tracts—is unclear. 
Throughout the entire genome, the most common motif equivalence is the A class, 
which represents >30% of all microsatellite tracts, and 98% of all 1 bp microsatellite motifs 
(Figure 6.4, page 233).  Although A class microsatellites are among the 10 most common 
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equivalence classes in exons, they are only ~2.5% of all microsatellite in exons (Figure 6.5, 
page 234).  Of the ten most common equivalence classes in exons, seven have 3 bp motifs, 
however, AC, AG, and A class microsatellites still account for >16% of all microsatellites in 
exons.  Overall, microsatellites with the potential to cause frameshift mutations compose 
~21% of all microsatellites in exons. 
C class motifs are much more common in exons than they are in the rest of the 
genome—nearly 15% of all exon microsatellites with 1 bp motifs have a G class motif (Table 
6.2, page 289).  In contrast, G class motifs comprise just 1.6% of genome-wide 
microsatellites with 1 bp motifs.  AT, AC, and AG classes each comprise over 30% of all 
genome-wide microsatellites with 2 bp motifs, and only 0.7% of all microsatellites with 2 bp 
motifs are in the CG class (Table 6.3, page 289).  The distribution of 2 bp microsatellite 
equivalence classes in exons differs markedly from their distribution genome-wide.  CG class 
motifs are >1400% more common in exons than they are genome-wide, AG class motifs are 
~71% more frequent in exons than they are genome-wide, and AT microsatellites are only 
found with 13% of the frequency as they are genome-wide.  The most common genome-wide 
microsatellites with 3 bp motifs are from the AAT, ACC, AAG, AGG, and AAC classes, 
with frequencies from 25% to 10%.  Once again, exons exhibit a markedly different 
distribution of microsatellite equivalence classes.  The AGC, AGG, AAG, CCG, and ACC 
classes compose 25% to 10% of all exon microsatellites with 3 bp motifs, while the AAC and 
AAT classes are <5% of exon microsatellites with 3 bp motifs (Table 6.4, page 290).   
There are 33 equivalence classes for motif lengths of at least 4 bp, which is somewhat 
unwieldy, so only a brief overview will be provided here.  The most common genome-wide 
microsatellites with 4 bp motifs are from the AAAC, AAAG, AAAT, and AAGG 
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equivalence classes, with frequencies ranging from 24% to 8%.  The most common exon 
microsatellites with 4 bp motifs are from the AAAG, AGCC, AGGC, and CCCG classes, 
with frequencies ranging from 18% to 7%.  While the CCCG class is common in exon 
microsatellites with 4 bp motifs, it is only present in 0.3% of genome-wide microsatellites 
with 4 bp motifs.  The most common genome-wide microsatellites with 5 bp motifs are from 
the AAAAC, AAAAG, and AAAAT classes, with frequencies from 30% to 15%.  No other 
motif has a frequency above 5%.  There are only 116 exon microsatellites with 5 bp motifs.  
Of those, most are from the AGCCC, AAAAG, CCGCG, AAGAG, and CCCCG classes, 
with frequencies from 15% to 8%.  Aside from the AAAAG class, the most common 5 bp 
motif equivalence classes in exons occur with frequencies <2% genome-wide.  The most 
common genome-wide microsatellites with 6 bp motifs are from the AAAAAC, AAAAAG, 
and AAAAAT classes, with frequencies from 28% to 13%.  Of the 413 exon microsatellites 
with 6 bp motifs, many occur with frequencies from 7% to 1%.  Of the most common 
genome-wide microsatellites with 6 bp motifs, the AAAAAG class is the only one observed 
in exons.  In general, motifs with high GC content appear to be more prevalent in exon 
microsatellites than they are in microsatellites from introns and intergenic regions. 
6.2 SSC whole exome sequencing data 
In this study, exome sequencing data from 875 SSC quads (3,500 individuals) was 
analyzed for de novo microsatellite mutations.  No families with more or less than four 
individuals were considered.  Within this dataset, 787 of children with autism are male, and 
only 81 are female, which is a nearly 10-fold enrichment of males versus females with 
autism.  This is nearly double the sex bias reported by the CDC (Centers for Disease Control 
and Prevention (CDC) 2014).  Siblings are nearly equally likely to be male or female—463 
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siblings are females, while 405 are male.  Each member of the cohort was subject to exome 
capture using the NimbleGen SeqCap EZ Exome v2.0, then barcoded, pooled, and sequenced 
on the Illumina HiSeq 2000 platform using 101-bp paired end reads. 
6.3 uSeq microsatellite mapping performance 
6.3.1 General mapping statistics 
An average of 9% of all read pairs contain at least one microsatellite in the SSC 
dataset (Figure 6.6, page 235).  After aligning microsatellite reads from SSC individuals to 
the condensed reference genome, an average of 8% of reads failed to align (Figure 6.7, page 
236).  An additional 15% of reads had mapping quality scores below 30, which we have 
chosen as our mapping quality threshold (Figure 6.8, page 237).  Only ~1% of all read pairs 
align to disparate chromosomes (Figure 6.9, page 238). 
6.3.2 PCR replicate statistics 
On average, 4% of read pairs are in PCR replicate sets (Figure 6.10, page 239).  The 
number of distinct replicate sets varies by SSC individual, with an average of ~400,000 
replicate sets (Figure 6.11, page 240).  Most PCR replicate sets are very stable—only 0.6% 
of PCR replicate sets are discordant in the average SSC individual (Figure 6.12, page 241).  
The observed stability within the PCR replicate sets is an encouraging indication of 
microsatellite stability during the SSC sample preparation protocol.  As discussed in section 
5.2.4.1, we expect that most discordance in replicate sets would be due to slippage events 
occurring at microsatellite loci during PCR.  The fact that PCR replicate set discordance is so 
low indicates that most microsatellite loci exhibit a remarkable amount of stability during 
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sample preparation.  Therefore, we would not expect PCR slippage noise to be a major 
complication when calling genotypes at most loci. 
6.3.3 Overlapping read pairs 
Nearly 7% of all read pairs in an average SSC individual overlap and report the same 
microsatellite locus (Figure 6.13, page 242).  An overlapping read pair occurs when a 
sequencing fragment is shorter than twice the read length.  The relatively high proportion of 
overlapping reads suggests that many read fragments in SSC individuals are less than 200 bp 
in length.  Most overlapping reads report identical microsatellite tract lengths—only 0.3% of 
all overlapping read pairs are discordant in the average SSC individual (Figure 6.14, page 
243).  This provides further encouragement regarding the stability of most microsatellites 
detected in the SSC dataset.  A read pair would be most likely to report discordant tract 
lengths due to base miscalls or other errors introduced by the sequencing instrument.  The 
low read pair discordance rate indicates that the Illumina HiSeq 2000 instrument used to 
sequence microsatellite reads is not especially error-prone at most microsatellite loci. 
6.3.4 SSC microsatellite profiles 
Since the data from the SSC dataset is obtained from exome sequencing, we do not 
expect to capture anywhere near the complete complement of microsatellite loci in GRCh37.  
While we expect that loci within the exome target region will have the most consistent 
coverage in the SSC population, loci outside of the target region may have sporadic coverage 
in a subset of SSC individuals.  We see an average of ~1,000,000 profiles in each SSC 
individual (Figure 6.15, page 244).  Since there are only ~40,000 microsatellite loci in exons, 
this represents extensive off-target coverage throughout the genome. 
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Although uSeq is not limited to detecting microsatellite loci that are in its reference 
set, >96% of the reported microsatellite profiles in an average SSC individual are at reference 
microsatellite loci (Figure 6.16, page 245).  This suggests that the reference microsatellite set 
defined by uSeq captures a significant portion of the full microsatellite complement of many 
human genomes.  An abundance of non-reference microsatellite profiles could indicate that 
GRCh37 is a poor reference for microsatellite loci.  Frequent non-reference profiles would 
imply a high rate of microsatellite emergence within human genomes or frequent mutations 
that affect a microsatellite’s detectability.  We see no evidence to support either assumption. 
A non-reference microsatellite profile may not represent a truly novel microsatellite 
locus.  As discussed in section 5.2.2.4.1, sequencing reads with incorrect alignments and 
undetected terminal repeats usually align near their true position within the reference 
genome.  This error mode can produce significant coverage at spurious microsatellite loci.  
For this reason, we limit our SSC analysis to reference microsatellite loci only.  uSeq may be 
able to identify novel microsatellite loci in the SSC if it incorporated a local realignment step. 
6.3.5 Well-covered microsatellite loci 
HTS data from populations of individuals is essential to uSeq’s current genotyping 
strategy.  As a means of guaranteeing accurate genotypes, “well-covered” loci are identified 
using ad hoc filters.  In total, 5,453,739 reference microsatellite loci are observed in at least 
one SSC individual, which is ~94% of all reference loci.  In simulations of single-ended 
microsatellite reads, just under 90% of microsatellite loci have a high quality alignment with 
80 bp of flanking sequence.  Paired-end sequencing data provides a clear improvement in 
mapping microsatellite loci—more reads containing microsatellites can be aligned to 
reference loci with less flanking sequence. 
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Most uSeq reference microsatellite loci are observed in a fraction of SSC individuals 
(Figure 6.17, page 246).  The average number of SSC individuals covered at a reference 
microsatellite locus is ~650, while the median is 415.  This indicates a heavily skewed 
distribution with most loci only observed in <30% of all SSC individuals.  The majority of 
reference microsatellite loci reported in any SSC individual’s profile by uSeq will be due to 
sporadic coverage outside the exome. 
Microsatellite loci with higher maximum locus coverage tend to have coverage in 
more SSC individuals (Figure 6.18, page 247).  This would indicate that most loci 
consistently observed in the SSC dataset are likely to be in or near exome target regions, and 
would accordingly have higher coverage.  The maximum locus coverage is the highest 
observed coverage for any SSC individual at microsatellite locus, and is highly correlated 
both with the mean locus coverage and total locus coverage, which are other measures of 
how consistently a locus is captured within the SSC (all pairwise Pearson correlations >0.97). 
To identify reference microsatellite loci that are consistently covered throughout the 
SSC population, we limit our analyses to loci detected in at least 60% of SSC individuals 
with maximum locus coverage of at least 25 (Figure 6.18, page 247).  These filters limit our 
analyses to 133,300 reference microsatellite loci, or ~2.3% of uSeq reference microsatellite 
loci.  83% of all exon microsatellite loci in the uSeq reference set are observed in the SSC 
dataset, a dramatic enrichment as compared to other genomic contexts (Table 6.5, page 290).  
Introns comprise 57% of all well-covered loci, and another 26% of all well-covered loci are 
in exons.  Well-covered loci span all genomic contexts (Figure 6.19, page 248).   
The NimbleGen EZ Exome V2.0 capture kit has probes designed primarily to target 
NCBI RefSeq protein-coding regions and CCDS genes from September 2009; miRBase 
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miRNAs from September 2009 (version 14); and additional customer inputs.  Probes 
designed to target these regions cover a total of 44.1 Mb of the reference genome (Roche 
Nimblegen 2010).  Of the 133,300 well-covered loci in the SSC dataset, ~81% are either 
directly targeted by a capture probe or are within 200 bp of a capture probe (Figure 6.20, 
page 249).  The remaining 19% of well-covered loci are <3 Mb from the nearest probe.  
There is a clear relationship between the distance to the nearest EZ Exome capture probe and 
the mean locus coverage (Figure 6.21, page 250).  Similarly, the median per-locus mean 
coverage is ~15X for all well-covered loci in the SSC dataset, while the median per-locus 
mean coverage is ~7X for well-covered loci that are more than 200 bp from the nearest 
capture probe.  Well-covered loci that are far from specified capture regions may have 
consistent coverage within the SSC population due to weak homology of other genome 
regions to capture-targeted regions. 
6.3.6 uSeq coverage in whole exome and whole genome sequencing data 
In the interest of determining the reproducibility of uSeq microsatellite genotypes, 
whole genome sequencing data was obtained from two SSC families.  This data can serve as 
a sort of technical replicate, since the biological material is the same, although the 
sequencing strategy is different.  It is also useful in understanding the particular biases 
introduced by exome sequencing.  Whole genome sequencing was obtained using the 
Illumina HiSeq 2000 platform using 101-bp paired end reads. 
As a means of determining the consistency of uSeq genotypes in the same individuals 
with different experimental protocols, we compared the allele coverage for confidently 
genotyped alleles from whole genome and exome sequencing data.  More then 97% of high-
confidence homozygous genotypes have >90% of total coverage at the same genotyped allele 
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in both datasets (Figure 6.22A, page 251).  The same trend appears to be true for the first 
allele in high-confidence heterozygous genotypes (Figure 6.22B, page 251).  These results 
confirm that microsatellite loci are consistently detected by uSeq.  When a genotype is called 
by uSeq with high confidence, the pipeline can reproducibly detect sequencing data 
consistent with the genotype from the same biological sample independent of the 
experimental protocol used for sequencing. 
6.3.7 Comparing uSeq coverage to standard laboratory pipeline 
At reference microsatellite loci, uSeq coverage is generally as good or better than a 
GATK-based pipeline that realigns and recalibrates indels (Figure 6.23, page 252).  This is 
true when the GATK-aligned reads are subject to the same filters as uSeq-aligned reads, i.e. 
only one overlapping read is counted towards coverage in overlapping read pairs, reads must 
have a minimum mapping quality score of 30, and the read must completely contain the 
microsatellite.  Among all loci with at least 10X coverage in either pipeline, uSeq has ~6% 
more reads on average.  This demonstrates that the uSeq alignment strategy is comparable to 
commonly used indel-detection pipelines at microsatellite loci.  When spot-checked, the most 
common reasons for higher coverage in the GATK-based pipeline are SNVs or indels 
interrupting the microsatellite, which could be true genomic variation or sequencing artifacts.  
Additionally, reads may have different mapping quality scores in either pipeline, so reads 
that might be above the mapping quality threshold in one pipeline could fall below that 
threshold in the other. 
There are some loci where uSeq reports no coverage while GATK reports coverage.  
While analysis has not been exhaustive, all cases analyzed so far where uSeq has no coverage 
appear to be due to microsatellite regions that are frequently duplicated in human genomes.  
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This can arise when two regions in the reference genome have identical flanking sequence 
but differing microsatellite tract lengths.  In these situations, GATK-based pipelines may 
align reads uniquely to one of the regions due to the microsatellite tract length.  Since the 
flanking sequence for both loci are identical, uSeq will consider any reads mapping to these 
regions as having multiple reference genome alignments, and will therefore not consider 
them. 
6.4 uSeq genotyping 
6.4.1 Per-allele, per-person expected coverage estimates 
The uSeq genotyper relies on per-allele, per-person expected coverage estimates to 
assess whether a genotype has observed coverage consistent with a bi-allelic genotype 
model.  As described in section 5.3.3.2.2, a high correlation between observed coverage and 
expected coverage estimators indicates that the SVD-estimated parameters are an accurate 
representation of the underlying, non-biological processes influencing coverage.  The mean 
correlation between observed coverage and expected coverage for SSC individuals is >0.98, 
demonstrating the reliability of the SVD-derived expected coverage estimators in real 
sequencing data (Figure 6.24, page 253).   
Of the 3,500 people in the SSC dataset, four people from three families had low 
correlations between expected and observed coverage (<0.8) and exceptionally low total 
coverage.  Families containing these individuals were excluded from genotyping.  One SSC 
individual had exceptionally low coverage in the dataset, and the family containing this 
individual was excluded as well.  The median total read count in the SSC dataset is 
3,177,601; every individual with poor correlation and/or bad coverage had a total read count 
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between 11 and 309,753.  Finally, all individuals in this study had DNA obtained from whole 
blood, except for individuals from three families.  These families were also excluded from 
genotyping.  Therefore, genotyping was performed on 3,472 SSC individuals. 
When analyzing observed coverage in different genomic contexts, there is a clear 
difference in the coverage distribution at microsatellite in exons and outside of exons (Figure 
6.25, page 254).  The median coverage across all SSC individuals in all well-covered exon 
microsatellite loci is 33X, indicating robust coverage for exon microsatellites throughout the 
dataset.  The exon coverage distribution is very overdispersed, with a long tail that extends 
well past 100X coverage.  This behavior is reflective of the coverage variation among SSC 
individuals, as well as the variation in probe capture efficiency for different microsatellite 
loci.  The median coverage among all SSC individuals at loci outside of exons is 10X, a 
dramatic decrease from exonic coverage.  While the non-exon coverage distribution still 
exhibits some overdispersion, it is not nearly as dramatic as it is in the exon coverage 
distribution.  Although the high median exon coverage is very favorable for de novo mutation 
detection, the median coverage for non-exon loci is less promising.  It is likely that some de 
novo mutations outside of exons will be missed—low coverage in any trio member will lead 
to less certain genotype calls, which can deflate Mendel obedience scores, even for true de 
novo mutations. 
6.4.2 Locus-specific error rate estimates 
The median EM-estimated locus noise rate is ~0.001, while the mean noise rate is 
0.013.  Both summary statistics describe a noise rate distribution that suggests that noise will 
not be a confounding factor for genotyping at most microsatellite loci.  Error rates are 
strongly influenced by microsatellite motif length (Figure 6.26, page 255).  Although most 
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microsatellite with motifs of at least 3 bp appear to be incredibly stable, microsatellites with 
1 and 2 bp motifs often have error rates greater than 0.01.  Most notably, many microsatellite 
loci with 1 bp motifs appear to be highly unstable—17% of 1 bp motifs have estimated error 
rates above 0.10.  Only 0.9% of microsatellites with motifs longer than 2 bp have noise rates 
in excess of 0.01. 
In addition to clear motif length dependence, microsatellites appear to be increasingly 
unstable for longer reference tract lengths (Figure 6.27, page 256).  This is particularly 
apparent for microsatellites with 1 bp motifs—these microsatellites regularly have slippage 
rates above 0.10 for tract lengths as short as 11 or 12 bp (Figure 6.27A, page 256).  As 
microsatellites with 1 bp motifs extend, slippage rates might be too high to be able to call 
genotypes accurately.  If this slippage is due to the particular methods of sample preparation 
and not somatic variation, it is likely that protocols involving less PCR might make it 
possible to genotype longer microsatellites with 1 bp motifs.  The increase in error rate with 
longer tract lengths for microsatellites with longer motifs is much less dramatic (Figure 
6.27B, page 256).  Microsatellites with 2 bp motifs regularly have error rates below 0.10 
independent of reference tract length, and error rates above 0.10 are almost never observed 
for microsatellites with motifs of at least 3 bp. 
The error rate distributions in Figure 6.26 and 6.27 (pages 255 – 256) have a distinct 
bimodal form that requires consideration.  For all motif lengths larger than 1 bp, the first 
distribution has a mean of approximately 0.005, and the second distribution has a mean 
slightly greater than 0.001.  When analyzing the tract length distributions for 1 and 2 bp 
motifs in Figure 6.27 on page 256, this first distribution is almost entirely attributable to 
microsatellites with the minimum detectable tract length for either motif length.  This lower 
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peak is likely due to slippage events at these microsatellites that are undetectable by uSeq, 
which suggests that error rate estimates for the minimum detectable tract lengths may be 
slightly underestimated.  Even at longer tract lengths, error rates below 0.01 are regularly 
observed.  This suggests that the shortest detected microsatellites are highly stable and can be 
genotyped accurately. 
Even when accounting for motif length and reference tract length, the distribution of 
locus-specific error rate estimates varies considerably over several orders of magnitude.  For 
instance, error rates for 2 bp microsatellite motifs with a reference tract length of 9 bp can 
vary from as low as ~0.0001 to as high as ~0.01.  This indicates that error rate estimated from 
these characteristics might be highly inaccurate for any specific locus.  Two other common 
HTS microsatellite genotypers estimate error rates for a particular microsatellite locus by 
considering motif length and tract length, as well as additional parameters.  lobSTR also 
considers GC content and STR purity, while RepeatSeq only adds base-calling quality score 
to its error rate estimation (Gymrek et al. 2012; Highnam et al. 2013).  While these models 
may describe the average error rates for a particular allele length or reference locus, they are 
almost certainly incapable of encompassing the full variation in error rates due to parameters 
not included in their models.  uSeq is the only microsatellite pipeline to account for this 
variability, and it does so by considering population-level information at each locus.  The 
uSeq genotyper’s superior accuracy in locus error rate estimates contributes to more accurate 
genotype calls, which in turn allow for specific identification of de novo mutations. 
The error rate estimates at each locus reflect the MLE error rate estimate derived from 
the EM, provided the uSeq genotyping model is correct for an individual and/or locus.  If a 
locus is not bi-allelic in an individual, or the error rate cannot be described by a binomial 
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distribution, the estimated error rate will not be accurate.  These assumptions could be 
violated at loci with high levels of somatic instability.  Although it is reasonable to assume 
that most loci are somatically stable, some of the least stable loci we observe could be a 
product of population-wide somatic instability.  In addition, while the per-locus error rate 
describes the behavior of most individuals at the locus accurately, some individuals at the 
locus may have unexpectedly high error due to somatic mutation.  In these cases, the noise 
goodness-of-fit test could flag individuals with potential somatic mutations at a locus. 
6.4.3 Per-allele bias estimates 
Per-allele capture bias differs dramatically for reference and non-reference 
microsatellite loci (Figure 6.28, page 257).  The mean bias for reference alleles is 1.05, which 
tracks closely to the median of 1.01, indicating a relatively unskewed distribution.  As a 
reminder, a bias estimate near 1 indicates that a microsatellite allele’s coverage in the 
population is consistent with each individual’s per-allele expected coverage.  If an allele’s 
bias is below 1, it is consistently observed with less than expected coverage throughout the 
population.  Similarly, if an allele’s bias is above 1, it is consistently observed with more 
coverage than expected within the population.  The reference allele bias distribution is 
narrowly distributed around 1, which implies that reference alleles are usually observed with 
coverage consistent with their expected coverage estimators (Figure 6.28A, page 257). 
Non-reference alleles have capture biases that vary widely (Figure 6.28B, page 257).  
The mean bias for non-reference alleles is 0.46, while the median is 0.26, which suggests a 
heavily skewed distribution.  This is clearly demonstrated by the distribution of non-
reference allele biases, which exhibits bimodal behavior.  Many non-reference alleles have 
extreme biases—almost 44% of all non-reference alleles have biases ≤0.15.  Less than 30% 
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of non-reference alleles have capture biases between 0.75 and 1.25.  In contrast, 94% of 
capture bias estimates for reference microsatellite alleles fall within this range.  This suggests 
that exome capture can be extremely inefficient for non-reference alleles.  When interpreting 
microsatellite genotypes—and almost certainly indels in general—there is a considerable 
chance that many non-reference alleles are not consistently observed within a study 
population.  Without a model for capture bias, any indel or microsatellite genotyper could 
have significantly compromised accuracy.  Although not addressed in this study, this clear 
bias at microsatellite loci may be a general feature of indel and microsatellite sequencing 
studies independent of sample preparation protocol. 
Allele capture bias will be especially problematic when attempting to call de novo 
mutations.  Some true de novo mutations may be missed when a novel allele in a child is 
assumed noise due to extreme capture bias.  More troubling, spurious microsatellite de novo 
mutations could be called when a parent has low coverage at a putative novel allele due to 
capture bias.  By modeling allele capture bias, uSeq is able to consider de novo mutations 
with considerable specificity.  In trios where a child has a novel allele with strong capture 
bias, the genotyper would require higher coverage to demonstrate that the allele is truly novel 
and not due to noise.  Alternatively, when a child has an apparently novel allele that has 
extreme bias, any parental coverage for the same allele would be a strong indication that 
there is no de novo mutation within that trio at that locus.  Additional consideration for 
parental coverage at biased alleles is especially important for improving the specificity of de 
novo mutation identification. 
Allele capture bias is only capable of including an allele in a genotype if it is 
distinguishable from noise coverage at its locus.  If a locus has a very high noise rates, an 
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allele with very strong capture bias may not be detected since it would appear to be no 
different than noise at the locus.  This would in turn lead to decreased sensitivity to detect de 
novo mutations for alleles with strong bias or high noise rates. 
6.4.4 Genotype quality statistics 
6.4.4.1 Genotype confidence 
In total, 462,765,520 genotypes are called in the SSC dataset.  Most genotypes are 
called confidently—the median genotype confidence for all loci and SSC individuals is >0.99 
(Figure 6.29, page 258).  No SSC individual has uniformly low genotype confidence.  82% 
of all well-covered loci have a median confidence above 0.9.  This indicates that some loci 
do not have clear bi-allelic genotype calls that can be called confidently.  The most probable 
explanations for low locus median confidence are low coverage, high levels of noise, or 
extremely biased alleles.  Any of these factors could make it difficult to confidently 
distinguish among possible genotypes at a particular locus. 
6.4.4.2 Allelic goodness-of-fit 
Nearly 16% of all allelic goodness-of-fit p-values are 1, while the rest appear to be 
uniformly distributed between 0 and 0.9 (Figure 6.30, page 259).  This bias can be explained 
by loci with both low expected and observed coverage.  The two-sided Poisson exact test will 
return a p-value of 1 if the observed coverage is equal to the expected coverage or one less 
than the expected coverage.  When expected coverage is low, there is a good chance of 
observing either of these two values by chance.  For instance, if we apply our allelic 
goodness-of-fit test to a simulated dataset of individuals with low coverage sampled from a 
Poisson distribution with a rate of 10, the p-value distribution is strikingly similar to the one 
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observed in the SSC dataset.  As the median expected coverage increases, this distribution 
becomes increasingly uniform.  This suggests that non-exonic loci in the SSC are likely to be 
the primary contributors to the unusual behavior of our observed distribution.  When 
expected coverage is low, it will be difficult to confidently distinguish a bi-allelic genotype 
from a genotype with one or more null alleles.  In these situations, a high marginal null 
probability can be particularly informative when determining whether a bi-allelic genotype 
model is supported by the data. 
Median allelic goodness-of-fit scores for each SSC individual range between 0.3 and 
0.6, which would indicate that there are no individuals with particularly poor overall fit to 
their expected coverage estimators and the appropriate allele bias estimates.  90% of locus 
median allelic goodness-of-fit scores are between 0.43 and 0.83, indicating that most loci do 
not appear to have generally poor allelic goodness-of-fit scores.  Some loci do have 
uniformly low allelic goodness-of-fit scores.  These loci likely represent locus-specific 
phenomena that cause significant deviations between expected and observed coverage.  
These could be biological in nature or they could represent some other systematic noise that 
did not contribute significantly to overall coverage, and therefore did not exceed the required 
threshold to be included in the expected coverage estimator matrix. 
6.4.4.3 Noise goodness-of-fit 
Noise goodness-of-fit primarily consists of two regimes—goodness-of-fit p-values 
near 1, and goodness-of-fit p-values near 0 (Figure 6.31, page 260).  More than 85% of all 
genotypes have noise goodness-of-fit p-values of 1, while another 6% have goodness-of-fit 
p-values less than 0.01.  This behavior is primarily due to the behavior of the one-sided 
binomial exact test used to calculate the p-values and the generally low error rates at 
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microsatellite loci.  In a one-sided binomial exact test, the goodness-of-fit p-value will be 1 
any time the observed error coverage is less than the expected error coverage.  Since the 
expected error rate for most loci is on the order of 0.001 and the expected coverage for most 
loci is <50, the expected error coverage for most people at most loci will be considerably less 
than 1.  Therefore, most noise goodness-of-fit p-values will be 1.  For these same loci, p-
values for any individuals with some error coverage will be much closer to 0 than they are to 
1.  For instance, if an individual has one putative error read at a locus with 10X coverage and 
an error rate of 0.001, the goodness-of-fit p-value will be <0.01.  If coverage in the SSC 
dataset was higher, or microsatellite loci were noisier, the noise goodness-of-fit p-values 
would likely be more uniformly distributed. 
The median noise goodness-of-fit p-value for each individual in the SSC is 1, which 
indicates that no individuals are consistently noisier than expected.  The median noise 
goodness-of-fit p-value for nearly 95% of all loci is 1, and all but 16 loci have median noise 
goodness-of-fit p-values above 0.01.  This behavior seems to indicate most loci are generally 
well described by their respective locus-wide error rate estimates.  The few loci that do not 
appear to be well modeled by the estimated error rates may have multiple copies in non-
reference genomes or have frequent somatic mutations. 
In essence, if the alternative error rate were only moderately higher than the estimated 
error rate, the noise goodness-of-fit p-value is underpowered to reject the null hypothesis that 
noise coverage in an SSC individual at a locus is drawn from a binomial distribution with the 
estimated locus-wide error rate.  However, the noise goodness-of-fit p-value should still be 
capable of distinguishing genotypes with much higher apparent error rates than the locus-
wide error rate. 
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6.4.4.4 Null calls and marginal null probability 
The median single null call frequency among all well-covered loci is <0.004, which is 
roughly 13 genotypes with a single null allele called per locus (Figure 6.32A, page 261).  
Single null call frequencies for 90% of all loci are less than 0.1.  The median double null call 
frequency among all well-covered loci is <0.0006, which is roughly two people with a double 
null call per locus.  88% of loci have a double null call frequency below 0.1, and 44% of all 
loci do not have any double null genotypes (Figure 6.32B, page 261).  The low frequency of 
null genotype calls indicates that the uSeq genotyper detects most microsatellite alleles in the 
SSC dataset.  Most genotype calls containing null alleles are likely to be due to stochastically 
lower than expected coverage.  This is reinforced when evaluating coverage of null genotype 
calls at loci with low null frequencies in GATK-aligned reads—these spot-checked SSC null 
genotypes are not due to SNVs, indels, or slippage events that would make an allele 
undetectable.  However, loci with high null frequencies could still indicate a SNV or non-
microsatellite indel that affects a microsatellite locus. 
Even when a null genotype is not the most likely genotype for an SSC individual, the 
marginal null probability for the locus can be an indication of the overall likelihood that the 
locus genotype contains a null allele (Figure 6.33, page 262).  The median marginal null 
probability is 0.003, and nearly 80% of genotypes have null probabilities less than 0.1.  The 
average median marginal null probability for SSC individuals is 0.004, indicating that most 
individual do not have consistently high null probabilities.  Median marginal null 
probabilities for each locus are less consistent.  The average median marginal null probability 
for all loci is 0.05, while the remaining 22% of loci have higher marginal null probabilities.  
Higher locus-wide marginal null probabilities are primarily due to low observed coverage at 
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a locus, especially compared to their respective expected coverage estimators.  High marginal 
null probabilities suggest that coverage at a locus is insufficient to strongly support a bi-
allelic genotype model.  While this may not be a large impediment to accurate microsatellite 
genotyping in general, it bears special consideration when calling de novo microsatellite 
mutations. 
6.4.5 Polymorphism in genotyped loci 
At 68% of well-covered loci studied, all SSC individuals without a null genotype call 
are homozygous for the reference.  The remaining 32% of well-covered loci have highly 
variable non-null heterozygous genotype call frequency (Figure 6.34, page 263).  Nearly 
75% of heterozygous loci have ≤10 individuals with a heterozygous genotype.  This would 
seem to indicate that most well-covered loci evaluated as part of this SSC study are generally 
stable.  Low levels of heterozygous genotype calls may be due to low mutation rates at the 
shortest microsatellite loci. 
Many of the loci that were genotyped in SSC individuals as part of this study have 
multiple detected alleles (Figure 6.35, page 264).  Nearly 34% of all loci have at least two 
genotyped alleles, regardless of null genotype status.  27% of loci have two detected alleles 
within the SSC population, 4% have three alleles, and the remaining 2% have more than 
three alleles detected at a locus.  This indicates that although many loci may have few 
heterozygous genotypes, many loci within the SSC dataset exhibit some degree of 
polymorphism.  The combination of infrequent heterozygous genotype calls and high levels 
of polymorphism at microsatellite loci suggests that although these loci are generally stable, 
their mutation rates are sufficient to introduce rare novel alleles.  As microsatellite 
genotyping studies expand to larger populations, we would expect to see more microsatellite 
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loci with rare polymorphism and infrequent heterozygous genotype calls.  Non-reference 
microsatellite alleles shared by SSC individuals from different families may not necessarily 
derive from the same initial mutation at a specific locus.  Polymorphism in SSC individuals 
from different families could result from multiple independent founding mutations. 
 
6.5 Comparing uSeq to other microsatellite genotypers 
To determine the performance of uSeq as compared to RepeatSeq and lobSTR, SSC 
family auSSC14395 was processed by all pipelines.  lobSTR version 2.0.3 was used for the 
analyses described here, along with its reference set.  Paired-end reads were provided as 
BAM input to lobSTR, and reads were trimmed based on a quality score of 20.  lobSTR was 
allowed to process reads in parallel using two threads, which is the maximum amount of 
processors used by the uSeq pipeline.  All genotypes called used the genotyping model 
provided in version 2.0.3 of the lobSTR resource bundle.  RepeatSeq version 0.8.2 was used 
for the analyses described here, along with the latest annotation file provided by the authors 
as of February 25, 2014.  All confident sites were emitted using the -emitconfidentsites flag 
and reads flagged as repeats by BWA are excluded.  A minimum mapping quality score of 30 
was required, which is the same threshold used by uSeq.  Reads were aligned using BWA, 
then realigned and recalibrated using GATK before submitted to RepeatSeq.  The GATK 
resource bundle file (GATK_ResourceBundle_5777_b37_phiX174_chrAll.fa) was provided 
as RepeatSeq’s required FASTA input. 
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6.5.1 Reference microsatellite sets 
The uSeq reference microsatellite set is nearly 3.5 times larger than the reference sets 
used by lobSTR and RepeatSeq.  There are 1,638,523 lobSTR reference microsatellite loci, 
while the uSeq reference microsatellite set contains 5,784,968 loci.  All of the loci in the 
RepeatSeq reference microsatellite set are contained in the lobSTR reference microsatellite 
set, so comparisons will only be made between lobSTR and uSeq.  The uSeq and lobSTR 
reference sets overlap at 1,576,477 lobSTR-defined reference loci (Figure 6.36, page 265).  
Only 62,198 reference microsatellite loci are unique to lobSTR, which is <4% of all lobSTR 
reference loci.  All of these loci are interrupted microsatellite tracts, as determined by the 
TRF scores of microsatellite loci unique to lobSTR.  In contrast, 3,679,234 microsatellite loci 
are unique to the uSeq reference set, which is a dramatic increase in the number of detectable 
loci.   
Since lobSTR and RepeatSeq both detect interrupted microsatellite loci, it is possible 
that a single lobSTR reference microsatellite locus contains several uSeq microsatellite loci.  
81% of lobSTR reference microsatellite loci overlap a single uSeq reference microsatellite 
locus (Figure 6.37, page 266).  An additional 17% of lobSTR reference microsatellites 
contain two or three uSeq reference microsatellite loci, while the remaining 2% are 
composed of more than three uSeq reference loci.  This indicates that although lobSTR—and 
by extension, TRF—detects interrupted microsatellite loci, the vast majority of these loci 
contain a core of at least one uninterrupted microsatellite repeat that is detectable by uSeq.  
When evaluating the TRF scores, 62% of all lobSTR reference microsatellite loci that 
overlap with a uSeq reference microsatellite have the maximum possible TRF score.  The 
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maximum possible TRF score for a locus indicates that the locus is uninterrupted and would 
be identical to the corresponding uSeq reference microsatellites. 
Novel uSeq reference microsatellite loci are distributed throughout all genomic 
contexts (Figure 6.38, page 267).  In introns and intergenic regions, 3,598,602 microsatellite 
loci are uniquely detected by uSeq.  In UTRs and miRNAs, uSeq uniquely detects 51,320 
microsatellite loci.  Most importantly, uSeq detects 37,988 microsatellite loci in exons in 
addition to the 3,887 that are also detected by lobSTR and RepeatSeq—ten times more loci 
than other pipelines.  In contrast, lobSTR and RepeatSeq have just 1,086 unique 
microsatellite loci in exons, UTRs, and miRNAs combined.  Many microsatellite loci that 
can significantly affect protein function, particularly in exons, are only detectable by uSeq. 
Nearly 93% of all microsatellite loci unique to uSeq have motif lengths of 1, 2, or 3 
bp (Figure 6.39, page 268).  Microsatellite loci with short tract lengths may be inconsistently 
detected by lobSTR or TRF.  This is likely to be the case as 99% of reference microsatellite 
loci unique to uSeq have tract lengths less than 18 bp (Figure 6.40, page 269).  While lobSTR 
appears to have some reference microsatellite loci with tract lengths as low as 8 bp, many 
short microsatellites observed by uSeq are not in its reference set.  This suggests that uSeq 
would be the more reliable genotyping pipeline for short microsatellite loci, since lobSTR 
detects them inconsistently.  Interestingly, a fraction of uSeq-specific reference microsatellite 
loci are up to 263 bp long.  It is not clear why these microsatellites would not be in the 
lobSTR reference microsatellite set. 
Loci unique to the uSeq pipeline exhibit significant polymorphism (Figure 6.41, page 
270).  Almost 60% of reference microsatellite loci shared by all pipelines are polymorphic, as 
determined by uSeq genotype calls within the SSC population.  An additional 30% of 
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reference microsatellite loci that are unique to uSeq are also polymorphic.  This indicates that 
many of the microsatellite loci detected by uSeq are highly informative, and neither lobSTR 
nor RepeatSeq will call genotypes at these polymorphic microsatellite loci.  Many of these 
loci have short reference tract lengths, since most of the additional microsatellites detected by 
uSeq are short.  The level of polymorphism for short microsatellite loci unique to uSeq 
indicates that they should be included in microsatellite genotyping studies, as they are still 
prone to slippage mutations and polymorphism.  lobSTR and RepeatSeq are not able to call 
genotypes at millions of potentially polymorphic microsatellite loci. 
6.5.2 Microsatellite locus coverage 
Pairwise coverage comparisons show that uSeq aligns microsatellite reads as well as 
RepeatSeq, and perhaps slightly better than lobSTR (Figure 6.42, page 271).  Pairwise 
coverage was assessed for all shared loci in two pipelines for a trio family member.  For all 
family members, lobSTR only reported even coverage, which was assumed to mean that 
lobSTR was unintentionally doubling coverage.  This is borne out by spot-checking 
alignments in the BAM files produced by lobSTR—reported coverage is double the number 
of reads aligned to a microsatellite locus.  With that assumption, all lobSTR coverage is 
halved.  If lobSTR coverage is erroneously doubled, uSeq has roughly twice the coverage as 
lobSTR; if lobSTR reported coverage is accurate, then uSeq and lobSTR coverage is 
generally equivalent.  The correlation between lobSTR and uSeq coverage is somewhat low, 
and uSeq appears to get consistently higher coverage than lobSTR for many microsatellite 
loci (Figure 6.42A, page 271).  RepeatSeq also seems to get consistently higher coverage 
than lobSTR (Figure 6.42C, page 271).  Higher coverage in uSeq is somewhat surprising, 
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since lobSTR can detect interrupted microsatellites, which should allow it to pick up more 
reads that have sequencing errors that disrupt microsatellite tracts. 
uSeq and RepeatSeq have very similar coverage for all common loci, and coverage is 
highly correlated between the two pipelines (Figure 6.42B, page 271).  Although coverage 
generally appears to be nearly equivalent between the two pipelines, RepeatSeq usually has 
somewhat higher coverage than uSeq.  This is most likely due to the GATK-based alignment 
strategy employed by RepeatSeq, which should allow it to detect and align interrupted 
microsatellite loci, unlike uSeq.  In addition, RepeatSeq does not use the same rules as uSeq 
for filtering PCR replicate sets and overlapping reads.  Some loci have higher coverage in 
uSeq than in RepeatSeq.  One possible explanation for this observation is that a GATK-based 
pipeline does not effectively map microsatellite indels at these particular loci.  This is 
consistent with the comparison of coverage at microsatellite loci in uSeq and a standard 
GATK-based pipeline, as discussed in section 6.2.7. 
uSeq aligns nearly as well as RepeatSeq, and at least as well as lobSTR.  This 
demonstrates that the uSeq alignment algorithm has accuracy comparable to these other 
microsatellite genotyping pipelines.  While it is unclear why lobSTR’s alignment algorithm 
seems to consistently underperform compared to uSeq and RepeatSeq, it is certainly an 
important consideration when choosing a microsatellite genotyper. 
6.5.3 Genotyping comparison 
Since uSeq only detects perfect microsatellites, it will often report different allele 
lengths than lobSTR or RepeatSeq.  Rather than comparing genotypes or alleles directly, we 
chose to compare each pipeline’s Mendel violation rate as a means of assessing genotype 
accuracy.  We identified the loci shared by all three pipelines in either the proband or sibling 
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trio, and calculated the Mendel violation frequency for different trio genotype confidence 
thresholds (Figure 6.43, page 273).  Although all pipelines demonstrate increasing accuracy 
as trio genotype confidence increases, both lobSTR and RepeatSeq maintain very high de 
novo mutation rates relative to the highest per-locus microsatellite mutation rate estimates 
described in the literature (Sajantila et al. 1999).  Since most previous microsatellite mutation 
rate estimates used highly polymorphic marker loci, the range of known microsatellite 
mutation rates is likely to be an overestimate relative to the mutation rate for non-marker 
loci.  In contrast, uSeq calls Mendel violations with an almost 10-fold lower frequency. 
Many of the Mendel violations called confidently by RepeatSeq or lobSTR are not 
called by uSeq.  When evaluating Mendel violations called with a minimum trio genotype 
confidence threshold of at least 0.8, ~50% of lobSTR and RepeatSeq Mendel violations are 
not called by uSeq because at least one trio member has a null allele.  However, the mean and 
median coverage is at least as high in uSeq as compared to lobSTR or RepeatSeq for these 
loci.  This indicates that uSeq null allele calls are not driven by lower coverage of these 
potentially Mendel-violating loci in the uSeq pipeline.  The remaining 50% of high trio 
genotype confidence Mendel violation calls by lobSTR or RepeatSeq have lower trio 
genotype confidence scores in uSeq.  Therefore, it seems that the increased accuracy of 
uSeq—as measured by the Mendel violation rate—is due to the additional parameters 
modeled by its genotyper.  By accounting for allele bias and expected coverage, and by 
having per-locus error rates, the Mendel violation false positive rate is greatly reduced. 
Most, if not all, of the Mendel violations called by any pipeline within this family are 
false positives.  Trio genotype confidence is only one means of identifying loci that can be 
screened for Mendel violations.  Since all three pipelines report genotype confidence scores, 
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we chose to use this metric to evaluate genotype accuracy.  However, true de novo mutations 
require the thorough analyses described in section 5.4. 
6.5.4 Run-time 
Of all three pipelines, lobSTR takes the longest time to process each individual.  Input 
sequence was provided to each pipeline as a BAM file, which lobSTR requires to be 
lexicographically sorted.  This sort took 20 – 40 minutes per BAM file.  The lobSTR 
alignment algorithm took 16 – 21 hours to complete using two threads.  Once alignment has 
completed, post-processing and genotype calling takes an additional 5 – 7 minutes.  
Therefore, lobSTR used approximately 32 – 42 hours of computing time to call 
microsatellites in each individual.   
RepeatSeq takes already aligned files as input, and reports all confident genotypes 
with additional “call” files in 14 – 17 minutes.  However, in this study, RepeatSeq took 
BWA-aligned and GATK-realigned and recalibrated reads.  The time taken to align the raw 
reads for each individual for RepeatSeq was 19 – 35 minutes, and post-processing took 45 – 
145 minutes.  Realignment was performed on a BAM file with all reads from the family, and 
took a total of ~27 hours.  Recalibration took an additional 14 hours.  An additional 2.5 hours 
were needed to merge realigned BAM files and index the recalibrated BAM file.  Although 
RepeatSeq takes very little pipeline-specific time, preparing data for input took >45 hours for 
this family, or ~11 hours per family member.  
 For the same individuals in the uSeq pipeline, microsatellite detection took 10 – 30 
minutes.  Alignments took an additional 10 – 30 minutes using BWA with two threads to 
enable parallel processing.  Post-processing, including BAM file production and reindexing, 
took 20 – 30 minutes.  Merging and marking duplicates in BAM files took ~25 minutes, and 
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profiling took another 17 – 25 minutes.  Therefore, the individual component to the uSeq 
pipeline took between 1.5 hours and 2.3 hours to align and process each individual, not 
including time spent waiting for cluster access.  The population component of the uSeq 
pipeline took ~7 days to merge over 5 million microsatellite loci in 3,500 individuals.  
Identifying well-covered loci, deriving an expected coverage model, genotyping, and finding 
de novo mutations took ~2.5 days, although genotyping was performed on 13 threads.  The 
total amortized processing time per SSC individual for the population component is ~16 
minutes of computer time and 4 minutes of wall clock time. 
If the total amount of time taken to process reads and call genotypes is considered, 
and time is amortized for each individual genotyped, uSeq is the fastest of the three pipelines.  
When only considering pipeline-specific runtime, RepeatSeq is the fastest pipeline.  
lobSTR’s processing time is primarily devoted to their alignment algorithm, although this 
does not appear to dramatically improve its coverage or genotyping accuracy as compared to 
uSeq or RepeatSeq.  This would not justify lobSTR’s extended alignment times, particularly 
when evaluating microsatellites in large populations.  Each individual in the SSC population 
requires about 1.5 – 2.5 hours of time—including amortized population component time—to 
detect, align, and process microsatellite reads; infer model parameters from the population; 
call genotypes; and identify de novo mutations. 
6.5.5 Summary 
uSeq can detect more microsatellite loci, align them as effectively, and genotype them 
more accurately than other microsatellite genotyping pipelines in exome sequencing data.  
The amortized run time for uSeq is very competitive, and is faster than lobSTR or RepeatSeq 
when considering both read alignment and genotyping time.  It is probable that uSeq’s EM-
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based genotyping model would maintain its advantage in whole genome sequencing 
studies—although allele capture bias may play less of a role, coverage estimators and locus-
specific error rates will still be relevant.  The superiority of the uSeq pipeline is particularly 
important when microsatellite genotyping is undertaken to identify potentially disease-
causing alleles or de novo mutations at microsatellite loci. 
6.6 De novo microsatellite mutations 
6.6.1 Trio genotype quality distributions 
Over 99.9% of the 231,382,755 Mendel obedience scores calculated for the SSC 
dataset are below 40 (Figure 6.44, page 274).  The vast majority of trio genotypes are Mendel 
obedient in the uSeq pipeline, which suggests that the genotypes being called are generally 
accurate and reliable.  As the Mendel obedience score threshold rises, the number of 
candidate de novo mutations drops precipitously—just over 56,000 trio genotypes have 
obedience scores above 40, while less than 17,000 have obedience scores above 60, a 
decrease of nearly 70%.  When identifying potential de novo mutations, we require that every 
person within the family has a definitive genotype, and therefore we do not allow for null 
alleles.  At a threshold of 40, ~50% of all potential Mendel violations have a null genotype in 
a family member. 
In preliminary analyses where we limited our analysis to families with no null 
genotypes and various Mendel obedience thresholds, it became immediately apparent that 
most candidate de novo mutations were likely to be false positives. 62 SSC families had 
unusually high de novo mutation frequencies for SNVs and microsatellite loci—these 
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families were excluded from any further analysis.  We assume that the “de novo” calls in 
these families are likely due to sample mix-ups.   
In an effort to eliminate more spurious de novo calls, we introduced several other trio 
quality measures.  While the Mendel obedience score specifically addresses the Mendelian 
behavior of a trio at a locus, these additional measures addressed the trio genotype quality of 
the likely de novo mutation.  These measures are the kinship score; trio noise and allelic 
goodness-of-fit; trio marginal null probability; and trio genotype confidence.  In addition, we 
filtered de novo microsatellite mutation calls from loci that appear to be very noisy, 
reasoning that they would be loci that are most prone to false positives. 
In our putative de novo mutation analysis, we set a liberal threshold on the Mendel 
obedience in an effort to assess its reliability for de novo mutation detection.  We chose to set 
conservative thresholds for the other trio genotype quality measures used to filter de novo 
mutations so that we could focus on the behavior of the Mendel obedience score.  These 
thresholds were set by observing the appropriate distributions and attempting to find 
thresholds that would maintain high genotype quality while minimizing false positives. 
Our first analyses demonstrated that many putative de novo microsatellite mutations 
had low kinship scores.  A low kinship score would suggest that these mutations required 
multiple mutational events in the parental germlines or during development (Figure 6.45, 
page 275).  As means of reducing the number of de novo mutations that required increasingly 
improbable kinship relationships, we set a minimum kinship score of 0.8. 
Most microsatellite loci with recurrent de novo mutations will be enriched for false 
positives and can be eliminated without losing too many true de novos.  Microsatellite loci 
with higher locus error rates are more likely to have recurrent de novo mutations (Figure 
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6.46, page 276).  This suggests that some spurious microsatellite de novo mutations are 
simply due to difficulty calling genotypes accurately at these unstable loci.  To minimize 
false positives in our analysis of the behavior of the Mendel obedience score, we limit our 
study to de novo mutations called at loci with estimated error rates less than 0.17. 
Thresholds on the remaining metrics were set to ensure that highly confident de novo 
mutations were called (Figure 6.47, page 277).  Minimum trio genotype confidence was set 
to 0.99 to ensure that the likeliest trio genotype was unambiguous (Figure 6.47A, page 277).  
The maximum trio marginal null probability was set to 0.01 to ensure that a trio had little 
chance of a null genotype (Figure 6.47B, page 277).  Allele fits and noise fits were set to 
0.00001 and 0.001, respectively, to ensure that no trio genotype being considered had 
suspiciously high coverage or was too noisy (Figure 6.47C-D, page 277).  These thresholds 
were set in an ad hoc manner as a means of isolating the behavior of the Mendel obedience 
score.  These thresholds performed successfully in this analysis, but a more detailed 
evaluation of the efficacy with which each parameter or parameter combination can 
distinguish true de novo mutations has not been undertaken.  Such an analysis could increase 
the sensitivity with which uSeq is able identify true de novo mutations. 
By setting these thresholds, we are able to narrow down our list of putative de novo 
microsatellite mutations from ~56,000 to 139.  These candidate de novo mutations were then 
manually evaluated, compared to previous de novo calls from the GATK-based lab pipeline, 
and compared to calls made by the local reassembly pipeline Scalpel (Narzisi et al. 2013).  A 
set of recurrent de novo mutations at one microsatellite was excluded from further analysis 
based on local reassembly evidence that demonstrated that the locus had a common indel 
polymorphism that removed a portion of the microsatellite locus and its flanking sequence.  
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Based on earlier analyses, an additional four de novo mutations were submitted for 
validation.  These additional mutations had been excluded in the latest analysis due to low 
kinship scores.  Candidate de novo mutations were submitted for validation sequencing using 
the protocol described in section 5.5.2.  After sequencing, each de novo mutation was 
analyzed and scored as valid (de novo confirmed), invalid (no evidence of de novo), failed 
(no primers or no DNA), or unclear (ambiguous alleles).  Of the 144 candidate de novo 
mutations, 22 were valid, 62 were invalid, 8 were unclear, and 52 failed. 
6.6.2 Determining a threshold Mendel obedience score for microsatellite de 
novo mutations 
The Mendel obedience scores of valid and invalid microsatellite de novo mutations 
are distinct and can be used to discern true events with high specificity (Figure 6.48, page 
278).  The ROC AUC for the Mendel obedience score is >0.95, which means that 95% of the 
time, the Mendel obedience score for a true de novo mutation will be higher than for a 
spurious de novo mutation.  Therefore, with the thresholds used in this study, the Mendel 
obedience score is a very robust means of identifying true de novo microsatellite mutations.  
The ROC curve can also be used to calculate specificity and sensitivity within the validation 
set at a particular Mendel obedience score threshold.  If we were to limit our false positive 
rate to <10% (6/62), we are still able to recover >91% (20/22) of all true positives if we set a 
minimum Mendel obedience score of 63.  This performance is comparable to large-scale 
microsatellite de novo mutation genotyping using capillary electrophoresis, which reported a 
false positive rate of 7.2% (Sun et al. 2012).  Our thresholds may exclude some de novo 
mutations, so the sensitivity described here is the Mendel obedience score’s ability to 
correctly identify true positives within the validation set, not the complete SSC dataset. 
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6.6.3 Microsatellite de novo mutations 
6.6.3.1 De novo mutation overview 
There are a total of 45 de novo mutations in the dataset above a Mendel obedience 
score threshold of 63—20 were valid, 6 were invalid, 4 were unclear, and 14 failed (Table 
6.6, page 294).  Other pipelines do not observe 36 of the de novo mutations identified by 
uSeq in this study, and 12 of the valid mutations are unique to this analysis.  De novo 
mutations are equally likely to occur in probands or their siblings in the complete set of 
candidate mutations, and in each context individually (Table 6.7, page 295).  Nearly 60% of 
de novo mutations are in introns, and an additional 30% are in exons.  All exon mutations 
were either valid or failed to validate (Table 6.8, page 295).  Invalid de novo mutations 
occurred exclusively in introns and intergenic regions.  38 of the 45 de novo mutations are 
slippage mutations, while the rest appear to be point mutations inside or adjacent to 
microsatellite loci.  Slippage insertions and deletions are equally common in probands and 
siblings (Table 6.9, page 295).  Unique mutations also do not appear to be more common in 
children with autism or their siblings (Table 6.10, page 295).  Omission and commission de 
novo mutations occur with equal frequency in children with autism and their siblings, and 
only three of the 45 de novo mutations are omissions (Table 6.11, page 296).  It is clear that 
uSeq is capable of reliably identifying novel de novo mutations that are undetectable with 
other pipelines.  However, there does not appear to be a single mutation characteristic that 
suggests a de novo mutation bias in children with autism or their siblings. 
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6.6.3.2 Unique slippage insertions occur exclusively in children with autism 
De novo mutations are found in varying contexts and some of them have very clear 
effects.  Recently, an analysis of de novo SNVs in exome sequencing data reported a link 
between FMRP-associated genes and autism incidence (Iossifov et al. 2012).  Although we 
do not observe the same significant association in our current study, we do observe two 
frameshift mutations in FMRP-associated genes (Darnell et al. 2011).  A mutation in a 
microsatellite with a 1 bp motif produces a frameshift mutation in a child with autism in the 
FMRP-associated gene KIF21A (Figure 6.49, page 279).  This mutation has not been 
observed in any other de novo mutation detection pipeline applied to the SSC.  This allele is 
also unique within SSC parents and is not found in dbSNP v138.   
An additional mutation in a microsatellite with a 1 bp motif produces a frameshift 
mutation in a child with autism in CHD8 (Figure 6.50, page 281).  CHD8 has been linked to 
autism incidence by several studies, both due to its association with FMRP and due to 
recurrent mutations in CHD8 identified in several studies (Darnell et al. 2011; Neale et al. 
2012; O'Roak et al. 2012a; O'Roak et al. 2012b; Sanders et al. 2012).  This same mutation 
was observed in a study of de novo mutations at targeted autism genes (O'Roak et al. 2012a).  
This mutation is also unique within the SSC parents and is not found in dbSNP v138. 
A third frameshift mutation in a child with autism is found in B4GALNT1 (Figure 
6.51, page 282).  The mutant allele is unique within the SSC dataset and does not appear in 
dbSNP v138.  It has been detected by other de novo mutation detection pipelines applied to 
the SSC dataset.  A homozygous insertion mutation identical to the heterozygous mutation 
observed in this study was reported in an individual suffering from the autosomal recessive 
disorder spastic paraplegia 26.  B4GALNT1 is involved in the synthesis of complex 
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gangliosides, which are components of the synaptic plasma membrane (Boukhris et al. 2013).  
Some studies have suggested that the genes affecting synaptic plasticity may pay a role in 
autism incidence (Darnell et al. 2011; Iossifov et al. 2012). 
A frameshift mutation also occurs in the HMMR gene, although it failed to validate 
(Figure 6.52, page 283).  Other de novo detection pipelines do not find the mutation, no SSC 
parents have the mutations, and it is in dbSNP v138.  There are no known associations of 
HMMR to autism.  A final potential frameshift mutation occurs in an ATCT microsatellite of 
the GDPD4 gene (Figure 6.53, page 284).  The microsatellite spans the junction between the 
last exon of the gene and its 3’ UTR, so its effect is unclear.  This mutation was valid and 
other de novo mutation detection pipelines have detected it.  It is unique in the SSC dataset 
and is not found in dbSNP v138. 
There are two in-frame slippage insertions mutations in children with autism in 
HEXIM1 and CD3EAP.  Both mutations were valid, and other pipelines detected them.  The 
HEXIM1 mutation adds an additional glutamate and leucine to an alternating poly-EL tract.  
The CD3EAP mutation adds one residue to a lysine tract.  All four mutations are unique in 
the SSC and none are found in dbSNP v138.  There are two non-slippage exon de novo 
mutations in children with autism detected at microsatellite loci in the CCDC27 and INSR 
genes.  Other pipelines detected both mutations.  While the CCDC27 mutation was valid, the 
INSR mutation failed to validate.  Figures for these mutations—and all de novo microsatellite 
mutations in Table 6.6—can be found in Appendix 1. 
Five de novo microsatellite mutations in exons are detected in siblings of children 
with autism, and all mutations are in-frame.  A de novo microsatellite mutation in a sibling in 
CPSF1 is not detected by other pipelines, is unique in the SSC dataset, and is not found in 
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dbSNP v138 (Figure 6.54, page 285).  This mutation removes one residue from an aspartate 
tract.  A second de novo mutation in a sibling removes a residue from a glutamate tract in 
VSIG10, which is seen in other SSC individuals, but is not seen in dbSNP v138.  Other 
pipelines do not detect this mutation either.  A third de novo mutation removes a residue 
from an aspartate tract in RNF6.  This mutation is unique in the SSC dataset and is not seen 
in dbSNP v138, but other pipelines detect it.  A de novo mutation in a sibling in a KDM8 
exon removes a residue from a glutamate tract.  Although this mutation is not seen within the 
SSC, it is commonly found in dbSNP v138, and other pipelines detect it.  A final de novo 
mutation in a sibling is detected in MED15, which adds a residue to a glutamine tract.  This 
mutation is common in the SSC dataset, although it is not seen dbSNP v138.  Other pipelines 
do not detect it.  This mutation is one of the four mutations that did not meet the criteria 
outlined for microsatellite de novo mutations.  All of these mutations were valid in targeted 
sequencing. 
All frameshift mutations detected in this study are in children with autism, and none 
are in their siblings.  This bias is not statistically significant (p = 0.13), although it is 
suggestive of a trend towards microsatellite frameshift mutations in children with autism.  An 
expanded analysis of the SSC dataset might reveal a statistically significant association.  
Considering all slippage mutations, there is no significant difference in the de novo mutation 
frequency in exons (7 in probands, 5 siblings).  Although unique slippage mutations in exons 
are more common in children with autism than in their siblings, this bias is not significant (7 
in probands, 2 in siblings, p = 0.18).   
Unique microsatellite insertions are more likely to occur in children with autism—six 
validated slippage mutations found in children with autism are unique insertions, while there 
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are none in their siblings (Table 6.12, page 296; p = 0.03).  If we include the slippage 
insertion observed in HMMR that failed to validate, this bias become more significant (p = 
0.016).  Moreover, if we consider GDPD4 to be a de novo mutation in an exon, then the bias 
is for unique exonic slippage insertions in children with autism as compared to their siblings.  
No unique slippage insertions are observed in siblings in any context.  There is one additional 
unique slippage insertion mutation in an intron of HYDIN.  Although this mutation is above 
the Mendel obedience threshold, it is invalid.  If we were to include this mutation, the bias 
towards unique insertions in children with autism would have a p-value <0.01. 
6.6.3.3 A Robertsonian translocation on chromosome 22 
The only two valid omission de novo mutations were observed in the same child on 
chromosome 22.  The first omission de novo mutation occurs in an AGGGG microsatellite in 
an intron of SF3A1, which is common in the SSC cohort and dbSNP v138 (Figure 6.55, page 
286).  A second omission de novo occurs ~7 Mb downstream, in a GT microsatellite in an 
intron of IL2RB (Figure 6.56, page 287).  This mutation is common in the SSC cohort, but is 
not observed in dbSNP v138.  Other pipelines fail to detect either mutation.  A third omission 
de novo was later found 3 Mb from the IL2RB mutation, in a GCA microsatellite in an exon 
of TNRC6B (Figure 6.57, page 288).  It was not submitted for validation, but it is consistent 
with the other omission de novo mutations detected in the same child on chromosome 22. 
At all loci, the parents are homozygous for two different alleles.  Mendelian 
inheritance dictates that each child should inherit one allele from each parent, and would 
therefore be heterozygous.  At all three loci, the unaffected sibling is heterozygous for the 
parental alleles.  However, the child with autism is always homozygous for the maternal 
allele, indicating that the child did not inherit a paternal allele.  Since two of the three 
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mutations validated, we sought to determine if events occurred by chance, or if they were 
part of a larger chromosomal phenomenon.  In an analysis of heterozygous SNVs from either 
parent on chromosome 22, the child with autism always had the maternal genotype, 
regardless of the paternal genotype.  This suggests that the child with autism inherited both 
copies of maternal chromosome 22, and perhaps no paternal copies.  This behavior is 
consistent with a homologous maternal Robertsonian translocation or maternal uniparental 
heterodisomy. 
One possible mechanism leading to a Robertsonian translocation is the fusion of two 
acrocentric chromosomes at the centromere, followed by the loss of the short chromosome 
arms and the retention of both long arms.  Since the short arm of chromosome 22 does not 
contain any unique genes, this translocation is not expected to have a phenotypic effect.  
However, this demonstrates that genome-wide de novo microsatellite genotyping could also 
be an effective means of identifying rare chromosomal events. 
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Figure 6.1: Microsatellite base frequency by context.  Base frequency is the total number of 
microsatellite bases within a context divided by the total number of bases in that context.  
~2.3% of bases in GRCh37 are in a microsatellite tract.  Exons are depleted for microsatellite 
tracts compared to the genome as a whole—just ~1.2% of bases in exons are in a 
microsatellite tract. 
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Figure 6.2: Microsatellite tract length distribution, genome-wide and in exons.  The 
percentage in context refers to the percentage of all microsatellites in GRCh37 or in exons 
only with a particular tract length.  Microsatellites in exons tend to be shorter than 
microsatellites in GRCh37 as a whole.  
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Figure 6.3: Microsatellite motif length distribution by genomic context.  Percentages for each 
context sum to 100%.  The frequencies of microsatellites with 1, 2, and 3 bp motifs are 
similar for GRCh37 as a whole, and in introns and intergenic regions.  Both 5’ and 3’ UTRs 
are enriched for microsatellites with 3 bp motifs relative to GRCh37.  Microsatellites with 2 
bp motifs are enriched in miRNA, although the total number of microsatellites in miRNA is 
low.  Microsatellites with 3 bp motifs are heavily favored in exons, which ensures that 
slippage mutations at most exon microsatellite loci do not disrupt the proper reading frame. 
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Figure 6.4: The most common motif equivalence classes throughout GRCh37.  
Microsatellites with A class motifs are the most common, while motifs composed exclusively 
of C and G nucleotides are more rare. 
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Figure 6.5: The most common equivalence classes in the exons of GRCh37.  Microsatellite 
motifs composed exclusively of C and G nucleotides are more common in exons than they 
are in the rest of the genome.  Although most exon microsatellites have 3 bp motifs, 3 of the 
most common microsatellite equivalence classes have motif lengths of 1 or 2 bp. 
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Figure 6.6: Percentage of read pairs containing at least one microsatellite in each SSC 
individual.  Approximately 9% of all read pairs have at least one microsatellite in the average 
SSC individual. 
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Figure 6.7: Percentage of unmapped microsatellite reads in each SSC individual.  
Approximately 8% of reads with microsatellites fail to map in the average SSC individual. 
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Figure 6.8: Percentage of microsatellite reads with low mapping quality scores for each SSC 
individual.  Any mapping quality score <30 is considered low.  15% of microsatellites have 
an alignment with a mapping quality score <30 in the average SSC individual. 
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Figure 6.9: Percentage of microsatellite read pairs that map to disparate chromosomes in each 
SSC individual.  Approximately 1% of read pairs map to disparate chromosomes in the 
average SSC individual. 
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Figure 6.10: Percentage of microsatellite read pairs in PCR replicate sets in each SSC 
individual.  Approximately 4% of read pairs are in PCR replicate sets in the average SSC 
individual. 
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Figure 6.11: Number of PCR replicate sets in each SSC individual.  The average SSC 
individual has ~400,000 replicate sets. 
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Figure 6.12: Percentage of discordant PCR replicate sets per SSC individual.  A PCR 
replicate set is considered discordant if all reads in the set do not report identical 
microsatellite tract lengths.  Only 0.6% of all PCR replicate sets are discordant in the average 
SSC individual. 
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Figure 6.13: Percentage of overlapping read pairs in each SSC individual that cover the same 
microsatellite locus/loci.  7% of read pairs in the average SSC individual contain the same 
microsatellite tract in both reads. 
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Figure 6.14: Percentage of overlapping read pairs reporting discordant microsatellite tract 
lengths.  Only 0.3% of overlapping read pairs report discordant tract lengths for the same 
microsatellite locus in the average SSC individual. 
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Figure 6.15: Number of microsatellite profiles observed per SSC individual.  The average 
SSC individual has ~1 million profiles for distinct microsatellite loci. 
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Figure 6.16: Percentage of reference microsatellite profiles per SSC individual.  Note that the 
x-axis starts at 0.90, not 0.00.  In the average SSC individual, >96% of all reported profiles 
are for uSeq reference microsatellite loci.  Many non-reference profiles reported are likely 
due to consistent, but incorrect, alignments of sequencing reads due to terminal microsatellite 
repeats.  The percentage of reported reference microsatellite profiles might increase if uSeq 
incorporated a local realignment step. 
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Figure 6.17: Number of SSC individuals with any coverage at each observed uSeq reference 
microsatellite locus.  Over 92% of the reference microsatellite loci observed have coverage in 
less than half of all SSC individuals. 
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Figure 6.18: Loci with coverage in more SSC individuals have higher maximum locus 
coverage.  Maximum locus coverage is the highest coverage in any SSC individual at a locus.  
Loci with higher maximum coverage are usually observed in more SSC individuals. 
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Figure 6.19: Well-covered uSeq reference microsatellite loci in SSC exome sequencing data.  
Most well-covered microsatellite loci are in introns, exons, or intergenic regions. 
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Figure 6.20: Distance of well-covered loci to nearest capture probe in NimbleGen EZ Exome 
V2.0 kit.  Just over 80% of all well-covered loci are within 250 bp of a capture probe, or are 
targeted directly by a capture probe.  The remaining ~20% of well-covered loci may have 
some degree of homology with the capture probe sequences. 
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Figure 6.21: Mean locus coverage decreases for well-covered loci that are further from EZ 
Exome capture probes.  Well-covered loci that are further away from an exome capture probe 
tend to have uniformly lower coverage than those that are either targeted directly or within 
~250 bp of a probe. 
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Figure 6.22: Comparing coverage of high confidence exome genotypes in whole genome and exome sequencing data.  Analysis 
was performed on eight SSC individuals from two families.  Exome genotypes have a minimum confidence of 0.9.  The proportion 
of total coverage at allele 1 in whole genome and exome sequencing data for high-confidence heterozygous genotypes is the 
coverage for the first allele in either dataset, divided by the total locus coverage for the appropriate individual.  Coverage 
comparisons are split by uSeq genotype call—(A) homozygous and (B) heterozygous genotypes.  The proportion of coverage for 
the first allele in whole genome and whole exome sequencing are consistent, suggesting that high confidence uSeq microsatellite 
genotypes are reproducibly observed when using different sequencing protocols. 
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Figure 6.23: Proportional coverage in an SSC individual at microsatellite loci compared to 
GATK.  Only reference microsatellite loci where either pipeline had at least 10X coverage 
were compared.  Proportional coverage is calculated as (uSeq coverage)/(uSeq coverage + 
GATK-based coverage).  Proportional coverage is shown for an SSC individual SSC08278.  
At the average locus observed by either pipeline, uSeq has 6% more reads than the GATK-
based pipeline.  Small discrepancies in coverage could be due to variable mapping qualities 
assigned to the same read in different pipelines or interrupted/short microsatellites only 
detected by the GATK-based pipeline.  Loci unique to the GATK-based pipeline (uSeq 
proportional coverage of 0) tend to be microsatellite loci with identical flanking sequence, 
but different tract lengths. 
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Figure 6.24: Correlation between observed coverage and SVD-inferred per-allele, per-person 
expected coverage estimators for each SSC individual.  The average SSC individual has a 
correlation >0.98 between their expected and observed coverage, which is consistent with the 
simulation results from 5.3.3.2.6.  This suggests that estimating per-allele expected coverage 
from observed coverage in the SSC dataset using SVD is performing as expected.
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Figure 6.25: Coverage across all SSC individuals at well-covered loci (A) in exons and (B) outside of exons.  In (A), the median 
coverage for all exon microsatellite loci and all SSC individuals is 33.  The exon coverage distribution is highly overdispersed—
many individuals have coverage higher than the median at many loci.  Coverage at exon microsatellites is very good—over 70% 
of all exon loci in all SSC individuals have coverage ≥20.  In (B), the median coverage for all non-exon microsatellite loci and all 
SSC individuals is just 10.  Fewer than 40% of all non-exon loci and all SSC individuals have coverage ≥20. 
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Figure 6.26: EM-estimated locus-specific error rates.  Colors represent the proportion of loci 
in a particular error rate bin with a given motif length.  Microsatellites with 1 and 2 bp motifs 
occasionally have considerably high error rates—in particular, 17% of microsatellites with 1 
bp motifs have error rates ≥0.10.  Microsatellites with motifs ≥3 bp tend to be much more 
stable—<1% of these loci have error rates above 0.01. 
 
 
  
 
256 
 
Figure 6.27: Locus-specific error rate estimates by reference tract length.  Tract lengths are shown for individual motif lengths of 
(A) 1 bp and (B) 2 bp.  Note that although the y-axes for both plots are identical, the x-axes differ—(A) ranges from 1e-4 to 1, 
while (B) ranges from 1e-6 to 1.  The observed bimodality in both (A) and (B) is due to the minimum detectable tract length—
some slippage errors at the shortest tract lengths might not be detectable by uSeq.  For a given motif length and reference tract 
length, error rates can vary by as much as an order of magnitude, suggesting that these parameters—even when combined with 
base calling quality, flanking GC content, or sequence identity—may not be capable of explaining the variation in error rates 
among similar loci. 
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Figure 6.28: EM-estimated per-allele capture bias rates.  Bias rates are shown separately for (A) alleles with reference tract lengths 
and (B) alleles with non-reference tract lengths.  The vast majority of bias estimates for reference alleles range from 0.75 to 1.25, 
indicating that strong bias is generally not observed for reference alleles.  In contrast, <30% of non-reference alleles have bias 
estimates from 0.75 to 1.25, and >44% have biases <0.15.  This suggests that many non-reference alleles are poorly captured in 
this exome sequencing study.  As a result, de novo mutations involving alleles with strong bias may not be detected. 
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Figure 6.29: Genotype confidence for all SSC genotypes at well-covered loci.  The median 
confidence is >0.99 for the more than 450 million genotypes called in this study. 
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Figure 6.30: Allelic goodness-of-fit for all SSC genotypes at well-covered loci.  The 
distribution of allelic goodness-of-fit p-values is not uniform due to low expected and 
observed coverage for many loci in the dataset, as discussed in the text. 
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Figure 6.31: Noise goodness-of-fit for all SSC genotypes at all well-covered loci.  The 
distribution of noise goodness-of-fit p-values is exceedingly non-uniform, due to the low 
expected error coverage at most well-covered loci in SSC individuals. 
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Figure 6.32: Null allele call frequencies in SSC genotypes.  Shown are (A) single null call frequencies by locus and (B) double 
null call frequencies by locus.  In (A), the median single null call frequency for all well-covered loci is <0.004, and 90% of all 
well-covered loci have single null call frequencies below 0.1.  In (B), the median double null call frequency is < 0.0006, and 88% 
of all well-covered loci have double null call frequencies below 0.1.  This suggests that most individuals at most loci have 
coverage consistent with bi-allelic genotypes.  Many loci with higher single or double null call frequencies are likely due to 
uniformly low coverage throughout the SSC population at a locus, which would make it difficult to confidently distinguish bi-
allelic and null genotype calls.  Some loci with high single or double null call frequencies may have undetected microsatellite 
alleles or may be in a common CNV. 
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Figure 6.33: Marginal null probabilities for all SSC genotypes at all well-covered loci.  The 
median marginal null probability for all genotypes is 0.003, and 80% of all genotypes called 
in this study had a marginal null genotype <0.10.  This is consistent with the observation that 
most genotypes appear to be bi-allelic. 
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Figure 6.34: The frequency of heterozygous SSC genotype calls for each well-covered locus.  
Heterozygous genotype call frequency is calculated for non-null genotypes only.  
Approximately 32% of all loci in this study have at least one individual with a heterozygous 
genotype call.  75% of all heterozygous loci have heterozygous genotype calls in ≤10 SSC 
individuals. 
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Figure 6.35: Number of alleles called in genotypes at all well-covered loci.  Alleles called as 
part of single null genotypes are included.  Nearly 34% of all well-covered loci have at least 
two genotyped alleles.  6% of all well-covered loci have ≥3 alleles, suggesting a large degree 
of polymorphism in many well-covered loci analyzed in this study. 
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Figure 6.36: Venn diagram of the reference loci for uSeq, lobSTR, and RepeatSeq.  
Intersections between all reference microsatellite sets were determined using BedTools 
(Quinlan and Hall 2010).  Of the 1.63 million reference microsatellite in lobSTR and/or 
RepeatSeq, >96% overlap at least one uSeq reference microsatellite locus.  All 62,198 loci 
that are unique to RepeatSeq and/or lobSTR are interrupted.  uSeq uniquely detects >3.6 
million uninterrupted microsatellite loci. 
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Figure 6.37: The number of uSeq reference microsatellite loci contained in the corresponding 
lobSTR/RepeatSeq reference microsatellite locus.  The vast majority of larger interrupted 
microsatellite tracts detected by lobSTR have at ≥1 uninterrupted core microsatellite that can 
be detected by uSeq. 
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Figure 6.38: Pipeline loci by context.  Loci are shown colored according to their uSeq status.  (A) shows the number of loci across 
all contexts, (B) is an inset of (A) to visualize lobSTR/RepeatSeq-specific loci and unique uSeq contributions to exons and UTRs.  
The vast majority of reference microsatellite loci in all pipelines are in intron and intergenic regions, as are most loci unique to 
either uSeq or lobSTR.  uSeq detects almost 38,000 microsatellite reference loci in exons that are not detected by lobSTR or 
RepeatSeq.
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Figure 6.39: Motif lengths of reference microsatellite loci by uSeq status.  Most of the 
reference microsatellite loci unique to uSeq have motif lengths ≤3 bp. 
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Figure 6.40: Tract lengths of reference microsatellite loci by uSeq status.  Over 99% of 
reference microsatellite loci detected uniquely by uSeq have tract lengths ≤18 bp.  Short 
microsatellite tracts are detected with greater consistency by uSeq than by lobSTR or 
RepeatSeq. 
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Figure 6.41: Locus polymorphism at reference microsatellite loci by uSeq status.  Number of 
alleles is calculated as the number of non-null alleles called by the uSeq genotyper at each 
locus.  In approximately 60% of loci detected by all three pipelines, uSeq called >1 allele in 
the SSC dataset.  The SSC dataset had >1 allele called by uSeq in another 30% of loci unique 
to the uSeq reference microsatellite set.  This suggests that uSeq is capable of detecting 
extensive polymorphism that would not be observed in other pipelines. 
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Figure 6.42: Pairwise pipeline coverage comparison in an SSC individual.  Coverage was 
compared for all loci genotyped by both pipelines for each pairwise comparison.  The red 
dashed line in each graph is the x = y line.  Two pipelines with similar coverage will have 
most of their points centered on this line.  Part (A) shows pairwise coverage for uSeq and 
lobSTR; (B) shows pairwise coverage for uSeq and RepeatSeq; and (C) shows coverage for 
lobSTR and RepeatSeq.  The coverage scale is the same for all plots.  Although only one 
individual is shown here, the trends are consistent for all individuals.  Coverage for lobSTR 
is modified as described in the text.  Among all three pipelines, both uSeq and RepeatSeq 
have consistently higher coverage than lobSTR at shared loci.  RepeatSeq has comparable 
coverage to uSeq. 
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Figure 6.43: Mendel violation frequency for lobSTR, RepeatSeq, and uSeq pipelines in sample trios.  Part (A) shows the Mendel 
violation frequency for the proband trio, (B) shows the Mendel violation frequency for the sibling trio.  The shaded grey box 
shows the range of literature-estimated per-generation, per-gamete microsatellite mutation rates, as discussed in Introduction 
section 1.2.4.  Trio genotype confidence is the product of each trio member’s individual genotype confidence.  uSeq has 
consistently lower Mendel violation rates than lobSTR or RepeatSeq, suggesting it has higher genotyping accuracy.  The 
literature-reported microsatellite mutation rates are based on highly unstable and polymorphic marker microsatellite loci, and are 
likely an overestimate for most microsatellite loci in the genome.  Therefore, Mendel violations at shared loci called by any 
pipeline are likely to be false positives. 
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Figure 6.44: Mendel obedience scores for all SSC trios.  Most trios have Mendel obedience 
scores ≤1, and >99.9% of all trios have Mendel obedience scores <40.  This indicates that 
most trios genotyped at well-covered loci in the SSC dataset have inheritance patterns 
consistent with Mendelian inheritance. 
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Figure 6.45: Comparing Mendel obedience scores and kinship scores for a subset of SSC 
trios.  The green box represents the kinship and Mendel obedience thresholds used as 
thresholds for de novo microsatellite mutations.  The minimum Mendel obedience score 
considered was 40, and the minimum kinship score was 0.80.  We chose these threshold to 
limit our analysis to trios that had a high likelihood of violating Mendel obedience while also 
minimizing calls that have low kinship scores, which would suggest a likely false positive. 
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Figure 6.46: Recurrent de novo mutations are common when EM-estimated per-locus error 
rate is high.  The red line is the maximum error rate used in our analysis of Mendel 
violations, which is set to 0.17.  Any trio with a Mendel obedience score ≥40 and a kinship 
score ≥0.8 is considered for this analysis.  As the estimated noise rate increases, recurrent de 
novo mutations at the same locus (in orange and blue) become more common.  Recurrent de 
novo mutations at a locus are more likely to be false positives than truly independent 
mutation events. 
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Figure 6.47: Trio genotype quality metrics used to filter de novo mutations.  Trio genotype 
metrics were (A) trio genotype confidence, (B) trio null probability, (C) trio allelic goodness-
of-fit, and (D) trio noise goodness-of-fit.  The minimum trio genotype confidence considered 
was 0.99, minimum allelic-goodness-of-fit was 0.00001, minimum noise goodness-of-fit was 
0.001, and maximum marginal null probability was 0.01.  Before being filtered for genotype 
quality, potential de novo mutations had to have a Mendel obedience score ≥40, a kinship 
score ≥0.80, and an EM-estimated locus error rate ≤0.17. 
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Figure 6.48: The Mendel obedience score is a very robust means of identifying true de novo 
microsatellite mutations.  The red line is marks where the true positive and false positive 
rates are equivalent, which would provide a ROC AUC of 0.5.  A ROC AUC of 0.5 would 
imply that a score is incapable of distinguishing true and false positives.  A ROC AUC close 
to 1 indicates that the Mendel obedience score is able to robustly distinguish true and false 
positives.  The ROC AUC for the Mendel obedience score is >0.95, indicating that with the 
thresholds specified in the text, the Mendel obedience score is capable of distinguishing 
between true and false positive de novo mutations. 
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Figure 6.49: A validated de novo microsatellite mutation in a child with autism in an exon of KIF21A.  The mutation is at a T 
microsatellite, so the mutation in the child with autism would produce a frameshift.  The title provides the microsatellite locus 
context, gene name, location, noise rate, and family information.  The labels on the y-axis correspond to each family member.  The 
first line of the label defines the family member’s relationship to the proband and their gender; the second line provides the 
member’s genotype and confidence; and the last line provides the genotype allelic and noise goodness-of-fits.  A green box 
surrounds the reference allele and a red box surrounds the novel allele.  Within the table, each cell reports the observed coverage 
for a tract length in the corresponding individual.  If the coverage corresponds to a genotyped allele, the unbiased expected 
coverage estimator is reported underneath the observed coverage in parentheses.  A box with all trio metrics discussed in the 
manuscript is to the left of the coverage plot. 
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Figure 6.50: A validated de novo microsatellite mutation in a child with autism in an exon of CHD8.  This mutation introduces a 
frameshift mutation in a T microsatellite. 
 
 
 
 
 
282 
 
Figure 6.51: A validated de novo microsatellite mutation in a child with autism in an exon of the B4GALNT1 gene.  This mutation 
introduces a frameshift mutation in a C microsatellite. 
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Figure 6.52: A de novo microsatellite mutation in a child with autism in an exon of the HMMR gene.  This mutation introduces a 
frameshift mutation in an A microsatellite.  This de novo mutation failed to validate. 
 
 
 
 
 
284 
 
Figure 6.53: A validated de novo microsatellite mutation in a child with autism that spans the final exon and 3’ UTR of the 
GDPD4 gene.  This mutation might introduce a frameshift mutation. 
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Figure 6.54: A validated in-frame microsatellite de novo mutation in CPSF1 in an unaffected sibling.  Since the mutation is in-
frame, it is unlikely to have a phenotypic effect. 
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Figure 6.55: The first de novo mutation indicating a Robertsonian translocation on chromosome 22 in the proband of auSSC14395.  
The mother is homozygous for a 21 bp allele in an AGGGG microsatellite in an intron of SF3A1, while the father is homozygous 
for a 16 bp allele.  Like the mother, the child with autism is homozygous for the 21 bp allele.  
 
 
 
 
 
287 
 
Figure 6.56: The second de novo mutation indicating a Robertsonian translocation on chromosome 22 in the proband of 
auSSC14395.  The mother is homozygous for an 18 bp allele in a GT microsatellite in an intron of IL2RB, while the father is 
homozygous for a 16 bp allele.  Like the mother, the child with autism is homozygous for the 18 bp allele. 
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Figure 6.57: The third de novo mutation indicating a Robertsonian translocation on chromosome 22 in the proband of 
auSSC14395.  The mother is homozygous for a 22 bp allele in a GCA microsatellite in an exon of TNRC6B, while the father is 
homozygous for a 25 bp allele.  Like the mother, the child with autism is homozygous for the 22 bp allele. 
 
 
 
 
 
289 
 All 1 2 3 4 5 6 
GRCh37 12.01 (10) 
11.83 
(10) 
10.90 
(9) 
10.33 
(9) 
16.99 
(15) 
19.82 
(18) 
22.03 
(21) 
Intergenic 12.15 (10) 
11.71 
(10) 
10.92 
(9) 
10.34 
(9) 
17.19 
(15) 
19.95 
(18) 
22.20 
(21) 
Intron 11.87 (10) 
12.00 
(10) 
10.90 
(9) 
10.32 
(9) 
16.74 
(15) 
19.67 
(18) 
21.82 
(21) 
5' UTR 11.17 (9) 
11.09 
(9) 
10.42 
(9) 
10.62 
(9) 
14.56 
(13) 
18.30 
(17) 
21.78 
(20) 
3' UTR 11.07 (9) 
11.00 
(9) 
10.35 
(9) 
10.47 
(9) 
14.85 
(13) 
18.22 
(17) 
21.08 
(20) 
Exon 10.14 (9) 
8.33 
(8) 
8.48 
(8) 
10.38 
(9) 
12.85 
(12) 
15.94 
(15) 
21.05 
(20) 
miRNA 10.88 (10) 
11.00 
(11) 
10.00 
(9) 
11.33 
(9.5) 
16.33 
(16) 
15.00 
(15) n/a 
Table 6.1: Mean microsatellite tract lengths for each genomic context and motif length.  
Medians are in parentheses.  Each column is labeled by its motif length(s).  Tract lengths in 
exons tend to be shorter than elsewhere in the genome for frameshift-inducing motif lengths. 
 
 A C 
GRCh37 98.4% 1.6% 
Intergenic 98.5% 1.5% 
Intron 98.3% 1.7% 
5' UTR 95.2% 4.8% 
3' UTR 95.8% 4.2% 
Exon 85.2% 14.7% 
miRNA 100.0% 0.0% 
Table 6.2: Distribution of 1 bp microsatellite equivalence classes by context.  C 
microsatellites are more prevalent in exons than they are in the rest of the genome. 
 
 AC AG AT CG 
GRCh37 35.8% 30.1% 33.4% 0.7% 
Intergenic 34.3% 30.1% 35.0% 0.5% 
Intron 38.0% 29.9% 31.5% 0.7% 
5' UTR 38.8% 32.2% 21.9% 7.1% 
3' UTR 41.7% 30.0% 23.0% 5.3% 
Exon 33.9% 51.6% 4.1% 10.4% 
miRNA 47.6% 0.0% 52.4% 0.0% 
Table 6.3: Distribution of 2 bp microsatellite equivalence classes by context.  AG 
microsatellites are more common in exons than they are elsewhere, while AT microsatellites 
are depleted in exons.  CG microsatellites are more common in exons and UTRs than they 
are in the rest of the genome. 
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 AAC AAG AAT ACC ACG ACT AGC AGG ATC CCG 
GRCh37 10.4% 13.0% 25.2% 16.8% 0.1% 2.6% 9.3% 13.0% 8.1% 1.5% 
Intergenic 10.8% 13.9% 26.9% 15.6% 0.1% 2.4% 8.6% 12.3% 8.5% 0.9% 
Intron 10.4% 11.8% 24.6% 19.2% 0.1% 2.9% 9.1% 13.4% 7.6% 1.0% 
5' UTR 6.5% 7.8% 10.4% 9.9% 0.4% 1.5% 14.9% 18.8% 3.9% 25.8% 
3' UTR 7.2% 8.7% 12.3% 11.3% 0.3% 1.9% 15.2% 18.7% 4.9% 19.5% 
Exon 3.3% 15.4% 1.3% 10.3% 1.2% 1.1% 25.3% 20.1% 9.0% 13.2% 
miRNA 16.7% 0.0% 16.7% 16.7% 0.0% 0.0% 0.0% 33.3% 16.7% 0.0% 
Table 6.4: Distribution of 3 bp microsatellite equivalence classes by context.  Most notably, AAT microsatellites are much less 
common in exons than they are in the rest of the genome; while AGC, AGG, and CCG microsatellites are more common in exons 
and UTRs than they are in the rest of the genome. 
 
 Count 
Percent of well-
covered loci 
Percent of reference 
microsatellite loci 
GRCh37 133,300 100.0% 2.3% 
Intergenic 16,946 12.7% 0.5% 
Intron 76,426 57.3% 3.3% 
5' UTR 2,412 1.8% 15.2% 
3' UTR 2,944 2.2% 7.1% 
Exon 34,569 25.9% 83.3% 
miRNA 3 0.0% 8.8% 
Table 6.5: Summary of well-covered loci in SSC exome-capture dataset.  "Percent of well-covered loci" refers to the proportion of 
microsatellites from a particular context within the well-covered set.  “Percent of reference microsatellite loci” refers to the 
proportion of microsatellites from a particular context within the SSC well-covered set.  Although introns make up a large portion 
of the well-covered set, the vast majority of reference intron microsatellite loci are not observed.  Most exon reference 
microsatellite loci are observed in the set of well-covered loci. 
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ID Chr Pos1 Motif Gene name  Genotype2 Score3 Code4 
Novel 
allele Unique5 Seen6 Status7 
13602 chr1 3679939 GAG CCDC27 
9 9   9 9 
9 9 10 9 131.61 EPICp 10 UR Y Y 
14559 chr1 16360072 C CLCNKA 
8 8 8   8 
9 9 9 10 72.64 ISICs 10 CR N F 
11138 chr1 77042616 AAAG ST6GALNAC3 
19 19 19 19 
15 19 15 23 87.14 ISICs 23 CD N F 
12892 chr2 72742084 AC EXOC6B 
24 24 24 24 
26 26 26 22 71.08 ISDCs 22 CR N F 
12424 chr4 4115618 A NA 
8   8 10   8 
10 10   9 10 67.06 IPICs 9 CR N F 
11800 chr4 70825805 A CSN2 
9 9 9 9 
9 9 9 8 126.89 ISDCs 8 UR N Y 
13791 chr5 162917426 A HMMR 
9 9   9 9 
9 9 10 9 99.07 EPICs 10 UR N F 
12579 chr6 49701625 AC CRISP3 
12 12 12 12 
12 12 12 10 79.56 ISDCs 10 UR N Y 
12473 chr6 69785876 T BAI3 
9 9 9   9 
9 9 9 10 278.18 ISICs 10 CR N N 
14393 chr6 109954066 ATAG AKD1 
45 41 45 49 
37 53 41 37 111.59 3SICs 49 CR N *Y 
13412 chr7 141315261 C AGK 
8 8 8 8 
8 8 9 8 155.13 IPICs 9 CR N Y 
13579 chr8 97245323 A GTPBP4 
11 11 11 11 
11 11 10 11 101.00 IPDCs 10 CR N Y 
13418 chr9 27217784 T EIF3H 
8 8 8 8 
8 8 9 8 84.71 IPICp 9 CR N N 
11549 chr9 79999548 TGA CPSF1 
33 33 33 33 
33 36 33 30 226.46 ESDCs 30 CR N Y 
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ID Chr Pos1 Motif Gene name  Genotype2 Score3 Code4 
Novel 
allele Unique5 Seen6 Status7 
12497 chr10 70056620 A PBLD 
13 12 12 12 
14 12 14 12 66.25 ISNOs 12 CR N *F 
14573 chr11 379842 C B4GALNT4 
8   8   8 10 
10 10 10   9 67.12 ISICs 9 CR N F 
11657 chr11 836759 C CD151 
8 8 8 8 
8 8 8 9 69.27 ISICs 9 CR N N 
14333 chr11 26692595 TG SLC5A12 
17 17 17 31 
31 31 17 29 113.15 3SICs 29 CR N ? 
13529 chr11 71344184 TTG NA 
20 20 20 20 
20 20 17 20 73.97 NPDCs 17 CR N N 
12952 chr11 76928312 ATCT GDPD4 
20 20 20 20 
20 20 24 20 82.67 (E3)PICs 24 UR Y† Y 
12728 chr12 39763594 T KIF21A 
8 8 8 8 
8 8 9 8 67.24 EPICs 9 UR N Y 
14070 chr12 58025103 C B4GALNT1 
8 8 8 8 
8 8 9 8 63.52 EPICs 9 UR Y Y 
11552 chr12 118506328 TCC VSIG10 
26 26 26 26 
20 26 26 23 192.16 ESDCs 23 CR N Y 
13508 chr12 124362257 G DNAH10 
8 8   9 8 
9 9 11 8 65.05 IPICp 11 CR N F 
11138 chr13 26788216 ATC RNF6 
13 13 13 13 
13 13 13 10 274.19 ESDCs 10 UR Y Y 
14233 chr14 21859176 T CHD8 
8 8 8 8 
8 8 9 8 72.54 EPICs 9 UR Y‡ Y 
14021 chr16 8858701 CA ABAT 
22 22 22 22 
24 24 24 20 71.60 ISDCs 20 CR N ? 
11376 chr16 8858701 CA ABAT 
22 22 22 22 
24 24 24 20 75.03 ISDCs 20 CR N ? 
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ID Chr Pos1 Motif Gene name  Genotype2 Score3 Code4 
Novel 
allele Unique5 Seen6 Status7 
14231 chr16 27230338 GGA KDM8 
12 12 12 12 
12 12 12   9 181.33 ESDCs 9 UM Y Y 
12997 chr16 28631315 TG SULT1A1 
25 25 25 25 
19 19 19 21 80.64 ISICs 21 CR N F 
12864 chr16 70993832 T HYDIN 
8 8 8 8 
8 8 9 8 65.98 IPICs 9 UR N N 
14573 chr16 72089985 TG HP 
10 10 10 10 
10 10 10 11 144.64 ISICp 11 UR N F 
13166 chr16 88585146 TGGA ZFPM1 
38 38 38 38 
38 38 34 38 199.65 IPDCs 34 CD N F 
13692 chr16 88585519 TGGA ZFPM1 
19 19 19 19 
22 22 22 26 99.50 ISICs 26 CR N F 
12493 chr17 42937082 AC EFTUD2 
11 11 11 11 
11 11 12 11 231.89 IPICp 12 UR N Y 
14066 chr17 43227526 GGAGCT HEXIM1 
21 21 21 21 
21 21 27 21 66.40 EPICs 27 UR Y Y 
13807 chr19 3910998 TG ATCAY 
12 12 12 12 
12 12 10 12 90.06 IPDCs 10 CR N F 
14679 chr19 7184372 TTG INSR 
10 10 10 10 
10 10 11 10 168.01 EPICp 11 UR Y F 
11436 chr19 45912490 AAG CD3EAP 
20 20 20 20 
20 20 23 20 111.84 EPICs 23 UD Y Y 
12723 chr21 9907174 CA NA 
13 13 13 13 
13 13 12 12 68.86 NPDCp 12 CR N ? 
12861 chr21 10969895 ATGG TPTE 
32 32 32 32 
32 32 36 32 76.35 IPICs 36 CR N F 
13508 chr21 14771784 AC NA 
9 9 9   9 
9 9 9 11 70.92 NSICs 11 CI N N 
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ID Chr Pos1 Motif Gene name  Genotype2 Score3 Code4 
Novel 
allele Unique5 Seen6 Status7 
13620 chr22 20920814 CAG MED15 
36 36 36 36 
36 36 36 39 63.72 ESICs 39 CR N *Y 
14395 chr22 30741231 AGGGG SF3A1 
21 16 21 21 
21 16 21 16 254.22 IPNOs 21 CD N *Y 
14395 chr22 37531258 GT IL2RB 
18 16 18 16 
18 16 18 18 126.51 IPIOs 18 CR N *Y 
Table 6.6: De novo microsatellite mutations above the validation threshold.  1Microsatellite start positions are provided in the 
GRCh36 human genome assembly.  2”Genotype” provides the family genotype at the microsatellite locus.  There is one line for 
each allele.  In each line, the numbers correspond to the microsatellite tract lengths in the mother, father, proband, and sibling, 
respectively.  3Mendel obedience scores for the trio containing the de novo mutation.  4This code describes the de novo mutation.  
The first character is “E”, “I”, “3”, “5”, or “N” for a de novo mutation in an exon, intron, 3’ UTR, 5’ UTR, or intergenic region, 
respectively.  If a locus spans multiple contexts, they are coded in parentheses.  The second character is either “P” or “S” for a de 
novo mutation in a proband or sibling.  The third character describes the de novo indel status—“I” is an insertion, “D” a deletion, 
and “N” a mutation that is identical to the reference tract length.  The fourth character describes the mutation as a commission (C) 
or an omission (O).  The final character indicates whether the mutation is due to a slippage event (s), or point mutation (p).  
5”unique” describes whether the mutation is unique in the SSC cohort or dbSNP v138.  The first character describes whether the 
mutation is unique (U) or common (C) in the SSC cohort.  The second character describes whether a mutation in the microsatellite 
is found in dbSNP v138.  “R” is a mutation that is not found in dbSNP, “I” is a dbSNP insertion, “D” is a dbSNP deletion, and 
“M” is a dbSNP missense mutation.  6The “Seen” field describes whether the de novo mutation has been detected previously.  
Unless noted otherwise, mutations were detected in unpublished results using a GATK-based pipeline or Scalpel.  7”Status” 
describes the validation status of each de novo mutation.  “Y” and “N” define valid and invalid mutations.  “F” is failed validation, 
and “?” is an ambiguous validation result.  Finally, the “*” marks de novo mutations that were submitted for validation despite not 
passing the appropriate thresholds. 
†Iossifov, et al. Neuron 2012 
‡O’Roak, et al. Science 2012 
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 Exon Intergenic Intron 3' UTR Total 
Proband 9 3 11 0 23 
Sibling 5 1 15 1 22 
p 0.42 0.63 0.55 1 1 
Table 6.7: Number of de novo mutations in children with autism and their siblings by 
context.  P-values are derived from a two-sided binomial exact text with an expected 
probability of 0.5.  No bias in the rate of de novo mutations between children with autism and 
their siblings is observed for any context. 
 
 Exon Intergenic Intron 3' UTR Total 
Valid 12 0 8 0 20 
Invalid 0 2 4 0 6 
Unclear 0 1 2 1 4 
Failed 2 1 12 0 15 
Table 6.8: Validation status by context for de novo mutations with a Mendel obedience score 
≥63.  Most of these de novo mutations validate or failed to validate. 
 
 Deletion Insertion NA Total 
Proband 4 12 1 17 
Sibling 9 11 1 21 
p 0.26 1 1 0.63 
Table 6.9: Insertions and deletions by child.  P-values are derived from a two-sided binomial 
exact text with an expected probability of 0.5.  A value of “NA” means that the novel allele 
has the same tract length as the reference allele.  No bias is observed in the rate of de novo 
mutations between children with autism and their siblings for insertions or deletions. 
 
 Unique Not unique Total 
Proband 8 9 17 
Sibling 4 17 21 
p 0.39 0.16 0.63 
Table 6.10: Novel allele unique status by child.  P-values are derived from a two-sided 
binomial exact text with an expected probability of 0.5.  No bias is observed in the rate of de 
novo mutations between children with autism and their siblings for unique or common 
mutations. 
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 Commission Omission Total 
Proband 15 2 17 
Sibling 20 1 21 
p 0.5 1 0.63 
Table 6.11: Commissions and omissions by child.  P-values are derived from a two-sided 
binomial exact text with an expected probability of 0.5.  No bias is observed in the rate of de 
novo mutations between children with autism and their siblings for commissions or omission. 
 
 Deletion Insertion Total 
Proband 0 6 6 
Sibling 2 0 2 
p 0.5 0.03 0.29 
Table 6.12: Validated unique de novo mutations.  P-values are derived from a two-sided 
binomial exact text with an expected probability of 0.5.  Significant p-values are in bold.  
Children with autism are significantly more likely to have a unique de novo microsatellite 
expansion than their siblings (p=0.03). 
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7 Conclusions and Perspectives 
7.1 A role for microsatellite mutation in autism incidence 
7.1.1 The role of de novo microsatellite mutations in autism 
This work presents the first evidence suggesting that microsatellite mutations may 
play a role in autism, and is among the first evidence of microsatellite mutations playing a 
role in a complex human disease.  Children with autism are significantly enriched for unique 
de novo insertions as compared to their siblings, and while not statistically significant, we 
only observe microsatellite frameshift mutations in children with autism. 
While frameshift mutations have an obvious effect on protein function, the effects of 
short in-frame insertions are less obvious.  If these mutations do have a role in the autism 
phenotype, perhaps the strongest parallel is to the disease etiology of OPMD.  As discussed 
in the introduction, small expansions of the GCG trinucleotide repeat in the first exon of 
PABPN1, which code for a polyalanine stretch, lead to the occurrence of OPMD (Brais, et al. 
1998).  Just 1 – 3 extra GCG repeats distinguish healthy individuals from those affected by 
OPMD.  These small expansions lead to misfolding and aggregation of the PABPN1 protein, 
which impair the function of the ubiquitin-proteasome pathway and inhibit molecular 
chaperone function (Calado et al. 2000; Abu-Baker et al. 2003).  While many short in-frame 
microsatellite mutations may be harmless, some of these mutations can have significant 
phenotypic effects. 
 
 
 298 
7.1.2 Expanding the analysis of the SSC 
 The current study exploited exome sequencing data from a significant portion of the 
SSC—875 families—but can be strengthened by incorporating data from 118 additional SSC 
quads and 257 SSC trios which have been processed at CSHL and WUGSC.  We would 
expect this data to lend more support to our observations of a unique insertion bias in 
children with autism.  With these additional families, we may observe a statistically 
significant bias for de novo frameshift mutations in children with autism.  Previous studies of 
the SSC exome data in the Wigler lab demonstrated a significant enrichment of de novo 
mutations in FMRP-associated genes (Iossifov et al. 2012).  Although an expanded analysis 
could reveal a similar trend for de novo microsatellite mutations, there is no statistical 
enrichment for FMRP-associated genes in our study. 
Collaborators of the Wigler lab have also sequenced SSC exome datasets, which are 
available for analysis.  Sequencing performed in the Eichler lab on the SSC collection would 
add 158 parent-proband trios and 31 quads.  The data generated by the Eichler lab has a mix 
of 50- and 76-bp paired end reads—shorter reads may lead to fewer detected microsatellites 
in this dataset (O'Roak et al. 2012b).  Sequencing performed in the State lab would add 225 
quads and 25 trios to our analysis.  As with the Eichler sequencing data, care must be taken 
when comparing results among datasets—in addition to having performed sequencing on 
Illumina’s GAIIx and HiSeq 2000 sequencing platforms with 76- or 101-bp paired-end reads, 
the State lab also used two different exome capture kits.  One is the NimbleGen EZExome 
V2.0 that has been used by the other studies, while the other is a custom array designed by 
the State lab (Sanders et al. 2012).  Shorter read lengths will hamper the observation of some 
microsatellite tracts, and each exome capture kit will have its own unique biases when 
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capturing alleles of varying lengths.  While uSeq should be sufficiently robust to call 
genotypes using HTS data generated from diverse experimental protocols, it is probably wise 
to call genotypes separately for data from each lab.  This will ensure that the per-allele 
expected coverage parameters, allele bias parameters, and locus noise parameters are 
protocol-specific. 
7.1.3 Transmitted microsatellite variants in autism 
In the current study, we have not evaluated the role of transmitted microsatellite 
polymorphisms in the autism incidence.  Given the size of our study population and the 
accuracy of our genotyping, this analysis is possible.  An initial analysis might leverage a 
statistic similar to the transmission disequilibrium test to identify microsatellite alleles that 
are more common in children with autism than their siblings.  Given the gender bias 
observed in autism, it would be reasonable to extend the analysis to the evaluation of gender-
specific biased variant transmission.  This analysis could identify alleles that have a sex-
specific effect on autism risk.  The tools for this analysis have yet to be developed, but the 
statistical tests may be simpler than those used to identify strong de novo microsatellite 
mutation candidates in this study. 
7.2 An expanded role for microsatellites in human disease 
7.2.1 Studying microsatellite mutations in cancer 
If past research is any indication, there is a broad role for microsatellite mutations in 
human disease etiology.  Most studies of microsatellite mutations in cancer describe 
frameshift mutations in mononucleotide microsatellites that disrupt the function of tumor 
suppressor genes (see, for example, Markowitz et al. 1995; Parsons et al. 1995; Malkhosyan 
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et al. 1996; Miyaki et al. 1997; Rampino et al. 1997).  The exception to this category is 
AIB1—the mutations are in-frame and the mechanism by which they increase breast cancer 
risk remains unclear (Kadouri et al. 2004).  Many mutations in tumor suppressor genes occur 
in short microsatellite tracts with 1 bp motifs—the mutations inactivating TGFβRII and BAX 
occur in a 10 bp A microsatellite tract and an 8 bp G microsatellite tract, respectively 
(Parsons et al. 1995; Rampino et al. 1997).  These mutations have only been characterized in 
tumors exhibiting MMP, implying that these short tracts may be generally stable, unless 
components of the MMR pathway are inactivated.  Of the de novo mutations we observe in 
our study, many are at loci whose reference lengths are between 8 and 10 bp.  This is despite 
the fact that there is no reason to assume that MMP is prevalent within our study cohort.  
Therefore, de novo mutations at otherwise stable short microsatellite loci may play a more 
significant role in cancer incidence than previous studies have indicated.  The effect of a 
particular microsatellite mutation can also depend on the genetic background of an affected 
individual—for instance, CAG expansions in AIB1 increase the risk of breast cancer in 
BRCA1 carriers, but not BRCA2 carriers (Kadouri et al. 2004).  The extent to which 
microsatellite mutations play a role in cancer is far from being completely defined. 
7.2.2 Studying microsatellite mutations in neurological diseases and other 
genetic disorders 
In neurological disorders—such as Huntington’s disease, Fragile X syndrome, or 
ALS—monogenic, highly penetrant microsatellite mutations act in a variety of ways to 
disrupt normal protein function (Kremer et al. 1991; Pieretti et al. 1991; Macdonald et al. 
1993; DeJesus-Hernandez et al. 2011; Renton et al. 2011).  Many neurological disorders, 
including myotonic dystrophy and SCA1, are autosomal dominant, which could indicate a 
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disease model for other heterozygous microsatellite mutations (see, for example, Mahadevan 
et al. 1992; Orr et al. 1993).  Disease-causing microsatellite mutations are not limited to 
exons—Fragile X is caused by a CGG repeat expansion in the 5’ UTR of FMR1 and 
Friedreich ataxia is caused by a GAA repeat expansion in the first intron of FXN (Kremer et 
al. 1991; Campuzano et al. 1996).  Microsatellite mutations in non-exonic regions may have 
a variety of phenotypic effects—for example, they can alter spacing between cis-regulatory 
elements such as transcription factor binding sites or splicing enhancers, or they can provide 
additional binding sites for regulatory molecules.  Sequence identity within a microsatellite 
tract in a particular haplotype can dramatically affect tract stability, as has been shown in 
FMR1 and SCA1 (Chung et al. 1993; Eichler et al. 1994; Chong et al. 1995).  The 
introduction of variant repeats into an ancient microsatellite tract in some genetic 
backgrounds, or their removal in others, is almost certain to play a role in disease incidence 
in uncharacterized microsatellite diseases.  Microsatellite mutations may also affect gene 
function in novel, yet unimagined ways.  It is almost certain that the full complement of 
diseases influenced by microsatellite mutations have yet to be characterized. 
7.2.3 Somatic microsatellite mutations 
Microsatellite instability is not limited to the germline.  Somatic microsatellite 
instability plays an obvious role in MMP cancers, but intact MMR machinery does not 
guarantee somatic microsatellite stability.  Somatic microsatellite instability has also been 
observed at disease loci in male germline cells, peripheral blood, and within specific tissues 
in the brain (see, for example, Chong et al. 1995).  Any disease caused by a mutant 
microsatellite allele can be caused by somatic mutation.  The elevated mutation rate 
 
 
 302 
suggested by many early studies of microsatellite loci rate at microsatellite loci suggests that 
these loci may play a significant role in sporadic disease incidence and require careful study. 
Somatic microsatellite mutations are also a rich source of intracellular variation that 
can be used to recover high-resolution developmental lineages.  Microsatellite mutations at a 
few hundred loci have been sufficient to distinguish developmental lineages in normal mice 
(Salipante and Horwitz 2006).  Somatic microsatellite mutations may be the only source of 
mutations sufficiently frequent enough to create measurable intracellular variation.  As has 
been made apparent in this study, microsatellite instability varies enormously among loci, so 
care needs to be taken that a set of loci capable of generating sufficient polymorphism are 
observed in the cells being analyzed. 
7.3 Understanding microsatellite stability 
Understanding the role of microsatellite mutations in human disease depends on 
in-depth knowledge of the factors influencing the stability of individual microsatellite loci.  
Several studies have already demonstrated that the per-generation, per-gamete microsatellite 
mutation rate can vary widely between loci, but many of the factors affecting microsatellite 
mutation remain poorly understood.  Microsatellite motif length is inversely correlated with 
mutation rates.  Motif composition clearly has an effect on microsatellite mutation rate, but 
that relationship is still poorly defined.  While it is clear that variant repeats stabilize 
microsatellite tracts, many studies identify the longest uninterrupted microsatellite sequence 
as the primary determinant of microsatellite stability for these loci, which could imply that 
the vast majority of slippage mutations occur in uninterrupted microsatellite sequence.  
Additionally, in our study, microsatellite loci with identical composition and identical 
reference tract lengths have vastly different levels of polymorphism within our study 
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population.  These differences may be due to the pressure of selective forces on particular 
microsatellite loci, stochastic variation between loci, or factors affecting microsatellite 
stability that have yet to be defined.   
Leveraging uSeq and current sequencing technology, we can thoroughly examine 
these factors in ways that were impossible until now.  Using the SSC study described here—
and other population-scale studies like it—we can investigate microsatellite polymorphism 
and mutation throughout the human genome.  These studies will allow us to better identify 
microsatellite loci that are likely to mutate, as well as aid in identifying haplotypes that are 
particularly stable or unstable.  This information will be invaluable in understanding the roles 
microsatellites may play in human disease, and will serve as an important tool in furthering 
our understanding of the dynamics of microsatellite instability. 
7.4 Population genetics of microsatellites 
Population genetics has been an invaluable tool in the advancement of the scientific 
community’s understanding of microsatellite loci.  Some of the early estimates of the per-
generation, per-locus microsatellite mutation rate were made based on extensions of 
population genetics to microsatellite loci (Brinkmann et al. 1998).  These same analyses may 
refine our estimates of microsatellite mutation rates based on polymorphism in the SSC 
dataset, and the same can be done in future studies.  Population genetics may also identify 
microsatellite loci that violate the neutral theory of natural selection.  This could be 
invaluable in identifying evidence of purifying selection at microsatellite loci, particularly 
with respect to coding regions. 
As our understanding of microsatellite polymorphism deepens, the population genetic 
analyses possible using microsatellite loci will also expand.  Population genetic analyses of 
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microsatellite loci have already enabled many fascinating studies, including support for the 
out of Africa hypothesis on the origin of modern humans and selective sweeps in natural 
populations of Drosophila melanogaster (Bowcock et al. 1994; Jorde et al. 1995; Jorde et al. 
1997; Schlötterer et al. 1997; Di Rienzo et al. 1998).  In tandem with other sources of genetic 
information, microsatellites can further develop our knowledge of the genetic histories of 
humans, other species, and complex interplay of humans with the biological systems with 
which they interact. 
The ability to genotype microsatellite loci throughout the genome in large populations 
enables a shift towards broader strategies for identifying genetic associations between 
microsatellite mutations and various phenotypes, including the family-based study design 
demonstrated in this project as well as GWAS.  However, the assumptions of linkage 
disequilibrium that are essential to GWAS studies need to be revisited for microsatellite loci.  
Alleles at polymorphic microsatellite loci are shared by geographically distinct populations, 
which might imply that microsatellite loci must be studied directly to call genotypes, and 
cannot be inferred from nearby SNPs in linkage disequilibrium (Bowcock et al. 1994).  
7.5 The importance of genome-wide microsatellite genotyping 
7.5.1 uSeq can detect arbitrarily small microsatellites 
Genome-wide microsatellite analyses are only possible with the recent development 
of algorithms and pipelines that leverage high-throughput sequencing data and address 
specific algorithmic challenges posed by microsatellite loci.  uSeq is a potent and powerful 
method for these types of analyses, and has several unique characteristics that make it 
superior for studying microsatellite mutations in large populations.  uSeq can detect 
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microsatellites with arbitrary tract length and repeat number thresholds—while our current 
study is limited to microsatellites with a tract length of at least 8 bp and 3 repeats of the same 
motif, microsatellite mutations can still occur in shorter tracts (Huang et al. 1996; Greene and 
Jinks-Robertson 1997).  Although the uSeq detection algorithm may be limited by the 
parameters for minimum tract length and motif length range, future implementations of uSeq 
can address this challenge easily.  Detecting short microsatellite tracts is particularly 
important in cancer—microsatellite mutations have been observed in tracts as short as 2 bp in 
the APC gene in both MMP and non-MMP tumors and mutations to 8 bp mononucleotide 
tracts in MSH3 and MSH6 are frequently deletions (Huang et al. 1996; Malkhosyan et al. 
1996).  In comparison to other microsatellite genotyping algorithms, uSeq can survey many 
more loci, and is the only pipeline to leverage population-level information to call highly 
accurate genotypes and identify strong de novo mutation candidates. 
7.5.2 uSeq is the only microsatellite pipeline capable of identifying de novo 
microsatellite mutations 
The ability to identify these de novo mutations is the result of the algorithms we have 
developed and implemented as part of the uSeq pipeline.  Although lobSTR and RepeatSeq 
both model microsatellite slippage errors as part of their genotyping methods, only uSeq has 
a locus-specific error model, which provides superior genotype-calling accuracy.  As is 
evident in our study, perfect microsatellites with identical motif and tract lengths can have 
widely varying error rates.  The logistic regression error model used by lobSTR and the 
empirically derived Bayesian model selection error model used by RepeatSeq are simply not 
equipped to address this variability.  Indeed, when comparing Mendelian inheritance 
violations among pipelines, many of the violations called by lobSTR and RepeatSeq are at 
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loci that the uSeq population EM identifies as being particularly noisy.  uSeq is also the only 
genotyper to define a per-allele, per-person expected coverage, which is essential for 
determining whether the observed coverage in an individual is sufficient to call a confident 
bi-allelic genotype.  uSeq is the only genotyper to consider allele bias, which is an important 
tool when distinguishing between noise and signal at microsatellite loci, and is particularly 
important when identifying de novo mutations.  While uSeq’s allele bias model was designed 
to address allele biases due to varying affinities of exome capture probes for microsatellite 
indels, it should be able to model allele bias arising from any number of sources, such as tract 
length or GC content.  uSeq’s superior genotyping accuracy is evident in its ability to identify 
de novo microsatellite mutations with high specificity and good precision.  While RepeatSeq 
and lobSTR have admirable genotyping accuracy, neither pipeline is capable of accurately 
identifying de novo microsatellite mutations (Gymrek et al. 2012; Highnam et al. 2013). 
7.5.3 uSeq is fast, requires relatively little disk space, and is highly 
parallelizable 
uSeq is rapid and efficient enough to use on large datasets, as demonstrated in its 
application to a 3,500-person exome sequencing study on a large portion of the SSC.  The 
complete analysis of the SSC dataset took less than 2 weeks on a 14-node computer cluster 
with 24 cores per node.  Less than one week of that time was spent on detection and 
alignment.  If we were to attempt the same analysis with lobSTR, which took ~19 hours on 
average to detect and align microsatellites per individual in one family using 2 cores, it 
would take more than 2 weeks of dedicated time on a similar cluster just to perform detection 
and alignments.  If a dedicated cluster were used to sort the alignments and call allelotypes, 
only 2 hours of time would be needed.  Since RepeatSeq does not perform its own 
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alignments, it would only take approximately 3 hours of dedicated cluster time to obtain 
genotypes, although the alignment algorithms recommended in the RepeatSeq manuscript 
can take 1 – 2 days to map just 43 million reads (Highnam et al. 2013).  uSeq output is not 
overly burdensome—approximately 2.1 GB of data is kept for each SSC individual 
processed (~7 TB total for 3,500 people), and the genotyper output for 3,500 individuals 
takes an additional ~25 GB.  uSeq performs well on large populations since it has low 
memory overhead and is primarily single-threaded, which allows for a highly parallelizable 
pipeline appropriate for use on large populations.  Neither RepeatSeq nor lobSTR have been 
tested in large populations, and the memory or CPU demands of either pipeline may limit 
either pipeline’s ability to efficiently process sequencing data from very large datasets. 
7.5.4 Improvements to uSeq 
uSeq can still be improved and expanded in several meaningful ways.  Among the 
most obvious improvements would be enabling detection of interrupted microsatellites and 
improving mapping accuracy for reads with 5’ or 3’ truncated microsatellites, as described in 
the methods section.  Adding imperfect microsatellite detection may increase the number of 
observable microsatellite loci, but based on previous work relating microsatellite stability to 
microsatellite sequence identity, these loci may not add much polymorphism (see, for 
example, Weber 1990; Henderson and Petes 1992; Eichler et al. 1994; McIver et al. 2011).  
Improving microsatellite mapping is not expected to dramatically alter coverage at reference 
microsatellite loci.  However, improved mapping would enable detection of novel 
microsatellite alleles not present in reference genomes, which could reveal 
population-specific microsatellite loci and could help elucidate the mechanisms of 
microsatellite emergence in the genome. 
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uSeq’s de novo mutation detection is currently geared towards quads, since this is the 
pedigree structure of the SSC data analyzed.  As we expand our analysis of the uSeq dataset 
to include trios, de novo detection will be modified to allow for arbitrary pedigree structures, 
which will expand uSeq’s utility in disease and population genetic studies.  Similarly, if uSeq 
is applied to matched tumor-normal data in cancer studies or sequencing data from different 
organs within one individual, other arbitrary structures defining the relationships between 
samples can be implemented. 
uSeq is currently not publicly available, although it can be made available on request.  
In the very near term, uSeq will be made available for download, which will encourage new 
development and applications.  Importantly, although uSeq has only been tested on human 
sequencing data, in theory, its function is independent of organism.  Applications to 
non-human data will help identify any species-dependence that may need to be resolved. 
7.6 Leveraging population data to call genotypes 
 One of the primary focuses of this project has been the development of methods for 
accurate microsatellite genotyping by leveraging population-level data to estimate per-allele, 
per-person expected coverage; per-allele bias; and per-locus noise parameters.  These 
considerations are not limited to microsatellite loci. 
Expected coverage is a relevant genotyping parameter in many experimental setups.  
In any capture experiment, expected coverage will vary among loci due to many factors, 
including the location of a target site relative to its capture probe; the capture probe affinity 
for its target region; and variability between experiments, even if they use the same protocol.  
In whole-genome studies, expected coverage can vary among loci depending on the 
uniqueness of a particular genomic region, its GC content, and experimental variability.  
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Genotyping algorithms must consider the likelihood that a particular locus is bi-allelic, which 
is made possible by having an estimator for expected coverage.  Even if a genotyper is not 
attempting to call CNPs, a bi-allelic genotype only makes sense if there is sufficient evidence 
that there are only two alleles at a locus.  In particular, when the detection of a particular 
genomic feature is not trivial, as is the case with indels, a good algorithm should consider the 
likelihood that it missed relevant data.  In uSeq, this uncertainty is reflected in the null 
genotype probability.  If expected per-allele coverage can be calculated accurately, genotypes 
with uncharacteristically low coverage can considered with the appropriate level of 
skepticism. 
As demonstrated in this thesis, indels can have a significant, unpredictable effect on 
observed coverage in targeted sequencing experiments.  Failure to consider allele bias will 
lead to inaccurate genotype calls, and will reduce the sensitivity and specificity of any 
downstream analyses.  For example, before implementing the uSeq allele bias model, many 
de novo calls were made in trios where a parent had lower than expected coverage for the 
novel allele.  In many of these cases, the low parental coverage was due to inefficient capture 
of the novel allele, and was readily apparent upon examination of that allele throughout the 
SSC study population.  Similarly, truly novel alleles can be missed when bias is not 
considered, particularly if that allele has less coverage than expected.  If the approach taken 
in uSeq is any indication, a robust allele bias model depends on having an accurate expected 
coverage model.  Allele bias may be an important consideration in whole-genome 
sequencing studies as well.  Even without the additional biases contributed by targeted 
capture approaches, the efficiency with which different indels are observed in sequencing 
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data might be expected to vary.  This could be due to allele length, or other factors that have 
yet to be characterized. 
Locus-specific error rates have a clear mechanism explaining their variability when 
considering microsatellite loci, but that does not limit their utility to microsatellite 
genotyping.  Sequencing technologies have systematic errors that are locus- or sequence-
specific—for instance, a 2011 study characterized two sources of sequence-specific error on 
Illumina’s Genome Analyzer II (Nakamura et al. 2011).  These systematic errors can vary 
between platforms, and could vary depending on the particular chemistry or protocol used to 
generate sequencing data.  Similarly, particular regions of the genome may have increased 
rates of mutation.  This is most apparent in the case of cytosine deamination.  Rather than 
defining locus-specific error models empirically for each combination of protocol, platform, 
and chemistry, the general approach used here to estimate locus-specific error rates given 
population-level sequencing data may prove to be simpler to implement and more accurate. 
7.7 Conclusion 
In the course of this thesis, we have developed a novel microsatellite pipeline that can 
readily detect and map reads with microsatellite indels and accurately call genotypes using a 
sophisticated genotyping model that leverages the richness of the data we have from our 
study population.  This approach has proven accurate enough to identify de novo mutations 
in families with sporadic autism.  Previously, the only way to identify de novo mutations at 
microsatellite loci was to target specific loci for analysis.  This approach was only feasible on 
a few thousand loci at most, and made it impossible to look for de novo microsatellite 
mutations in the complete exome, let alone genome-wide.  This is the first study that has 
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been able to survey microsatellites on such a scale in an unbiased manner and accurately 
identify de novo mutations.   
Using this ability, we have been able to identify a role for microsatellite mutations in 
autism incidence.  We expect the evidence for this association to be strengthened as we 
expand our analysis.  More broadly, the contribution of microsatellites to human disease and 
general phenotypic variation has been hampered for the last ten years by the absence of 
highly accurate HTS microsatellite genotyping methods.  uSeq is the most appropriate 
microsatellite genotyping pipeline for these analyses.  It provides significant advantages for 
microsatellite genotyping, both in terms of its accuracy and the scope of the genomic 
microsatellite landscape it can cover.  The door is now open to a much greater and nuanced 
understanding of microsatellite function.  Given the variety of effects attributed to 
microsatellite mutations over the last 20 years, it is exciting to consider what the future holds 
in store as we enter a new age of genome-wide microsatellite studies. 
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